Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003434	pf-prot	g/l (g/l)	4292	6146	0.13%
3003434	pf-prot	— (—)	661	782	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure and bmi 25plus

758

1012

5.37

321.44

1.6

1.4

27.75

37.39

g/l

60.00

658

936

Persons encountering health services for specific procedures and health care

1440

2757

3.28

321.11

1.5

1.4

32.35

33.75

g/l

2.98

1292

2481

Malignant neoplasm of respiratory system and intrathoracic organs

705

1330

5.18

316.00

1.5

38.67

29.89

g/l

57.87

659

1171

Bacterial Sepsis

938

2155

4.00

307.78

1.6

1.4

28.96

33.87

g/l

21.51

819

1956

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

850

971

7.88

307.65

1.5

38.59

29.57

g/l

56.94

799

858

All-cause Heart Failure

1484

1971

5.68

307.65

1.6

1.4

26.85

36.60

g/l

115.35

1271

1827

Heart failure, not strict

1562

1884

5.91

307.65

1.6

1.3

28.78

37.85

g/l

99.12

1362

1764

Asthma, excluding more controls

604

300

10.85

307.65

1.5

1.2

32.73

31.10

g/l

1.17

554

271

ILD differential diagnosis

947

537

8.96

307.65

1.5

1.2

34.25

27.87

g/l

19.26

865

456

Renal tubulo-interstitial diseases

1389

3008

3.61

307.65

1.6

1.4

29.39

34.46

g/l

32.82

1206

2751

Influenza and pneumonia

1759

2316

5.10

307.65

1.5

1.4

32.86

33.91

g/l

1.97

1573

2118

Heart failure,strict

1409

1495

7.14

307.65

1.6

1.3

26.96

37.60

g/l

120.04

1209

1399

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1764

2404

5.28

307.65

1.5

1.4

32.95

33.77

g/l

1.36

1580

2188

Lung cancer and mesothelioma

801

291

25.78

307.65

1.5

1.3

38.66

27.24

g/l

39.03

755

247

Asthma, unspecified (mode), excluding more controls

505

289

13.93

307.65

1.5

1.2

32.74

31.05

g/l

1.17

454

261

Pneumonia, organism unspecified

1691

2283

5.50

307.65

1.5

1.4

32.84

33.93

g/l

2.09

1524

2089

Pyothorax

377

213

23.21

307.65

1.6

1.5

37.09

31.22

g/l

7.92

351

189

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

678

858

7.02

307.65

1.4

1.5

38.54

29.06

g/l

53.27

636

751

Excluding asthma or asthma-COPD overlap

950

540

8.94

307.65

1.5

1.2

34.32

27.92

g/l

19.43

866

459

All pneumoniae

1769

2369

5.28

307.65

1.5

1.4

32.93

33.77

g/l

1.42

1581

2161

Heart failure and antihypertensive medication

677

494

9.49

307.65

1.7

1.4

27.48

38.06

g/l

48.29

589

459

Non-ischemic cardiomyopathy

749

1097

5.87

307.65

1.6

1.4

27.93

36.57

g/l

51.06

644

1022

Other medical care

948

1941

4.96

307.65

1.5

1.4

34.66

32.64

g/l

4.36

880

1733

1628

2005

5.21

307.65

1.5

1.4

32.91

33.52

g/l

0.80

1467

1826

COPD differential diagnosis

948

537

8.97

307.65

1.5

1.2

34.26

27.87

g/l

19.31

866

456

COPD (mode)

546

409

10.95

307.65

1.4

1.3

33.45

27.57

g/l

12.01

478

341

Renal failure

1046

2421

4.11

307.65

1.6

1.4

26.73

33.39

g/l

44.68

890

2195

Asthma (only as main-diagnosis), excluding more controls

503

300

10.09

307.65

1.5

1.2

32.40

31.10

g/l

0.82

458

271

Bacterial infection, other or unspecified

1139

2285

4.65

307.65

1.5

1.4

31.29

33.56

g/l

6.33

1029

2054

Other bacterial diseases

1596

2781

4.05

307.65

1.5

1.4

31.19

34.29

g/l

13.89

1432

2512

Other pulmonary diagnosis

974

540

9.17

307.65

1.5

1.2

34.32

27.92

g/l

19.45

892

459

Pneumonias (Asthma/COPD co-morbidities)

1770

2371

5.30

307.65

1.5

1.4

32.99

33.79

g/l

1.31

1582

2161

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

539

666

8.21

307.65

1.4

1.5

39.00

28.81

g/l

48.21

506

578

Suppurative and necrotic conditions of lower respiratory tract

415

263

19.61

307.65

1.6

1.5

36.77

31.22

g/l

8.07

386

238

Heart failure, strict

1534

2003

5.77

307.65

1.6

1.4

26.79

36.58

g/l

118.86

1312

1856

Other diseases of pleura

2776

1297

21.65

307.65

1.6

1.2

35.18

28.53

g/l

52.09

2602

1086

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1628

2005

5.21

307.65

1.5

1.4

32.91

33.52

g/l

0.80

1467

1826

Asthma, unspecified (mode)

530

513

8.31

307.65

1.5

1.2

32.72

27.89

g/l

9.36

477

436

Other pleural conditions

1152

304

52.41

307.65

1.8

1.2

35.35

27.51

g/l

19.22

1081

258

Pleural effusion

2044

473

63.37

307.65

1.7

1.2

36.22

28.37

g/l

29.88

1931

392

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

934

1481

5.77

307.65

1.4

1.5

36.56

30.06

g/l

36.04

871

1298

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1166

3119

3.56

307.65

1.6

1.4

34.31

32.15

g/l

6.24

1067

2793

Abnormal findings on diagnostic imaging of lung

1022

2631

3.91

307.65

1.5

1.4

34.63

31.75

g/l

9.50

936

2351

Dyspnoea

1479

3114

3.72

307.65

1.6

1.4

32.31

33.22

g/l

1.60

1343

2790

Diseases of the respiratory system

679

512

6.73

306.23

1.5

1.2

33.52

28.87

g/l

9.43

614

439

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1394

3225

3.15

304.41

1.5

1.4

30.47

34.01

g/l

16.58

1222

2934

Other heart diseases, wide

1043

1683

3.90

297.31

1.5

1.3

31.21

38.20

g/l

43.29

941

1575

Later onset COPD, excluding more controls

397

332

9.70

295.03

1.5

1.2

31.83

26.21

g/l

9.18

349

274

Implicit Sepsis

1170

2742

3.39

292.54

1.5

1.4

29.05

34.53

g/l

32.43

1019

2492

Asthma

637

535

6.45

288.83

1.5

1.2

32.48

27.87

g/l

9.43

585

455

Other heart diseases

563

573

6.60

288.75

1.6

1.3

31.52

39.55

g/l

27.15

502

532

Oxycodone

762

1776

4.29

281.68

1.5

1.4

35.46

31.71

g/l

11.62

712

1577

Valvular heart disease excluding rheumatic fever

759

1242

4.58

278.83

1.6

1.3

27.95

38.00

g/l

69.44

669

1158

Implicit bacterial Sepsis

843

2000

4.00

278.63

1.6

1.4

28.65

33.63

g/l

20.25

737

1811

Abnormalities of breathing

1180

2070

3.43

277.92

1.6

1.4

33.07

33.72

g/l

0.79

1064

1866

Non-rheumatic valve diseases

756

1239

4.56

276.80

1.6

1.3

27.89

37.99

g/l

69.72

667

1155

Non-small cell lung cancer

539

1015

5.69

274.20

1.4

1.5

39.00

30.26

g/l

44.87

506

888

Dialysis, with operation codes

387

528

7.85

270.20

1.7

1.4

26.03

34.26

g/l

20.71

333

480

Septicaemia

795

1973

3.99

266.93

1.6

1.4

29.16

33.11

g/l

12.21

696

1777

Anaemias

270

20.31

265.09

1.6

1.4

30.71

41.08

g/l

10.34

241

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

268

236

12.72

263.03

1.4

1.5

38.70

27.99

g/l

22.13

252

209

Chronic kidney disease

720

1767

4.23

261.28

1.7

1.4

25.87

32.94

g/l

35.42

614

1591

Asthma (mode)

591

537

6.10

259.03

1.5

1.2

32.43

27.87

g/l

9.02

543

456

Explicit Sepsis

806

2077

3.83

255.14

1.6

1.4

29.20

33.82

g/l

16.88

706

1886

Acute renal failure

533

1075

5.22

249.68

1.7

1.4

26.55

33.18

g/l

22.65

457

964

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

485

907

5.58

246.74

1.3

1.5

37.11

29.72

g/l

27.55

455

801

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

407

646

6.62

245.91

1.3

1.5

38.53

29.18

g/l

30.79

380

563

Nephropathy related operations

374

554

7.23

242.51

1.7

1.4

25.97

33.36

g/l

16.35

322

502

Asthma (only as main-diagnosis)

529

535

6.02

240.41

1.5

1.2

32.32

27.87

g/l

8.37

480

455

Condition for Implicit Sepsis (Organ dysfunction codes)

1148

2825

3.00

232.21

1.5

1.4

29.44

34.90

g/l

31.75

995

2585

Other septicaemia

705

1821

3.91

231.71

1.6

1.4

28.84

32.87

g/l

11.45

621

1636

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1028

1863

3.30

228.50

1.4

1.5

35.32

31.08

g/l

16.48

954

1643

Malignant neoplasm, wide definition for exclusion

1028

1864

3.30

228.33

1.4

1.5

35.32

31.08

g/l

16.47

954

1644

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1027

1864

3.30

227.78

1.4

1.5

35.35

31.09

g/l

16.67

953

1644

Other diseases of pericardium

182

105

19.34

226.23

1.7

1.3

33.48

37.21

g/l

2.14

170

100

Bacterial pneumoniae

663

1489

4.04

222.02

1.5

32.34

33.08

g/l

0.67

574

1356

COPD/asthma/ILD related infections

1196

2005

3.02

217.86

1.5

1.4

33.13

33.52

g/l

0.39

1085

1826

COPD/asthma related infections

1196

2005

3.02

217.86

1.5

1.4

33.13

33.52

g/l

0.39

1085

1826

Atrial fibrillation and flutter

444

473

6.26

215.69

1.6

1.3

30.09

39.20

g/l

28.66

405

439

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

232

221

11.45

215.12

1.7

1.5

38.61

28.31

g/l

18.66

221

195

Bacterial pneumonia, not elsewhere classified

638

1435

4.03

213.17

1.5

32.26

32.98

g/l

0.63

554

1306

Mesothelioma

155

30.15

213.05

1.9

1.4

40.56

30.37

g/l

8.22

148

Malignant neoplasm of heart, mediastinum and pleura

144

33.98

208.01

1.9

1.5

40.07

29.82

g/l

7.21

137

Malignant neoplasm

1040

2033

3.07

206.65

1.4

1.5

35.48

31.21

g/l

17.43

965

1794

Atrial fibrillation and flutter with reimbursement

411

412

6.56

205.80

1.6

1.3

29.64

38.85

g/l

27.57

371

381

Non-small cell lung cancer, adenocarcinoma, helper endpoint

268

351

8.51

195.70

1.4

1.5

38.70

31.42

g/l

13.69

252

320

Non-small cell lung cancer, adenocarcinoma

268

351

8.51

195.70

1.4

1.5

38.70

31.42

g/l

13.69

252

320

Care involving dialysis

242

280

9.30

194.08

1.7

1.4

24.37

33.21

g/l

13.96

207

254

GASTRO-related operations

792

1095

3.66

192.22

1.5

1.4

32.66

33.30

g/l

0.53

714

985

Any gastric operation

792

1095

3.66

192.22

1.5

1.4

32.66

33.30

g/l

0.53

714

985

Malignant neoplasm of bronchus and lung

534

1241

4.23

189.22

1.4

1.5

38.55

30.20

g/l

43.38

499

1089

Early onset COPD, excluding more controls

240

280

8.76

189.03

1.4

1.3

35.45

28.81

g/l

8.73

210

239

Diseases of arteries, arterioles and capillaries (FINNGEN)

358

401

6.39

182.85

1.6

1.3

29.70

38.85

g/l

22.24

322

368

Any event in cancer register

997

2075

2.88

178.12

1.4

1.5

35.12

31.67

g/l

11.39

922

1842

Fever of other and unknown origin

759

2274

3.15

177.93

1.5

1.4

32.28

33.81

g/l

2.47

695

2051

Cardiomyopathy

324

572

5.86

175.13

1.6

1.3

26.82

37.52

g/l

32.44

270

532

Malignant neoplasm of mesothelium and soft tissue

197

221

10.06

163.38

1.7

1.4

38.80

31.16

g/l

10.33

188

200

Cardiac arrhythmias

588

1058

3.71

161.62

1.6

1.3

30.81

37.90

g/l

27.17

539

988

Pneumothorax

174

167

11.04

159.74

1.7

1.2

33.70

28.05

g/l

4.49

162

140

Heart failure and coronary heart disease

735

1805

3.14

159.16

1.6

1.5

25.77

32.50

g/l

32.51

623

1619

Continuous positive airway pressure

315

487

5.73

158.29

1.5

1.3

30.38

38.29

g/l

15.64

253

454

First line medication for Crohn's disease

1225

2768

2.44

155.20

1.5

1.4

33.65

32.87

g/l

1.10

1113

2472

Aplastic and other anaemias

769

2611

2.86

151.80

1.5

29.29

32.53

g/l

9.06

678

2341

Non-invasive ventilation

296

517

5.50

147.51

1.5

1.3

29.50

38.41

g/l

19.80

270

488

Ascites

220

327

7.22

142.47

1.6

1.4

32.63

32.32

g/l

0.10

195

299

Primary_lymphoid and hematopoietic malignant neoplasms

382

947

4.15

137.31

1.6

1.5

31.78

29.49

g/l

2.74

360

829

Extracorporeal dialysis

194

267

7.87

135.02

1.7

1.5

24.92

32.19

g/l

8.38

165

240

Bacterial pneumonia (organism specified)

702

2333

2.79

132.33

1.5

32.46

32.41

g/l

0.03

613

2085

Other anaemias

699

2481

2.78

131.71

1.5

29.41

32.37

g/l

7.26

618

2220

Other and unspecified anaemias

692

2460

2.78

130.75

1.5

29.40

32.38

g/l

7.31

611

2203

Cardiomyopathy (excluding other)

228

391

6.04

127.22

1.5

1.3

26.56

37.74

g/l

24.43

188

363

Valvular operations

252

477

5.46

126.45

1.6

1.3

29.23

37.48

g/l

17.62

220

441

Erysipelas

709

2427

2.71

126.43

1.5

1.4

30.41

33.78

g/l

8.98

634

2185

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1028

3024

2.33

126.07

1.5

1.4

30.77

34.60

g/l

16.06

924

2738

Certain infectious and parasitic diseases

999

2062

2.45

124.61

1.5

1.4

31.67

34.80

g/l

9.27

899

1875

ILD medications: prednisolone, methylprednisolone, prednisone

1188

3066

2.21

122.42

1.6

1.4

32.56

33.30

g/l

1.04

1077

2750

Oral corticosteroids

1176

3272

2.20

121.49

1.6

1.4

32.77

33.14

g/l

0.41

1068

2937

Cardiomyopathies, Primary/intrinsic

219

381

5.95

120.41

1.5

1.3

26.38

37.64

g/l

24.13

181

354

Cardiovascular diseases (excluding rheumatic etc)

413

598

4.02

120.17

1.5

1.3

34.34

39.64

g/l

9.90

368

557

Other disorders of fluid, electrolyte and acid-base balance

500

1559

3.17

119.10

1.6

1.4

29.60

32.75

g/l

5.27

441

1387

Diseases of arteries, arterioles and capillaries

941

3060

2.33

116.89

1.5

28.69

33.45

g/l

21.40

817

2765

Conduction disorders

386

867

3.77

116.36

1.6

1.3

28.94

37.87

g/l

30.39

343

813

Presence of cardiac and vascular implants and grafts

742

2236

2.56

112.91

1.6

1.5

28.07

33.68

g/l

25.18

658

2007

Glomerular disorders in diseases classified elsewhere

258

552

4.89

112.89

1.6

1.5

25.89

32.61

g/l

11.48

217

500

Malaise and fatigue

640

2002

2.70

111.73

1.5

1.4

30.33

33.42

g/l

6.96

559

1799

AV-block

276

562

4.58

109.82

1.6

1.3

28.37

37.67

g/l

24.15

246

527

Cerebrovascular diseases (FINNGEN)

298

474

4.56

109.56

1.6

1.3

31.46

39.09

g/l

15.13

269

440

Glomerular diseases

337

901

3.87

109.47

1.6

1.5

25.87

32.63

g/l

14.37

285

822

Metabolic disorders

1035

2939

2.21

109.37

1.5

1.4

31.34

34.07

g/l

7.99

929

2656

ILD medications

1176

3072

2.12

108.71

1.6

1.4

32.69

33.32

g/l

0.82

1064

2755

Haemorrhage from respiratory passages

499

1567

3.01

108.57

1.5

1.4

30.71

32.93

g/l

3.18

444

1403

Bleeding

1002

3359

2.20

108.09

1.5

1.4

30.20

33.59

g/l

12.37

885

3024

Other arrhythmias

566

1532

2.86

107.87

1.5

1.3

30.79

38.01

g/l

30.19

507

1432

Inflammatory bowel disease treatment related agents

1198

3285

2.09

107.82

1.6

1.4

32.81

33.19

g/l

0.42

1085

2948

COPD

704

2385

2.48

102.41

1.4

1.5

33.08

32.38

g/l

0.72

615

2145

Respiratory insufficiency

123

134

9.47

102.35

1.5

1.3

31.50

26.74

g/l

2.99

115

Benign neoplasm of colon, rectum, anus and anal canal

561

1441

2.82

101.96

1.6

1.5

30.88

31.04

g/l

0.09

489

1280

Non-allergic asthma (mode), excluding more controls

126

141

8.95

101.31

1.6

1.2

31.33

31.24

g/l

0.02

114

128

Hypertensive diseases (excluding secondary)

372

574

3.80

101.00

1.6

1.3

33.52

39.40

g/l

10.69

332

533

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

239

525

4.70

100.85

1.6

1.5

33.66

29.21

g/l

5.63

225

460

Diabetic nephropathy, excluding more controls

283

569

4.31

100.63

1.6

1.4

27.00

33.26

g/l

10.15

239

514

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

116

121

10.02

100.17

1.2

1.4

39.02

26.92

g/l

11.97

108

103

General symptoms and signs

1075

2542

2.14

98.93

1.5

1.4

32.21

34.13

g/l

4.24

973

2296

Complications of surgical and medical care, not elsewhere classified

1049

3648

2.08

98.91

1.5

1.4

31.63

33.32

g/l

3.68

941

3287

Acute tubulo-interstitial nephritis

695

2572

2.43

98.76

1.5

1.4

31.09

34.02

g/l

7.00

618

2358

Other chronic obstructive pulmonary disease

680

2328

2.48

98.62

1.4

1.5

32.97

32.35

g/l

0.59

593

2094

Implicit viral Sepsis

305

825

3.80

97.24

1.6

1.4

27.97

32.99

g/l

8.55

270

743

Viral Sepsis

305

825

3.80

97.24

1.6

1.4

27.97

32.99

g/l

8.55

270

743

Benign neoplasm: Colon

512

1418

2.80

94.08

1.6

1.5

31.16

30.67

g/l

0.35

442

1258

Tramadol

802

2264

2.30

94.04

1.5

1.4

32.56

32.52

g/l

0.03

717

2021

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

329

553

3.81

92.63

1.5

1.3

32.70

39.17

g/l

11.50

301

514

L01XE Protein kinase inhibitors

155

252

6.58

92.22

1.4

1.5

36.49

32.44

g/l

3.36

148

227

Pulmonary heart disease, diseases of pulmonary circulation

496

1848

2.74

92.08

1.4

1.5

33.57

31.77

g/l

2.44

452

1633

Transplanted organ and tissue status

176

322

5.68

91.92

1.6

1.4

26.91

34.58

g/l

10.72

156

286

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

211

441

4.81

91.84

1.3

1.5

37.70

28.29

g/l

17.68

194

373

Symptoms and signs involving the circulatory and respiratory systems

907

2072

2.21

90.84

1.5

1.4

32.69

33.73

g/l

1.32

810

1868

Other chronic obstructive pulmonary disease, including avohilmo

762

2844

2.27

90.83

1.4

1.5

33.11

32.25

g/l

1.03

667

2567

Any reimbursement code in KELA

336

432

3.92

89.62

1.5

1.3

34.04

37.58

g/l

3.59

300

399

Hypertensive heart and/or renal disease

421

1092

3.06

89.52

1.5

1.4

27.36

34.28

g/l

21.49

360

994

Paroxysmal tachycardia

216

388

4.77

89.22

1.6

1.3

28.69

39.18

g/l

20.48

187

361

Neoplasms

593

1209

2.65

88.74

1.5

1.4

34.81

32.12

g/l

4.41

536

1087

Unspecified kidney failure

219

506

4.53

87.23

1.6

1.4

26.21

31.98

g/l

7.85

179

455

Opioids

930

2300

2.14

87.23

1.5

1.4

33.79

32.73

g/l

1.42

847

2055

COPD, hospital admissions

688

2560

2.32

86.56

1.4

1.5

33.06

32.09

g/l

1.15

601

2312

COPD, early/later onset

692

2577

2.31

86.34

1.4

1.5

33.02

32.14

g/l

0.99

603

2327

Pacemaker

562

2232

2.51

86.05

1.6

1.5

27.36

32.12

g/l

16.39

487

1987

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

332

622

3.52

84.80

1.3

1.4

34.69

29.40

g/l

9.64

307

537

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

332

622

3.52

84.79

1.3

1.4

34.69

29.40

g/l

9.64

307

537

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

15.63

84.44

1.3

1.4

40.07

28.17

g/l

6.08

Peripheral artery disease

686

2451

2.29

83.55

1.5

27.91

32.91

g/l

16.77

577

2212

Secondary hypertension

113

145

7.94

81.66

1.5

1.2

25.23

38.39

g/l

14.05

134

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

207

481

4.44

81.45

1.6

1.5

31.14

28.63

g/l

2.00

196

421

Infections, IBD-co-morbidities

247

444

4.14

80.83

1.6

1.3

29.31

35.18

g/l

7.38

218

402

Primary_lymphoid and hematopoietic malignant neoplasms

382

1342

2.92

79.56

1.6

1.5

31.78

31.97

g/l

0.10

360

1185

Iron deficiency anaemia

540

2227

2.44

79.23

1.5

29.13

32.31

g/l

6.36

469

1986

Pulmonary embolism

437

1654

2.70

78.73

1.4

1.5

34.49

31.75

g/l

4.60

399

1460

Polyarthropathies

789

2486

2.14

78.38

1.6

1.4

31.46

33.49

g/l

3.88

720

2222

Cardiovascular diseases

327

510

3.51

78.18

1.5

1.3

34.54

39.52

g/l

7.18

296

475

Pulmonary heart disease

437

1663

2.68

77.89

1.4

1.5

34.49

31.65

g/l

4.91

399

1468

COPD related to multimorbidity

616

2279

2.32

77.70

1.4

1.5

32.20

31.89

g/l

0.23

530

2057

Other CVD (FINNGEN)

156

215

5.86

77.59

1.6

1.3

29.71

38.50

g/l

11.19

136

201

Codes for special purposes

472

1867

2.56

77.31

1.5

32.83

32.94

g/l

0.06

429

1670

Provisional assignment of new diseases of uncertain etiology

471

1864

2.56

77.06

1.5

32.85

32.94

g/l

0.05

428

1667

Hypertension, essential

696

1769

2.26

76.57

1.6

1.4

32.55

35.67

g/l

6.92

624

1616

Venous thromboembolism

686

3112

2.17

76.21

1.4

1.5

33.55

32.27

g/l

1.76

621

2789

Pleural plaque

167

348

4.98

75.37

1.4

1.2

35.65

27.43

g/l

12.02

155

285

Type 2 diabetes, wide definition

883

2882

2.02

74.99

1.6

1.4

31.10

33.81

g/l

7.09

772

2617

All influenza

278

838

3.37

74.93

1.6

1.4

30.04

32.59

g/l

2.33

242

761

Asthma-related pneumonia

496

2039

2.47

74.89

1.5

31.84

32.06

g/l

0.14

439

1807

Dentinal caries

310

994

3.16

74.89

1.6

1.5

31.95

33.48

g/l

1.06

264

905

Asthma-related pneumonia or sepsis

496

2042

2.47

74.64

1.5

31.84

32.05

g/l

0.14

439

1809

Asthma, hospital admissions 3, pneumonia

496

2042

2.47

74.64

1.5

31.84

32.05

g/l

0.14

439

1809

Dental caries

334

1115

3.02

74.51

1.6

1.5

31.91

33.56

g/l

1.30

287

1012

Complications of procedures, not elsewhere classified

822

3551

2.02

74.33

1.5

1.4

31.70

33.30

g/l

2.80

745

3197

COPD, hospital admission 2, with asthma infections

517

1850

2.43

72.76

1.4

1.5

32.96

31.76

g/l

1.26

448

1659

Covid-19 confirmed case

360

1284

2.85

72.65

1.5

32.25

32.30

g/l

0.03

325

1149

Atherosclerosis, excluding cerebral and coronary sclerosis

641

2350

2.22

72.14

1.5

27.76

32.71

g/l

15.69

542

2120

DVT of lower extremities and pulmonary embolism

565

2495

2.29

72.13

1.4

1.5

33.79

31.95

g/l

2.72

512

2225

Parasetamol

729

1715

2.18

71.64

1.6

1.4

33.43

33.39

g/l

0.02

657

1538

Ulcer of lower limb, not elsewhere classified

260

779

3.45

71.42

1.6

1.5

27.70

31.39

g/l

4.07

214

700

Hyperkalaemia

138

258

5.66

70.92

1.6

1.4

25.46

32.03

g/l

6.24

118

237

Dialysis

123

8.28

70.84

1.5

1.4

21.68

34.20

g/l

11.50

108

Nutritional anaemias

606

2705

2.21

70.58

1.5

29.17

32.54

g/l

7.99

530

2426

Insulin medication

693

2844

2.11

70.05

1.6

1.4

29.02

33.28

g/l

13.68

604

2573

Adjustment and management of implanted device

299

989

3.10

69.49

1.7

1.4

28.55

31.52

g/l

4.13

255

867

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

469

1481

2.50

69.40

1.4

1.5

31.97

30.01

g/l

2.27

418

1297

Viral pneumonia

169

383

4.52

68.60

1.6

1.4

30.25

32.28

g/l

1.13

150

354

COPD, hospital admissions 3, with asthma pneumonia sepsis

461

1608

2.49

68.23

1.4

1.5

32.66

31.53

g/l

1.09

398

1437

Diabetic nephropathy

286

924

3.16

67.79

1.6

1.5

26.96

31.68

g/l

7.01

241

823

Cardiomyopathy, other and unspecified

123

218

5.83

66.48

1.6

1.3

27.96

37.01

g/l

8.46

100

205

ILD medications: immunosuppressive drugs

555

2419

2.22

65.78

1.5

1.4

32.57

33.84

g/l

1.36

507

2187

Pain in throat and chest

702

2058

2.10

65.71

1.4

32.56

33.68

g/l

1.32

616

1855

Calcific aortic valvular stenosis

486

2068

2.35

65.02

1.6

1.5

27.78

31.84

g/l

10.41

423

1842

Calcific aortic valvular stenosis, operated

486

2068

2.35

65.02

1.6

1.5

27.78

31.84

g/l

10.41

423

1842

Hypertensive Heart Disease

352

1052

2.79

64.98

1.5

1.4

27.76

34.10

g/l

15.76

301

956

Disorders of lipoprotein metabolism and other lipidaemias

864

2832

1.93

64.95

1.5

1.4

31.46

33.84

g/l

5.54

775

2555

Undetermined asthma, excluding more controls

9.28

64.75

1.5

1.2

33.81

31.01

g/l

0.78

Calcific aortic valvular stenosis, diagnosis (helper)

485

2066

2.35

64.72

1.6

1.5

27.78

31.84

g/l

10.40

423

1840

Operations 2 for CAVS

485

2066

2.35

64.72

1.6

1.5

27.78

31.84

g/l

10.40

423

1840

L04AD Calcineurin inhibitors

151

330

4.71

64.24

1.7

1.5

27.24

33.47

g/l

6.38

135

296

Calcific aortic valvular stenosis, including rheumatic fever

485

2071

2.34

64.22

1.6

1.5

27.78

31.86

g/l

10.48

423

1845

Chronic periapical parodontitis

282

956

3.01

62.63

1.5

32.58

33.44

g/l

0.50

248

876

Explicit bacterial Sepsis

170

416

4.21

62.62

1.6

1.4

30.55

32.84

g/l

1.33

144

377

Other and unspecified iron deficiency

402

1638

2.49

62.12

1.6

1.5

29.62

32.30

g/l

3.60

351

1455

Complications of medical and surgical care

748

3683

1.95

62.06

1.5

1.4

31.54

33.07

g/l

2.43

667

3321

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

238

581

3.36

60.83

1.4

35.91

29.47

g/l

11.54

220

500

Hypo-osmolality and hyponatraemia

256

837

3.12

60.36

1.6

1.4

30.99

31.95

g/l

0.51

230

750

Non-allergic asthma (mode)

126

245

5.15

60.33

1.6

1.3

31.33

27.97

g/l

1.80

114

208

Hypertensive diseases

655

1779

2.10

60.11

1.6

1.4

32.70

35.69

g/l

6.00

586

1626

Other diseases of the respiratory system

330

1249

2.71

59.80

1.5

31.70

31.09

g/l

0.36

305

1105

Other respiratory disorders and diseases

330

1249

2.71

59.80

1.5

31.70

31.09

g/l

0.36

305

1105

Hypertension

654

1779

2.09

59.75

1.6

1.4

32.71

35.69

g/l

5.95

585

1626

In situ neoplasms

326

1173

2.68

58.42

1.5

31.45

29.51

g/l

1.90

281

1025

Streptococcal septicaemia

151

357

4.38

58.38

1.5

1.4

30.83

32.04

g/l

0.48

127

322

Codeine

795

2276

1.93

57.88

1.5

1.4

32.77

32.69

g/l

0.05

732

2036

Gout

442

1759

2.34

57.77

1.6

1.4

28.34

32.65

g/l

10.34

397

1561

Chronic lower respiratory diseases

1083

3368

1.75

57.53

1.5

1.4

32.97

33.22

g/l

0.24

973

3038

Depression medications

131

104

6.37

57.38

1.6

1.4

35.12

42.21

g/l

4.61

117

Hypothyroidism (congenital or acquired)

115

6.85

57.37

1.7

1.4

33.76

41.59

g/l

4.86

108

Other disorders of skin and subcutaneous tissue

721

3477

1.92

56.98

1.5

30.13

33.21

g/l

8.04

631

3144

Abscess of lung

11.95

56.68

1.3

1.5

35.25

30.50

g/l

1.46

Benign neoplasms

523

1331

2.24

56.22

1.5

1.4

32.53

31.90

g/l

0.46

465

1194

Coronary atherosclerosis

758

2573

1.92

55.95

1.5

1.4

29.71

34.45

g/l

18.00

674

2333

Other dialysis

113

7.68

55.73

1.6

1.4

21.87

32.70

g/l

7.42

102

Cardiodefibrillation

513

2429

2.15

55.60

1.6

1.5

28.94

32.53

g/l

8.67

439

2188

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

505

1572

2.22

55.50

1.4

1.5

31.19

30.15

g/l

0.98

443

1381

Gout, FINNGEN

442

1986

2.27

54.97

1.6

1.4

28.34

32.13

g/l

8.42

397

1760

Insulin, combination of fast acting with intermediate-acting or long-acting

694

3378

1.91

54.47

1.6

1.4

29.02

33.10

g/l

13.01

604

3042

Hard cardiovascular diseases

804

2794

1.86

54.33

1.5

30.38

34.32

g/l

12.91

717

2553

Diseases of pulp and periapical tissues

380

1607

2.39

54.12

1.5

32.01

33.85

g/l

1.94

336

1458

Autoimmune diseases excluding thyroid diseases, strict definition

953

3006

1.78

53.83

1.5

1.4

31.96

33.58

g/l

2.94

849

2707

Insulin, fast-acting

409

1791

2.31

53.70

1.7

1.4

27.34

33.25

g/l

14.95

353

1612

Preparatory care for dialysis

106

202

5.57

53.51

1.7

1.5

24.47

31.91

g/l

5.51

181

Hypothyroidism, levothyroxine purchases

110

6.56

53.05

1.6

1.4

34.07

41.59

g/l

4.44

103

Hypothyroidism and >3 levothyroxin purchases

110

6.56

53.05

1.6

1.4

34.07

41.59

g/l

4.44

103

Autoimmune diseases excluding thyroid diseases

976

3101

1.76

53.04

1.5

1.4

31.91

33.52

g/l

3.00

872

2798

Non-follicular lymphoma, hilmo, excluding all cancers

140

336

4.29

53.02

1.7

1.5

31.21

28.38

g/l

1.86

132

295

Type 1 diabetes

271

989

2.77

52.29

1.6

1.4

27.10

33.99

g/l

12.56

231

902

Insulin, intermediate and long-acting

618

3135

1.95

52.21

1.6

1.4

28.88

33.22

g/l

12.78

537

2824

Hypothyroidism, drug reimbursement

8.11

51.60

1.5

1.3

34.06

40.06

g/l

2.49

Chronic periodontitis

227

762

3.05

51.56

1.5

31.50

33.19

g/l

1.08

201

698

Secondary uncertain malignant neoplasm

216

710

3.13

51.03

1.6

1.5

33.65

31.38

g/l

1.97

209

638

Oedema, not elsewhere classified

348

1457

2.41

50.13

1.6

1.4

29.69

33.24

g/l

5.71

303

1299

Diabetes, varying definitions

893

3055

1.76

49.40

1.5

1.4

31.47

34.02

g/l

6.78

793

2780

Asthma-related infections

570

2879

1.96

49.17

1.4

1.5

32.25

32.91

g/l

0.60

507

2575

Asthma, hospital admission 2, infections

570

2879

1.96

49.17

1.4

1.5

32.25

32.91

g/l

0.60

507

2575

Hernia of abdominal wall, postoperative

164

464

3.58

48.97

1.4

1.5

32.53

33.00

g/l

0.16

147

430

Diabetes mellitus

890

3056

1.75

48.40

1.5

1.4

31.50

34.00

g/l

6.53

790

2781

Pure hypercholesterolaemia

742

2737

1.83

48.33

1.5

1.4

31.87

33.75

g/l

3.38

666

2469

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

462

1476

2.17

48.28

1.4

1.5

31.18

29.81

g/l

1.37

407

1294

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

455

1455

2.18

48.23

1.4

1.5

31.40

29.77

g/l

1.81

395

1274

Myocardial infarction

612

2285

1.95

48.13

1.5

1.4

29.08

34.24

g/l

15.75

528

2065

Insulin, fast-acting or short human

411

1896

2.19

47.61

1.7

1.5

27.33

33.04

g/l

14.18

355

1702

Later onset COPD

459

1712

2.15

47.58

1.4

1.5

31.74

31.22

g/l

0.37

399

1537

Amputation

184

574

3.31

47.54

1.7

1.4

27.18

31.45

g/l

3.70

147

515

Peripheral arterial reconstruction

291

1168

2.56

47.00

1.5

27.79

31.31

g/l

4.06

241

1033

STROKE

530

1831

2.03

46.65

1.5

1.4

30.68

35.81

g/l

14.20

476

1698

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

860

3035

1.74

46.37

1.5

1.4

31.65

34.01

g/l

5.61

757

2760

Gout, idiopatic and unspecified

362

1610

2.30

46.31

1.7

1.5

28.16

32.39

g/l

8.35

323

1433

Type 1 diabetes, wide definition, subgroup 1

212

726

2.96

46.15

1.6

1.4

26.57

34.29

g/l

11.37

178

668

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

452

1465

2.14

46.02

1.4

1.5

31.36

29.77

g/l

1.72

392

1283

Ischemic heart diseases

772

2729

1.79

45.48

1.6

1.4

30.19

34.69

g/l

16.32

690

2482

Disorders of lens

701

2436

1.83

44.84

1.5

30.28

34.32

g/l

11.92

626

2200

ILD, hospital admissions 3, with pneumonia sepsis

129

333

4.00

44.38

1.6

1.5

32.21

30.84

g/l

0.54

114

307

Disorders resulting from impaired renal tubular function

140

6.04

44.22

1.6

1.4

25.30

31.75

g/l

3.40

125

Gout, strict definition

279

1132

2.53

44.07

1.7

1.5

27.58

32.47

g/l

8.71

245

1005

Invasive ventilation

125

318

4.07

43.94

1.5

30.11

32.08

g/l

0.71

108

288

Care involving use of rehabilitation procedures

523

2570

1.95

43.82

1.4

30.88

33.50

g/l

4.27

461

2313

Major coronary heart disease event

777

2980

1.76

43.71

1.6

1.5

29.81

33.72

g/l

12.24

679

2691

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

602

3264

1.85

43.65

1.5

1.4

31.63

32.97

g/l

1.67

536

2944

Type 2 diabetes

867

3031

1.71

43.51

1.5

1.4

31.37

33.94

g/l

6.74

773

2756

Fall on same level

975

3306

1.66

43.05

1.5

1.4

31.81

33.80

g/l

4.72

877

2977

Diseases of oesophagus, stomach and duodenum

949

3493

1.66

43.01

1.5

1.4

31.71

33.49

g/l

3.74

842

3166

Antihypertensive medication - note that there are other indications

313

688

2.50

42.73

1.5

1.3

33.74

38.95

g/l

8.39

279

641

Ischaemic heart disease, wide definition

758

2715

1.76

42.66

1.5

1.4

30.14

34.68

g/l

16.35

676

2468

Diabetes, insulin treatment (Kela reimbursement)

912

3358

1.67

42.47

1.5

1.4

31.49

33.77

g/l

5.54

801

3049

Iron deficiency anaemia secondary to blood loss (chronic)

217

791

2.80

42.43

1.5

27.86

31.37

g/l

3.60

191

705

L04AA Selective immunosuppressants

222

818

2.75

42.36

1.6

1.5

30.21

33.77

g/l

3.44

202

738

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

212

766

2.84

42.25

1.8

1.5

27.76

33.06

g/l

5.79

191

688

ILD, hospital admission 2, with pulmonary infections

137

383

3.67

41.98

1.6

1.4

32.32

31.78

g/l

0.18

118

348

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

251

447

2.83

41.97

1.5

1.3

32.68

34.89

g/l

1.43

221

403

Other diseases of blood and blood-forming organs, wide

260

1045

2.53

41.69

1.5

34.03

32.39

g/l

1.28

236

937

Major coronary heart disease event excluding revascularizations

731

2897

1.76

41.66

1.6

1.5

29.33

33.70

g/l

14.09

638

2616

Gout, unspecified

300

1294

2.37

41.35

1.7

1.5

27.81

32.52

g/l

8.30

265

1148

Type 1 diabetes, wide definition

221

824

2.71

41.07

1.6

1.5

26.71

34.00

g/l

11.11

187

750

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

216

4.67

40.67

1.4

37.19

27.49

g/l

12.37

193

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

117

301

4.00

40.45

1.5

29.54

28.08

g/l

0.48

265

Endocrine, nutritional and metabolic diseases

615

1680

1.87

40.36

1.6

1.4

32.45

35.21

g/l

5.34

558

1540

Kidney transplant status

156

5.38

40.20

1.6

1.5

23.76

34.06

g/l

7.67

139

Chronic periodontitis, complicated

142

420

3.48

39.99

1.6

1.5

31.69

32.81

g/l

0.41

127

376

Peripheral artery operations in Hilmo

209

772

2.77

39.93

1.6

1.4

27.63

32.25

g/l

4.85

171

686

Malignant neoplasm of ovary

155

5.38

39.52

1.2

1.4

39.55

31.68

g/l

5.25

140

Lymphoid leukaemia

186

4.90

39.25

1.6

1.5

31.50

27.82

g/l

1.61

166

Diabetes medication

876

3240

1.65

39.11

1.5

1.4

32.01

33.69

g/l

3.24

779

2939

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

153

482

3.25

38.85

1.5

32.60

28.79

g/l

3.20

137

421

Coronary artery bypass grafting

408

1522

2.07

38.72

1.5

29.08

33.71

g/l

10.10

347

1377

Glucagon-like peptide-1 (GLP-1) analogues

615

2853

1.79

38.61

1.5

1.4

30.89

32.73

g/l

2.90

534

2573

COPD-related respiratory insufficiency

196

714

2.82

38.60

1.4

1.5

31.14

30.94

g/l

0.08

169

632

Diseases of liver

351

1657

2.14

38.56

1.7

1.4

28.83

33.42

g/l

7.51

315

1492

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

165

384

3.23

38.36

1.5

1.3

32.83

34.43

g/l

0.73

141

348

Senile cataract

663

2336

1.78

38.31

1.5

30.31

34.18

g/l

10.85

589

2108

Amputation of toe

134

395

3.52

38.13

1.6

1.5

27.29

31.25

g/l

2.55

108

356

Other bacterial intestinal infections

225

882

2.60

38.09

1.6

1.5

26.98

32.09

g/l

7.13

194

787

Disorders of choroid and retina

809

3574

1.66

38.01

1.5

30.34

33.17

g/l

7.51

720

3217

Benign neoplasm: Colon, unspecified

239

962

2.51

37.76

1.5

30.12

29.67

g/l

0.20

194

853

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

136

406

3.43

37.70

1.5

32.68

28.50

g/l

3.42

122

354

Enlarged lymph nodes

174

602

2.94

37.44

1.5

33.48

33.56

g/l

0.03

163

546

Cirrhosis of liver, NAS

225

4.41

36.93

1.8

1.5

27.22

32.61

g/l

2.83

201

Enterocolitis due to Clostridium difficile

161

542

3.05

36.58

1.6

1.4

25.83

30.91

g/l

5.43

137

490

Intestinal infectious diseases

796

3790

1.64

36.55

1.5

1.4

30.02

33.68

g/l

11.99

714

3412

Other retinal disorders

676

3192

1.72

36.52

1.5

29.30

32.81

g/l

9.75

602

2866

Hyperlipidaemia, other/unspecified

446

2212

1.93

36.34

1.5

1.4

30.58

33.22

g/l

3.97

398

1986

malignant neoplasm of female genital organs

169

586

2.94

36.32

1.3

1.5

37.87

31.71

g/l

7.58

155

528

Injuries to the head

923

3792

1.59

36.21

1.5

1.4

31.73

33.40

g/l

3.36

832

3409

Undetermined asthma

159

4.95

35.99

1.5

1.4

33.81

27.20

g/l

3.64

138

568

2952

1.78

35.82

1.5

32.41

33.15

g/l

0.65

503

2662

Cerebrovascular diseases

768

3359

1.65

35.23

1.5

29.73

33.21

g/l

10.45

663

3040

Myocardial infarction, strict

542

2194

1.82

35.22

1.5

1.4

29.51

34.19

g/l

11.95

464

1985

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

6.48

35.12

1.6

1.5

30.53

25.93

g/l

1.63

Chronic lymphocytic leukaemia, helper endpoint

6.48

35.12

1.6

1.5

30.53

25.93

g/l

1.63

Fibrosis and cirrhosis of liver

116

328

3.65

35.11

1.8

1.5

27.89

32.52

g/l

2.72

105

292

Agranulocytosis

142

455

3.19

35.10

1.4

1.5

35.95

33.06

g/l

2.13

130

411

Heart failure and hypertrophic cardiomyopathy

7.13

35.06

1.8

1.4

24.66

31.83

g/l

2.88

Malignant neoplasm of breast

375

1333

2.05

34.47

1.4

34.88

32.53

g/l

3.21

344

1199

Infections of the skin and subcutaneous tissue

476

2586

1.85

34.34

1.6

1.5

31.67

33.83

g/l

2.96

435

2319

Bacterial intestinal infections, IBD co-morbidities

221

905

2.48

34.18

1.6

1.5

26.79

31.54

g/l

6.22

191

807

Diabetic retinopathy, excluding more controls

274

658

2.38

33.79

1.5

1.4

28.24

33.45

g/l

7.34

239

601

Substance abuse, excluding more controls

526

2588

1.79

33.68

1.4

1.5

33.31

33.36

g/l

0.03

479

2339

COPD, hospital admissions 1, only main diagnosis

459

2110

1.88

33.67

1.4

1.5

32.64

31.89

g/l

0.63

408

1890

Malignant neoplasm of breast, HER2-negative

367

1335

2.04

33.46

1.4

34.92

32.57

g/l

3.17

336

1201

Diseases of the digestive system

495

2754

1.81

33.39

1.6

1.4

28.73

32.76

g/l

9.31

439

2467

Myocardial infarction, without ST-elevation

516

2682

1.80

33.36

1.4

1.5

28.24

32.30

g/l

9.64

447

2404

Alcohol use disorder, Swedish definition

540

2862

1.77

33.17

1.5

32.09

33.17

g/l

1.07

477

2578

Diarrhoea and gastroenteritis of presumed infectious origin

578

3058

1.73

32.92

1.5

1.4

30.36

33.66

g/l

7.33

525

2734

576

3008

1.73

32.64

1.5

32.33

33.25

g/l

0.89

511

2709

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

540

3116

1.75

32.29

1.4

1.5

31.63

32.75

g/l

1.16

482

2813

Symptoms and signs involving the urinary system

730

3492

1.63

32.15

1.5

1.4

31.33

33.14

g/l

3.30

637

3152

Vocal cord dysfunction

119

331

3.38

32.10

1.5

1.4

33.31

38.33

g/l

3.56

109

315

Other disorders of kidney and ureter

170

635

2.74

31.90

1.6

1.5

27.07

32.61

g/l

6.03

145

572

Mental and behavioural disorders due to psychoactive substance use

542

2962

1.74

31.74

1.4

1.5

33.29

33.16

g/l

0.08

492

2665

Acute peritonitis

104

293

3.66

31.70

1.6

1.5

27.72

31.50

g/l

1.74

263

Other diseases of the digestive system

387

2036

1.92

31.57

1.6

1.5

28.50

32.36

g/l

6.93

341

1805

Other acute lower respiratory infections

502

2725

1.77

31.40

1.5

32.76

32.55

g/l

0.14

456

2432

GI-bleeding

391

2068

1.91

31.38

1.6

1.5

28.46

32.32

g/l

6.94

345

1833

Coronary revascularization (ANGIO or CABG)

535

2132

1.77

31.33

1.6

1.4

29.30

34.12

g/l

13.16

461

1927

Fungal Sepsis

145

4.96

31.14

1.6

1.4

28.90

32.99

g/l

1.41

132

Other CVD

260

1194

2.22

30.93

1.5

30.04

30.79

g/l

0.44

231

1052

Disorders of gallbladder, biliary tract and pancreas

877

3660

1.55

30.79

1.4

1.5

31.97

33.16

g/l

1.82

791

3292

Cardiac arrest

145

4.61

30.47

1.5

1.2

26.46

38.51

g/l

9.05

135

Substance abuse

526

2927

1.73

30.31

1.4

1.5

33.31

33.16

g/l

0.09

479

2633

Benign neoplasm of colon, rectum, anus and anal canal

635

3506

1.65

30.17

1.6

1.5

30.92

32.86

g/l

3.37

549

3170

957

3334

1.52

29.63

1.5

1.4

32.44

33.09

g/l

0.76

872

2996

Persons encountering health services in other circumstances, wide

1026

3565

1.50

29.50

1.6

1.4

32.38

33.23

g/l

1.20

932

3196

Need for other prophylactic measures

194

4.19

29.23

1.5

31.04

31.97

g/l

0.23

173

Emergency coronary revascularization (for ACS)

656

2907

1.64

29.14

1.5

28.96

32.72

g/l

10.57

572

2608

Cough

315

1518

2.01

29.11

1.5

1.4

33.75

33.28

g/l

0.27

292

1376

Other disorders of glucose regulation and pancreatic internal secretion

106

319

3.40

29.10

1.6

1.5

28.00

31.60

g/l

1.91

287

Cardiomyopathy in other diseases

22.75

28.88

1.7

1.5

23.68

37.75

g/l

1.87

Autoimmune diseases

925

3106

1.53

28.88

1.6

1.4

31.94

33.52

g/l

2.80

828

2802

Used for control exclusion in common control thyroid runs

878

2893

1.54

28.83

1.6

1.4

31.70

33.61

g/l

3.62

784

2609

Syncope and collapse

418

2043

1.83

28.72

1.5

1.4

30.24

33.44

g/l

5.42

370

1839

Volume depletion

131

451

2.97

28.71

1.5

1.4

27.37

31.28

g/l

2.96

113

404

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

149

525

2.75

28.55

1.3

1.4

32.51

28.89

g/l

2.84

134

448

Sub-endpoint used in defining T1D endpoints

296

1445

2.03

28.48

1.6

1.5

26.91

32.37

g/l

9.59

249

1292

Codeine or tramadol medication

959

3547

1.50

28.37

1.5

1.4

33.01

33.09

g/l

0.06

878

3184

Osteopathies and chondropathies

480

2633

1.74

28.37

1.5

30.83

33.10

g/l

3.31

415

2367

Hypokalaemia

134

470

2.90

28.33

1.4

31.20

32.59

g/l

0.53

123

425

Glomerulonephritis

124

421

3.01

27.84

1.6

1.5

25.49

32.55

g/l

5.81

106

378

Nonischemic cardiomyopathy

220

3.88

27.67

1.4

26.95

33.82

g/l

4.56

201

Diseases of the skin and subcutaneous tissue

859

2813

1.54

27.60

1.5

1.4

32.12

33.64

g/l

2.53

769

2531

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

842

3616

1.52

27.34

1.5

1.4

32.22

33.16

g/l

1.24

767

3249

Non-follicular lymphoma

140

517

2.78

27.02

1.7

1.5

31.21

31.67

g/l

0.17

132

465

Implicit fungal Sepsis

135

4.79

26.86

1.6

1.4

29.06

33.11

g/l

1.30

125

Type 2 diabetes, definitions combined

775

2997

1.55

26.80

1.5

1.4

32.24

33.86

g/l

2.86

695

2726

Bronchitis

873

3824

1.50

26.72

1.5

1.4

32.42

33.13

g/l

0.84

795

3430

Type 2 diabetes, strict (exclude DM1)

780

3027

1.55

26.61

1.5

1.4

32.26

33.84

g/l

2.75

697

2752

Use of hypnotics and sedatives

894

3457

1.50

26.57

1.4

1.5

33.25

33.08

g/l

0.14

815

3104

Drug-induced neutropenia

279

3.46

26.48

1.4

1.5

36.90

33.04

g/l

2.64

248

Asthma (diagnoses ohter than nonallergic)

705

3893

1.56

26.42

1.5

1.4

32.47

33.09

g/l

0.66

641

3496

Amiodarone users

152

596

2.62

26.08

1.5

27.06

31.77

g/l

4.67

128

539

Other (not insulin) diabetes medications

805

3193

1.53

26.07

1.5

1.4

32.55

33.54

g/l

1.33

715

2896

Stroke, including SAH

656

3092

1.58

25.65

1.5

29.78

33.09

g/l

8.32

564

2796

Hypertensive Renal Disease

175

4.16

25.43

1.6

1.4

24.24

33.60

g/l

6.75

160

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

175

4.13

25.37

1.6

1.5

28.60

27.53

g/l

0.25

154

Alcoholic liver disease

133

498

2.73

24.99

1.7

1.5

28.13

33.15

g/l

3.31

117

448

Abnormal findings on examination of blood, without diagnosis

494

2792

1.67

24.97

1.6

1.5

30.76

32.60

g/l

2.30

433

2513

Early onset COPD

240

1164

2.09

24.85

1.4

1.5

35.45

32.85

g/l

2.56

210

1050

Mental and behavioural disorders due to alcohol

463

2691

1.69

24.52

1.5

32.83

33.09

g/l

0.16

417

2417

Type 2 diabetes, definitions combined, including avohilmo

765

2988

1.52

24.40

1.5

1.4

32.07

33.91

g/l

3.51

685

2714

Other disorders of teeth and supporting structures

214

1001

2.16

24.34

1.6

1.5

31.09

33.19

g/l

1.47

190

917

Fracture of femur

319

1564

1.88

24.25

1.3

1.5

29.96

31.07

g/l

0.75

276

1373

Oesophageal varices

168

4.13

24.23

1.9

1.6

26.23

32.32

g/l

3.10

148

Convulsions, not elsewhere classified

190

836

2.26

24.23

1.5

33.71

33.81

g/l

0.04

171

750

Hypertrophic cardiomyopathy

182

3.99

24.11

1.8

1.5

27.42

32.16

g/l

1.98

164

Mental and behavioural disorders due to alcohol, excluding acute intoxication

412

2398

1.73

24.04

1.5

32.78

33.15

g/l

0.22

370

2146

Coagulation defects, purpura and other haemorrhagic conditions

191

861

2.25

23.85

1.5

30.75

32.51

g/l

1.10

168

780

Presence of other functional implants

555

2444

1.62

23.84

1.4

1.5

29.84

33.92

g/l

10.94

502

2203

Hypoglycaemia, other or unspecified

254

3.42

23.69

1.6

1.4

27.62

31.76

g/l

1.94

226

Other respiratory diseases principally affecting the interstitium

229

1114

2.09

23.64

1.5

31.61

31.25

g/l

0.15

199

990

Asthma/COPD (KELA code 203)

722

3364

1.52

23.59

1.5

1.4

32.21

33.22

g/l

1.35

659

3034

Gastroduodenal ulcer

321

1748

1.85

23.51

1.5

1.4

29.96

32.22

g/l

2.30

285

1557

Benign neoplasm: Sigmoid colon

159

667

2.41

23.47

1.6

1.5

34.06

28.88

g/l

5.64

143

582

Lymphoid leukaemia

274

3.31

23.08

1.6

1.5

31.51

31.42

g/l

0.02

249

Stroke, excluding SAH

628

3020

1.56

22.99

1.5

29.83

33.01

g/l

7.30

538

2737

All influenza (not pneumonia)

114

411

2.80

22.89

1.6

1.4

29.75

32.66

g/l

1.37

102

378

Benign neoplasm: Colon

533

3293

1.60

22.80

1.6

1.5

31.03

32.64

g/l

2.17

458

2979

Hydronephrosis

128

493

2.64

22.72

1.5

1.4

32.66

32.59

g/l

0.02

116

443

Benign neoplasm: Rectum, anus and anal canal

171

752

2.30

22.67

1.5

31.95

29.29

g/l

1.87

146

665

Factors influencing health status and contact with health services

275

687

2.02

22.64

1.5

1.4

32.10

34.05

g/l

1.48

239

618

Benign neoplasm: Rectum

154

648

2.41

22.60

1.5

31.45

29.16

g/l

1.30

130

572

Pain in limb

635

2986

1.54

22.56

1.6

1.4

32.36

33.30

g/l

1.10

569

2674

Direct fill therapy

125

477

2.66

22.54

1.6

1.5

32.68

33.43

g/l

0.24

109

431

L02BA Anti-estrogens

135

535

2.55

22.52

1.4

35.91

32.62

g/l

2.63

125

484

Other cataract

424

1945

1.70

22.40

1.5

30.12

33.76

g/l

6.72

384

1748

Medicines for HER+ breast cancer

258

1297

1.95

22.31

1.4

35.47

32.64

g/l

3.58

238

1172

Pain, not elsewhere classified

205

978

2.11

22.14

1.5

1.4

34.89

33.97

g/l

0.44

180

876

Polyneuropathies and other disorders of the peripheral nervous system

244

1247

1.98

21.94

1.6

1.5

28.58

32.17

g/l

4.19

219

1114

Amputation of foot

133

4.44

21.93

1.6

1.5

25.95

31.46

g/l

2.00

120

Cellulitis

207

999

2.10

21.77

1.6

1.5

31.74

32.89

g/l

0.63

186

909

Biguanides

791

3325

1.47

21.74

1.5

1.4

32.78

33.26

g/l

0.46

696

3010

Acute bronchitis

384

2211

1.71

21.73

1.5

32.89

32.16

g/l

0.52

349

1957

Diseases of peritoneum

123

476

2.63

21.67

1.6

1.5

28.04

32.09

g/l

2.42

113

430

Emphysema

106

382

2.84

21.53

1.3

1.5

33.28

31.10

g/l

0.93

336

Misadventures to patients during surgical and medical care

147

620

2.41

21.52

1.8

1.5

29.97

32.36

g/l

1.42

133

562

Non-small cell lung cancer, squamous, helper endpoint

335

2.99

21.42

1.4

1.5

37.19

29.77

g/l

8.58

300

Non-small cell lung cancer, squamous

335

2.99

21.42

1.4

1.5

37.19

29.77

g/l

8.58

300

Injuries to the hip and thigh

463

2619

1.63

21.37

1.5

31.03

32.16

g/l

1.11

412

2331

Other soft tissue disorders, not elsewhere classified

730

3039

1.49

21.32

1.5

1.4

32.31

33.33

g/l

1.28

655

2721

Purpura and other haemorrhagic conditions

144

605

2.42

21.28

1.5

30.16

32.29

g/l

1.21

133

547

Secondary right heart disease

218

3.52

21.28

1.5

28.11

30.32

g/l

0.80

196

Idiopathic gout

132

536

2.52

21.15

1.7

1.5

28.21

32.36

g/l

3.79

119

482

Benign neoplasm: Ascending colon

121

470

2.61

21.13

1.8

1.5

30.21

29.34

g/l

0.35

108

410

Symptoms and signs involving the digestive system and abdomen

843

2912

1.46

21.03

1.5

1.4

32.65

33.31

g/l

0.69

754

2622

Osteomyelitis

296

3.08

20.90

1.8

1.5

28.31

31.57

g/l

1.42

267

Constipation

754

3700

1.47

20.85

1.5

1.4

32.20

32.95

g/l

0.81

674

3331

Hypotension

208

1024

2.06

20.85

1.5

29.31

30.65

g/l

0.80

183

909

Intestinal stricture

318

1798

1.79

20.80

1.4

1.5

31.69

32.05

g/l

0.18

288

1589

Nephrotic syndrome

109

4.65

20.70

1.5

1.4

24.42

32.07

g/l

2.42

Pneumonia derived septicemia

130

4.29

20.64

1.3

1.5

34.47

31.60

g/l

0.76

114

Viral pneumonia (unknown virus, not influenza)

202

3.53

20.62

1.7

1.5

30.86

32.42

g/l

0.40

180

Carcinoma in situ of skin of other and unspecified parts of face

325

2.96

20.60

1.6

1.5

29.27

26.58

g/l

1.21

281

Ischaemic Stroke, excluding all haemorrhages

596

2958

1.53

20.60

1.4

1.5

29.16

33.06

g/l

10.44

512

2680

Abnormalities of heart beat

257

1351

1.90

20.54

1.6

1.4

31.26

33.11

g/l

1.62

232

1216

Falls/tendency to fall

843

2924

1.45

20.51

1.5

1.4

32.02

34.01

g/l

4.05

752

2640

Retention of urine

395

1999

1.69

20.51

1.6

1.5

31.33

32.44

g/l

0.90

335

1811

Unspecified acute lower respiratory infection

146

630

2.35

20.30

1.5

31.56

32.65

g/l

0.46

132

567

Diabetic retinopathy

359

1306

1.76

20.30

1.5

28.01

31.97

g/l

6.53

311

1157

Colorectal cancer, excluding all cancers (controls excluding all cancers)

235

1176

1.95

20.23

1.4

1.5

30.74

29.42

g/l

0.83

206

1035

Benign neoplasm: Transverse colon

353

2.82

19.88

1.4

1.5

32.74

29.35

g/l

1.81

307

Chronic pancreatitis

138

592

2.37

19.53

1.5

1.4

30.18

33.48

g/l

2.07

126

530

Cytomegaloviral disease

5.95

19.44

1.4

1.5

27.02

32.88

g/l

1.48

Hepatic failure, not elsewhere classified

145

3.99

19.44

1.7

1.4

25.32

31.84

g/l

3.12

130

Chronic lymphocytic leukaemia

160

3.86

19.31

1.6

1.5

30.53

30.86

g/l

0.06

142

L02BG Aromatase inhibitors

216

1107

1.97

19.25

1.4

35.88

32.73

g/l

3.70

199

1009

Open wound of head

458

2861

1.59

19.22

1.5

31.39

32.88

g/l

1.78

421

2554

Other and unspecified polyneuropathies, also in other diseases

216

1110

1.97

19.21

1.6

1.5

28.91

31.88

g/l

2.84

192

991

Other pulmonary heart/vessel disease

243

3.23

19.18

1.5

1.4

28.14

30.84

g/l

1.08

220

Examination and observation for other reasons

487

1873

1.59

19.00

1.5

1.4

32.73

33.71

g/l

0.86

444

1686

Nausea and vomiting

233

1210

1.91

18.94

1.6

1.4

31.09

32.18

g/l

0.62

208

1070

Paralytic ileus and intestinal obstruction

269

1490

1.82

18.88

1.4

1.5

31.65

32.15

g/l

0.25

244

1316

Cytomegalovirus infection, IBD co-morbidity

5.77

18.82

1.4

1.5

27.02

33.58

g/l

1.77

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

105

405

2.65

18.74

1.7

1.5

30.44

31.62

g/l

0.38

370

L04AX Other immunosuppressants

401

2481

1.62

18.69

1.5

1.4

34.44

33.74

g/l

0.48

372

2245

Pneumococcal septicemia

127

4.15

18.68

1.3

1.4

34.44

31.13

g/l

0.87

112

Gout due to impairment of renal function

7.11

18.60

1.5

1.3

22.56

27.88

g/l

1.11

Left bundle-branch block

206

3.36

18.60

1.2

1.3

29.46

37.19

g/l

5.22

193

Alcohol use disorder, ICD-based

366

2218

1.66

18.59

1.5

32.86

33.27

g/l

0.23

328

1983

Malignant neoplasm of breast, HER-positive

237

1255

1.88

18.31

1.4

35.84

32.71

g/l

3.99

219

1138

Gastric ulcer

211

1094

1.95

18.29

1.5

28.36

31.71

g/l

3.44

185

970

Malignant neoplasm of skin

631

3239

1.48

18.22

1.5

30.93

32.49

g/l

2.48

563

2898

Unspecified haematuria

434

2350

1.59

18.20

1.5

30.44

32.76

g/l

3.20

378

2122

Other diseases of intestines

784

3208

1.43

18.12

1.5

1.4

32.80

33.71

g/l

1.08

705

2894

Certain disorders involving the immune mechanism

170

819

2.10

18.06

1.6

1.4

30.98

33.26

g/l

1.38

152

742

Sequelae of external causes of morbidity and mortality

233

1254

1.88

17.99

1.5

1.4

30.74

32.45

g/l

1.22

208

1130

Diabetic retinopathy, strict definition

192

847

2.02

17.88

1.6

1.5

26.19

32.28

g/l

8.07

163

746

Left ventricular outflow tract obstruction (LVOTO), broad definition

351

2.72

17.83

1.5

31.86

33.36

g/l

0.49

314

ILD, hospital admissions

181

900

2.04

17.76

1.5

32.55

31.35

g/l

0.58

156

805

Other interstitial pulmonary diseases

183

914

2.03

17.74

1.5

32.55

31.31

g/l

0.62

158

816

Persons encountering health services in other circumstances

280

1599

1.76

17.65

1.5

1.4

31.22

33.43

g/l

1.90

265

1437

Second line medication for Crohn's disease

404

2540

1.60

17.65

1.5

1.4

34.41

33.73

g/l

0.47

375

2301

Symptoms and signs concerning food and fluid intake

105

416

2.56

17.64

1.4

31.43

32.33

g/l

0.25

382

Morphin

5.32

17.61

1.6

1.4

36.74

27.01

g/l

3.99

Insulin, fast-acting (human)

118

494

2.41

17.61

1.5

1.4

26.73

32.95

g/l

5.23

100

450

Interstitial lung disease

183

918

2.03

17.53

1.5

32.55

31.30

g/l

0.63

158

820

Interstitial lung disease endpoints

183

918

2.03

17.53

1.5

32.55

31.30

g/l

0.63

158

820

Parodontitis or operation codes

716

3707

1.43

17.46

1.4

1.5

33.32

33.10

g/l

0.17

643

3344

Mycoses

231

1253

1.86

17.41

1.5

31.44

32.69

g/l

0.68

202

1130

Pneumonia due to Streptococcus pneumoniae

112

4.19

17.30

1.4

1.5

34.21

30.83

g/l

0.76

105

Intracranial trauma

419

1974

1.59

17.28

1.5

1.4

31.71

34.43

g/l

3.96

378

1772

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

130

574

2.30

17.24

1.4

1.5

28.76

27.81

g/l

0.38

117

501

Parodontitis

714

3707

1.43

17.23

1.4

1.5

33.35

33.09

g/l

0.20

642

3343

Benign neoplasms

760

3002

1.42

17.00

1.6

1.4

32.39

33.43

g/l

1.28

675

2709

Other disorders of white blood cells

224

3.15

16.96

1.7

1.5

34.85

32.51

g/l

0.71

196

Persons encountering health services for specific procedures, not carried out

188

3.34

16.95

1.6

1.4

35.02

33.13

g/l

0.44

169

Chronic periodontitis, including avohilmo

709

3704

1.42

16.90

1.4

1.5

33.33

33.11

g/l

0.18

637

3341

Chronic ulcer of skin, not elsewhere classified

339

2.71

16.89

1.6

1.5

31.13

31.27

g/l

0.04

310

Carcinoma in situ of skin

294

2.84

16.87

1.4

1.5

31.02

26.94

g/l

1.92

256

Aortic valve malfunction, age under 60 years

328

2.72

16.79

1.5

31.50

33.54

g/l

0.72

292

Symptoms and signs involving cognition, perception, emotional state and behaviour

755

3777

1.41

16.76

1.5

32.07

33.24

g/l

1.64

668

3415

Exposure to unspecified factor

717

3950

1.41

16.67

1.5

1.4

32.11

33.33

g/l

1.69

638

3559

Substance use, excluding alcohol

137

627

2.20

16.61

1.3

1.5

36.69

34.33

g/l

1.38

125

566

Dermatitis

477

3158

1.52

16.59

1.5

1.4

32.95

33.03

g/l

0.04

431

2834

Amyloidosis, other/unspecified

4.83

16.57

1.6

1.4

23.90

32.48

g/l

3.43

Bronchiectasis

389

2.57

16.54

1.6

1.4

32.93

32.16

g/l

0.26

351

Other embolism and thrombosis

137

630

2.20

16.50

1.5

29.90

32.06

g/l

1.19

127

565

Persons encountering health services for other counselling and medical advice, not elsewhere classified

847

3503

1.38

16.47

1.6

1.4

32.41

33.31

g/l

1.15

768

3140

Benign neoplasm of other and ill-defined parts of digestive system

129

580

2.25

16.37

1.5

30.95

29.36

g/l

0.67

109

502

Other or unspecified ileus, impaction or obstruction

202

1073

1.90

16.31

1.4

1.5

32.57

31.72

g/l

0.40

181

947

Viral pneumonia (known virus, not influenza)

4.52

16.30

1.5

29.59

30.59

g/l

0.19

In situ neoplasms

326

1991

1.65

16.18

1.5

31.45

31.90

g/l

0.27

281

1776

Fentanyl

114

491

2.35

16.05

1.6

1.5

37.00

29.77

g/l

7.16

108

429

Malignant melanoma, excluding all cancers (controls excluding all cancers)

137

637

2.17

16.02

1.7

1.5

31.54

28.96

g/l

1.65

121

555

Immunodeficiencies

142

3.67

15.95

1.8

1.4

33.11

32.73

g/l

0.06

120

305

1821

1.67

15.94

1.4

32.60

33.04

g/l

0.25

279

1624

Other disorders of skin and subcutaneous tissue, not elsewhere classified

144

685

2.13

15.92

1.5

30.84

32.09

g/l

0.61

135

620

Osteoporosis

245

1325

1.78

15.90

1.5

29.24

31.68

g/l

2.04

213

1187

Gastrointestinal diseases

395

1232

1.61

15.86

1.6

1.4

32.67

34.51

g/l

1.88

355

1129

Amyloidosis

103

4.27

15.82

1.6

1.4

24.80

31.78

g/l

2.61

Other disorders involving the immune mechanism, not elsewhere classified

4.37

15.81

1.4

27.45

31.76

g/l

1.08

Decubitus ulcer and pressure area

311

2.74

15.80

1.6

1.5

28.70

30.82

g/l

0.87

286

Problems related to lifestyle

299

2.74

15.73

1.6

1.4

34.93

33.64

g/l

0.37

271

Diagnoses used for exclusion with ILD

254

1464

1.75

15.70

1.5

30.90

32.10

g/l

0.78

229

1294

Injuries to the thorax

398

2570

1.56

15.61

1.5

32.42

32.41

g/l

0.01

367

2288

Other and unspecified dermatitis

388

2491

1.57

15.60

1.5

32.32

33.22

g/l

0.67

348

2236

Hernia

726

3538

1.40

15.49

1.5

1.4

32.26

33.24

g/l

1.25

651

3173

Unspecified privation

105

444

2.40

15.44

1.6

1.5

32.02

31.89

g/l

0.03

402

Abnormal results of function studies

271

2.81

15.21

1.7

1.5

32.91

32.49

g/l

0.09

246

Disorders of thyroid, IBD co-morbidities

133

443

2.20

15.21

1.6

1.3

33.07

35.29

g/l

1.11

120

404

Other malignant neoplasms of skin (=non-melanoma skin cancer)

558

3050

1.45

15.12

1.5

30.98

32.32

g/l

1.73

495

2729

Basal cell carcinoma

568

3145

1.45

15.11

1.5

31.16

32.27

g/l

1.31

498

2823

Thrombocytopenia, unspecified

295

2.73

15.10

1.6

1.5

29.84

32.37

g/l

1.11

266

Genitourinary diseases

463

1519

1.53

15.07

1.5

1.4

31.88

35.65

g/l

7.49

412

1383

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

314

2.66

14.91

1.7

1.5

29.18

31.96

g/l

1.13

284

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

378

2.49

14.91

1.4

1.5

32.89

28.90

g/l

1.98

330

Other special examinations and investigations of persons without complaint or reported diagnosis

556

1920

1.47

14.87

1.6

1.4

31.95

33.62

g/l

2.12

502

1728

Persons with potential health hazards related to communicable diseases

188

996

1.88

14.85

1.4

33.24

34.64

g/l

0.70

162

912

Rheumatoid arthritis

295

1628

1.66

14.81

1.4

34.71

33.15

g/l

1.27

275

1449

ILD, hospital admissions 1, main diag only

159

808

2.00

14.78

1.5

31.99

31.41

g/l

0.21

136

724

Multiple myeloma and malignant plasma cell neoplasms

170

3.31

14.71

1.4

1.5

30.39

27.55

g/l

0.64

150

Multiple myeloma, excluding all cancers (controls excluding all cancers)

170

3.31

14.71

1.4

1.5

29.87

27.50

g/l

0.51

150

Covid-19 suspected case

124

574

2.17

14.66

1.7

1.5

34.63

33.67

g/l

0.37

114

518

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.37

14.63

1.4

28.31

31.49

g/l

0.67

Fracture of rib(s), sternum and thoracic spine

279

1683

1.67

14.61

1.5

32.30

32.16

g/l

0.07

256

1491

Basal cell carcinoma, including avohilmo

574

3172

1.43

14.48

1.5

31.13

32.26

g/l

1.36

504

2845

Angina pectoris

530

2464

1.46

14.42

1.6

1.4

30.80

34.39

g/l

7.87

465

2230

Tobacco use

153

3.40

14.27

1.5

34.51

33.05

g/l

0.31

133

Medical observation and evaluation for suspected diseases and conditions

546

1920

1.46

14.22

1.5

1.4

32.04

33.63

g/l

1.96

492

1728

399

2.40

14.18

1.5

35.57

33.42

g/l

0.89

360

Other diseases of intestine

132

637

2.10

14.14

1.5

29.78

31.94

g/l

0.94

116

580

Asthma and opportunity respiratory infection

222

2.96

14.12

1.5

33.47

31.87

g/l

0.45

200

Other external causes of accidental injury

645

2289

1.42

14.12

1.5

1.4

31.81

33.95

g/l

3.72

580

2056

Accidents

645

2289

1.42

14.12

1.6

1.4

31.79

33.95

g/l

3.80

579

2056

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

157

807

1.96

14.05

1.4

1.5

31.41

28.86

g/l

1.69

138

698

Congenital malformations of heart and great arteries

381

2.41

14.05

1.6

1.5

31.38

33.13

g/l

0.68

342

Sulfasalazine

208

1169

1.79

14.04

1.4

35.97

33.52

g/l

1.94

185

1055

Malignant neoplasm of kidney, except renal pelvis

113

516

2.23

13.99

1.4

1.5

32.85

31.62

g/l

0.48

101

463

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

118

528

2.18

13.96

1.7

1.5

29.17

33.61

g/l

3.36

104

477

Other and unspecified disorders of white blood cells

171

3.24

13.92

1.8

1.4

32.80

31.84

g/l

0.20

152

Malignant neoplasm of urinary organs

124

591

2.14

13.79

1.5

32.48

31.23

g/l

0.53

110

533

Aortic aneurysm

263

1560

1.67

13.78

1.5

31.01

32.92

g/l

1.73

239

1411

Reimbursement for rheumatic diseases

425

2855

1.49

13.74

1.4

1.5

34.08

33.23

g/l

0.65

392

2565

ILD medications: azathioprine

104

461

2.27

13.72

1.5

1.4

31.38

33.36

g/l

0.74

416

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

225

1305

1.74

13.67

1.4

1.5

35.34

32.25

g/l

2.83

207

1171

Other nutritional deficiencies

404

2634

1.50

13.61

1.5

1.4

33.28

33.73

g/l

0.29

373

2388

Seropositive rheumatoid arthritis

230

1341

1.72

13.58

1.4

35.42

32.99

g/l

1.97

212

1192

Elevated blood glucose level

331

2.52

13.42

1.5

29.44

32.20

g/l

0.99

304

Lung diseases due to external agents

162

857

1.92

13.40

1.5

31.05

30.82

g/l

0.08

145

758

Other arthritis (FG)

245

1466

1.68

13.26

1.5

1.4

32.62

33.63

g/l

0.65

232

1308

Vitreous haemorrhage

104

471

2.24

13.13

1.4

1.5

28.65

32.04

g/l

1.85

422

Diverticular disease of intestine

618

2956

1.39

13.10

1.5

1.4

31.02

33.28

g/l

4.00

550

2660

Seropositive rheumatoid arthritis, wide

230

1363

1.70

12.95

1.4

1.5

35.42

32.33

g/l

2.92

212

1219

Cutaneous abscess, furuncle and carbuncle

188

1052

1.80

12.93

1.7

1.4

31.21

33.52

g/l

1.52

175

955

Viral infections characterized by skin and mucous membrane lesions

295

1862

1.59

12.84

1.6

1.5

31.52

33.06

g/l

1.27

260

1679

Congenital malformations of the circulatory system

101

440

2.24

12.84

1.7

1.5

30.79

33.74

g/l

1.58

396

Other symptoms and signs involving the circulatory and respiratory systems

195

2.96

12.83

1.6

1.4

32.68

32.71

g/l

0.01

180

Finngen Rheumatological endpoints

703

2944

1.37

12.80

1.5

1.4

32.44

33.59

g/l

1.50

645

2631

Deposits [accretions] on teeth

220

2.80

12.73

1.5

32.29

33.19

g/l

0.20

201

Artificial opening status

219

2.84

12.65

1.5

1.4

31.51

33.46

g/l

0.54

202

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

116

3.63

12.63

1.1

1.4

36.13

27.33

g/l

1.97

102

Rheumatoid arthritis, including avohilmo

309

1982

1.57

12.62

1.4

1.5

34.70

32.40

g/l

2.52

289

1771

Benzodiazepine use

748

3983

1.34

12.57

1.4

1.5

34.15

32.80

g/l

2.17

677

3581

Injuries to the abdomen, lower back, lumbar spine and pelvis

319

2049

1.56

12.55

1.5

31.81

32.18

g/l

0.20

287

1811

Vascular disorders of the intestines

361

2.40

12.52

1.6

1.4

27.80

30.71

g/l

1.30

332

Parodontitis and operation codes

643

3666

1.37

12.50

1.4

1.5

33.32

33.13

g/l

0.13

579

3307

Open wound of lower leg

121

593

2.06

12.46

1.5

30.56

32.54

g/l

0.93

103

540

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

424

2.27

12.45

1.5

32.28

32.09

g/l

0.05

378

Obesity related asthma

245

1493

1.65

12.39

1.5

32.67

33.38

g/l

0.40

223

1355

Other/unspecified seropositive rheumatoid arthritis

225

1343

1.69

12.36

1.4

1.5

35.34

32.32

g/l

2.73

207

1202

Sequelae with surgical and medical care as external cause

180

1011

1.80

12.31

1.6

1.5

31.11

32.21

g/l

0.56

162

906

Azathioprine

104

485

2.16

12.18

1.5

1.4

31.38

33.35

g/l

0.74

438

External causes of morbidity and mortality

499

1743

1.44

12.03

1.6

1.4

31.92

34.16

g/l

3.30

455

1555

Haemorrhage, not elsewhere classified

171

3.06

12.00

1.5

1.4

29.93

32.41

g/l

0.74

155

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

155

840

1.86

11.90

1.3

1.5

30.79

28.85

g/l

1.07

140

728

Other benign neoplasms of skin

223

1314

1.67

11.90

1.4

1.5

32.22

29.82

g/l

2.09

204

1151

Candidiasis

107

510

2.12

11.89

1.6

1.5

31.34

32.33

g/l

0.29

463

Cholelithiasis, broad definition with cholecystitis

684

3497

1.34

11.72

1.4

1.5

32.31

33.01

g/l

0.70

612

3144

Other complications of surgical and medical care, not elsewhere classified

342

2.37

11.59

1.5

1.4

34.03

32.55

g/l

0.47

314

Chronic nephritic syndrome

154

3.12

11.49

1.9

1.4

25.43

32.52

g/l

2.11

138

Thoracic aortic aneurysm

142

759

1.89

11.47

1.4

1.5

31.61

33.48

g/l

1.08

132

682

Other diseases of arteries and capillaries

395

2.26

11.41

1.6

1.4

27.87

32.65

g/l

2.79

353

Coronary angioplasty

373

1941

1.49

11.40

1.5

28.82

33.89

g/l

11.15

330

1755

Autoimmune diseases related-to ILD

599

3890

1.36

11.40

1.5

1.4

31.97

33.27

g/l

1.62

545

3498

Dysphagia

215

1298

1.67

11.36

1.5

31.63

32.46

g/l

0.47

201

1146

Sulfonylureas

403

2219

1.46

11.34

1.6

1.5

29.21

32.01

g/l

4.11

345

1997

Poisoning by drugs, medicaments and biological substances

134

705

1.91

11.27

1.4

1.5

35.91

33.72

g/l

1.09

122

641

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

135

3.24

11.26

1.4

1.5

31.83

27.82

g/l

0.95

120

Asthma, including avohilmo

861

3862

1.30

11.26

1.5

1.4

32.39

33.22

g/l

1.15

785

3465

Missing teeth due to accident, extraction or parodontitis

110

542

2.05

11.24

1.6

1.5

31.81

33.27

g/l

0.53

493

Parodontitis or/and operation codes

418

1711

1.46

11.21

1.4

1.5

33.16

32.83

g/l

0.19

375

1572

Thyrotoxicosis, other and/or unspecified

137

730

1.89

11.11

1.6

1.5

30.97

32.89

g/l

1.05

124

661

Congenital malformations of cardiac septa

146

3.08

11.08

1.9

1.4

29.46

32.22

g/l

0.79

127

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

139

744

1.88

11.08

1.4

1.5

36.32

34.87

g/l

0.65

128

689

Seropositive rheumatoid arthritis, strict definition

125

650

1.94

10.95

1.4

1.5

37.41

32.54

g/l

3.27

114

584

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

106

520

2.06

10.95

1.7

1.5

31.26

28.80

g/l

1.38

454

Congenital malformations, deformations and chromosomal abnormalities

323

2073

1.50

10.76

1.6

1.4

31.89

34.11

g/l

2.62

297

1879

Delirium, not induced by alcohol and other psychoactive substances

131

697

1.90

10.73

1.4

1.5

30.61

30.67

g/l

0.02

114

609

Statin medication

454

1792

1.42

10.71

1.5

1.4

31.08

35.28

g/l

9.35

402

1642

Benign neoplasm of ovary

367

2.25

10.67

1.3

1.5

32.44

29.56

g/l

1.08

311

Thyrotoxicosis

170

983

1.74

10.55

1.6

1.5

31.24

32.90

g/l

0.95

154

888

Diseases of the myoneural junction and muscle

115

590

1.97

10.53

1.5

31.23

31.86

g/l

0.20

106

527

Acute pancreatitis

177

1038

1.72

10.48

1.5

30.85

32.24

g/l

0.72

157

925

Phlebitis and thrombophlebitis (not including DVT)

184

1091

1.70

10.45

1.4

1.5

33.81

32.76

g/l

0.48

166

972

Non-Hodgkin lymphoma, all

243

2.58

10.45

1.7

1.5

29.93

30.48

g/l

0.13

221

Abdominal and pelvic pain

758

2912

1.31

10.44

1.5

1.4

32.32

33.31

g/l

1.17

682

2622

Benign neoplasm of other and unspecified endocrine glands

346

2.27

10.40

1.6

1.5

33.00

29.65

g/l

1.34

303

Fracture of lumbar spine and pelvis

200

1213

1.66

10.39

1.5

30.66

31.37

g/l

0.33

175

1070

Injury of other and unspecified intrathoracic organs

285

2.43

10.38

1.4

1.5

34.52

32.18

g/l

0.83

254

Zoster [herpes zoster]

160

915

1.77

10.38

1.6

1.5

30.72

31.36

g/l

0.26

143

818

Benign neoplasm: Colon, unspecified

239

1519

1.59

10.33

1.5

30.12

32.29

g/l

1.79

194

1355

Abnormal findings on diagnostic imaging of other body structures

479

2.07

10.26

1.8

1.5

33.09

31.80

g/l

0.42

442

Other specified/unspecified arthritis

211

1303

1.63

10.23

1.5

1.4

32.59

33.72

g/l

0.67

199

1166

Other gastritis (incl. Duodenitis)

203

1245

1.64

10.15

1.6

1.4

30.42

32.75

g/l

1.64

174

1108

Benign neoplasm: Stomach

282

2.40

10.10

1.5

29.69

28.11

g/l

0.38

247

Other antidepressants

814

3298

1.29

10.05

1.5

33.31

32.95

g/l

0.32

734

2977

Thyrotoxicosis with toxic multinodular goitre

253

2.49

10.05

1.7

1.4

33.37

32.37

g/l

0.27

228

Other and unspecified local infections of skin and subcutaneous tissue

366

2.21

9.95

1.7

1.5

30.88

32.20

g/l

0.41

332

Other infectious diseases

373

2.20

9.94

1.7

1.5

30.96

31.54

g/l

0.14

341

Benign neoplasm: Caecum

360

2.22

9.93

1.6

1.5

29.54

28.72

g/l

0.22

310

Syphilis

3.69

9.88

1.6

1.5

28.15

34.09

g/l

1.69

Disorders of mineral metabolism

330

2.27

9.81

1.5

1.4

31.57

33.46

g/l

0.58

300

Injury, poisoning and certain other consequences of external causes

398

1389

1.44

9.78

1.6

1.4

32.33

34.24

g/l

2.13

363

1241

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

318

2.29

9.75

1.5

1.4

31.28

32.83

g/l

0.43

284

Psychiatric diseases

822

3211

1.28

9.74

1.4

1.5

33.04

33.23

g/l

0.15

737

2905

Arterial embolism and thrombosis

301

2.33

9.65

1.4

1.5

26.72

31.44

g/l

2.18

272

Other viral diseases

158

916

1.73

9.64

1.4

1.5

33.41

33.99

g/l

0.22

147

832

DVT of lower extremities

175

1048

1.68

9.64

1.4

1.5

32.33

31.98

g/l

0.12

152

922

Supplementary factors related to causes of morbidity and mortality classified elsewhere

213

1339

1.60

9.63

1.5

31.10

32.95

g/l

1.24

194

1200

Benign neoplasm: Adrenal gland

199

2.65

9.60

1.8

1.5

32.46

29.12

g/l

0.94

175

Degeneration of macula and posterior pole

456

2737

1.38

9.59

1.4

1.5

29.84

32.25

g/l

3.85

416

2448

Concussion

327

1943

1.46

9.57

1.5

1.4

32.78

34.42

g/l

1.52

300

1744

Leiomyoma of uterus

165

532

1.75

9.54

1.4

34.08

29.94

g/l

2.83

149

465

Persons encountering health services for examination and investigation

522

1920

1.37

9.52

1.5

1.4

32.31

33.62

g/l

1.48

467

1728

Amputation of ankle bones

119

3.22

9.45

1.4

1.5

24.93

30.52

g/l

1.48

106

Superficial injury of head

166

985

1.70

9.43

1.5

31.07

32.36

g/l

0.69

153

880

Discitis, unspecified

4.08

9.42

1.2

1.5

35.46

29.03

g/l

1.44

Obesity and other hyperalimentation

365

2548

1.42

9.41

1.5

1.4

33.43

33.76

g/l

0.20

337

2316

Other local infections of skin and subcutaneous tissue

395

2.12

9.37

1.7

1.5

31.16

32.46

g/l

0.41

359

Obesity

363

2539

1.42

9.30

1.5

1.4

33.44

33.76

g/l

0.19

335

2308

Other (seronegative) rheumatoid arthritis, wide

155

909

1.72

9.24

1.4

1.5

32.68

31.99

g/l

0.29

146

818

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

4.24

9.23

1.5

1.3

33.49

25.68

g/l

1.55

Disorders of other endocrine glands

288

1921

1.48

9.19

1.5

1.4

30.87

32.72

g/l

1.52

260

1715

Unspecified fall

365

2568

1.42

9.17

1.4

1.5

30.81

32.75

g/l

2.20

329

2288

Intracranial injury

423

2971

1.38

9.14

1.5

31.54

32.97

g/l

1.49

379

2661

Drug-induced hypoglycaemia without coma

4.10

9.14

1.7

1.4

27.40

29.91

g/l

0.41

Malignant neoplasm of digestive organs

377

2652

1.41

9.10

1.4

1.5

31.78

31.91

g/l

0.06

340

2369

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

3.83

9.10

1.4

33.81

27.74

g/l

1.16

Other/unspecified rheumatoid arthritis

115

621

1.87

9.09

1.5

32.70

31.71

g/l

0.38

108

558

Tuberculosis, IBD comorbidity

441

2.05

9.08

1.4

1.5

35.30

30.43

g/l

2.50

399

Disorders of calcium metabolism

247

2.42

9.08

1.5

1.4

32.79

33.32

g/l

0.11

226

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

413

2.07

9.06

1.3

1.4

36.67

34.78

g/l

0.64

371

Other and unspecified myopathies

428

2.06

9.05

1.5

30.45

31.09

g/l

0.18

387

Obesity due to excess calories

267

1794

1.49

8.94

1.5

33.34

33.90

g/l

0.30

246

1629

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

114

616

1.87

8.93

1.4

1.5

31.28

28.92

g/l

1.21

541

Mixed connective tissue disease

195

2.60

8.91

1.4

32.93

33.10

g/l

0.03

169

Poisoning by medicine

113

610

1.86

8.89

1.4

1.5

35.38

33.80

g/l

0.65

104

551

Disorder of lipoprotein metabolism, unspecified

129

727

1.79

8.89

1.5

1.4

30.93

32.26

g/l

0.54

117

652

Other specified/unspecified systemic involvement of connective tissue

178

2.68

8.89

1.3

32.30

33.73

g/l

0.27

156

Fracture of shoulder and upper arm

270

1821

1.49

8.87

1.5

30.97

32.47

g/l

1.19

241

1626

Weight loss

438

2.03

8.86

1.4

1.5

31.97

31.95

g/l

0.00

395

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

486

1.97

8.83

1.4

1.5

31.02

28.62

g/l

0.97

424

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

213

1369

1.56

8.80

1.5

31.25

33.42

g/l

1.74

196

1249

Systemic connective tissue disorders

262

1761

1.50

8.80

1.5

30.81

32.61

g/l

1.47

235

1581

Arthropathies in other diseases classified elsewhere

135

2.94

8.75

1.6

1.4

29.06

33.13

g/l

1.05

121

Type of accident

195

1230

1.59

8.74

1.5

30.73

32.97

g/l

1.57

177

1104

Diseases of the eye and adnexa

515

1915

1.35

8.74

1.5

1.4

33.37

35.02

g/l

1.98

468

1739

Cholelithiasis

638

3458

1.30

8.70

1.4

1.5

32.06

33.01

g/l

1.05

569

3109

Acute pancreatitis (for exclusion)

177

1093

1.63

8.70

1.5

30.85

32.09

g/l

0.62

157

983

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

315

2.22

8.69

1.3

1.5

35.91

27.71

g/l

3.55

278

Tubulo-interstitial nephritis, not specified as acute or chronic

265

2.33

8.64

1.5

1.4

30.36

32.02

g/l

0.52

237

Septal defects

138

2.87

8.60

1.8

1.4

31.35

32.48

g/l

0.24

120

Carcinoma in situ of skin of scalp and neck

3.36

8.57

1.6

1.4

29.41

26.48

g/l

0.62

Melanocytic naevi of trunk

291

2.25

8.56

1.5

1.6

33.75

29.60

g/l

1.52

253

General examination and investigation of persons without complaint and reported diagnosis

485

1910

1.36

8.55

1.5

1.4

32.95

33.63

g/l

0.53

454

1719

Melanocytic naevi

133

764

1.75

8.53

1.5

33.31

30.72

g/l

1.52

117

679

L01XX Other antineoplastic agents

280

2.29

8.52

1.3

1.5

31.93

31.78

g/l

0.04

254

Duodenal ulcer

121

679

1.80

8.49

1.4

1.5

32.51

31.58

g/l

0.31

108

607

Other diseases of pancreas

358

2.12

8.48

1.4

1.5

30.99

32.42

g/l

0.43

321

N06DA Anticholinesterases

164

2130

0.62

8.47

1.3

1.5

30.19

30.99

g/l

0.39

145

1887

Use of anticholinesterases

164

2130

0.62

8.47

1.3

1.5

30.19

30.99

g/l

0.39

145

1887

Chronic gastritis

252

1699

1.49

8.38

1.5

1.4

30.60

32.30

g/l

1.31

216

1514

Diseases of pulp and periapical tissues, including avohilmo

810

3345

1.26

8.37

1.5

1.4

33.18

32.84

g/l

0.31

725

3002

Dissection of aorta

156

2.75

8.32

1.5

1.4

31.56

32.10

g/l

0.09

141

Intestinal malabsorption

128

2.93

8.30

1.9

1.3

25.30

33.59

g/l

2.80

111

Volvulus

118

3.04

8.26

1.5

1.4

28.17

29.44

g/l

0.20

108

Neurological diseases, wide definition

167

499

1.68

8.25

1.5

1.3

31.98

35.72

g/l

2.62

149

452

Dental pulpitis 1

809

3350

1.26

8.19

1.5

1.4

33.18

32.86

g/l

0.28

725

3006

Fracture of lower leg, including ankle

375

2718

1.38

8.15

1.5

32.06

33.64

g/l

1.68

336

2454

Attention to artificial openings

152

2.75

8.13

1.2

1.4

31.75

31.68

g/l

0.01

138

ILD-related respiratory insufficiency

182

2.60

8.08

1.4

1.5

31.50

31.08

g/l

0.08

164

Other neurological diseases

589

3671

1.29

8.07

1.5

30.11

32.99

g/l

6.17

530

3293

Suicide or other Intentional self-harm

136

800

1.71

8.05

1.4

1.5

36.16

33.91

g/l

1.21

125

726

Other symptoms and signs involving the digestive system and abdomen

113

632

1.80

8.00

1.4

33.65

33.06

g/l

0.17

107

573

Dental pulpitis 4

807

3350

1.25

8.00

1.5

1.4

33.15

32.85

g/l

0.26

723

3007

Pain (limb, back, neck, head abdominally)

588

2262

1.31

7.98

1.6

1.4

31.75

33.56

g/l

2.62

516

2045

Other disorders of veins

265

1822

1.46

7.95

1.5

33.28

33.26

g/l

0.01

241

1637

Sequelae of other external causes

207

2.45

7.93

1.5

1.4

28.27

32.25

g/l

1.53

183

Acute posthaemorrhagic anaemia

160

2.68

7.93

1.2

1.4

31.42

31.36

g/l

0.01

147

Dipeptidyl peptidase 4 (DPP-4) inhibitors

115

651

1.79

7.88

1.7

1.4

32.63

32.25

g/l

0.11

590

Migraine, single triptan purchase ok & required. ICD-code if available is included

192

1990

0.65

7.84

1.4

35.27

34.57

g/l

0.34

172

1827

Triptan medication for migraine, single purchase ok

192

1990

0.65

7.84

1.4

35.27

34.57

g/l

0.34

172

1827

Tuberculosis, wide

466

1.94

7.83

1.4

1.5

35.30

30.40

g/l

2.55

418

Unstable angina pectoris

367

2215

1.38

7.82

1.6

1.5

30.20

33.09

g/l

4.06

321

2000

Carcinoma in situ of skin of other and unspecified parts of face

502

1.90

7.81

1.6

1.5

29.27

30.66

g/l

0.50

453

Congenital malformations of the urinary system

167

2.61

7.78

1.7

1.3

26.26

32.70

g/l

2.77

147

Exclusions for E4_PCOS_CONSORTIUM

363

1642

1.39

7.75

1.4

34.81

33.04

g/l

1.65

327

1486

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

257

1063

1.48

7.75

1.5

31.99

30.94

g/l

0.58

213

945

Sequelae of cerebrovascular disease

344

2185

1.39

7.69

1.4

1.5

30.23

32.31

g/l

2.19

306

1973

Familial hypercholesterolemia

146

889

1.66

7.66

1.7

1.4

31.32

32.37

g/l

0.46

138

791

Sleep disorders (combined)

697

3627

1.26

7.64

1.5

1.4

33.94

33.07

g/l

1.03

633

3271

Pyogenic arthritis

326

2.11

7.64

1.5

29.64

32.55

g/l

1.01

294

Open wound of ankle and foot

367

2.03

7.57

1.6

1.5

30.35

32.50

g/l

0.63

332

Benign neoplasm: Rectosigmoid junction

124

2.87

7.56

1.3

1.6

33.57

27.57

g/l

1.32

113

Malignant neoplasm of breast, HER-negative

130

769

1.70

7.56

1.3

1.4

33.22

32.09

g/l

0.49

117

692

Diseases of oral cavity, salivary glands and jaws

714

2906

1.26

7.55

1.5

1.4

31.79

33.07

g/l

1.65

631

2608

Other and unspecified drugs and medicaments

314

2.12

7.55

1.5

31.11

32.84

g/l

0.47

279

Any mental disorder

827

3340

1.24

7.54

1.4

1.5

32.66

33.18

g/l

0.52

743

3014

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

375

2.02

7.51

1.4

1.5

30.43

28.34

g/l

0.70

325

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

139

840

1.66

7.47

1.4

36.32

34.21

g/l

1.12

128

765

Osteonecrosis

227

2.32

7.36

1.4

1.5

34.08

32.54

g/l

0.42

208

Asthma, hospital admissions , main diagnosis only

551

3848

1.29

7.34

1.5

1.4

32.41

33.15

g/l

0.75

501

3463

Multiple myeloma and malignant plasma cell neoplasms

248

2.26

7.25

1.4

1.5

30.39

31.17

g/l

0.13

222

Tuberculosis

402

1.97

7.23

1.4

1.5

36.02

30.35

g/l

2.88

361

Cholecystitis

132

796

1.67

7.22

1.4

1.5

33.78

30.96

g/l

1.37

116

705

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

235

2.27

7.21

1.3

1.5

33.04

27.51

g/l

2.34

197

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

388

1.98

7.19

1.4

1.5

30.43

28.26

g/l

0.74

336

Corns and callosities

281

2.16

7.18

1.4

1.5

33.63

32.59

g/l

0.24

251

Acidosis

3.34

7.17

1.5

28.71

33.14

g/l

0.81

Malnutrition

3.42

7.16

1.6

1.4

22.26

32.11

g/l

2.61

Alcohol dependence

212

1429

1.49

7.13

1.6

1.5

34.59

33.41

g/l

0.68

192

1275

Respiratory tuberculosis

336

2.05

7.10

1.4

1.5

37.29

31.08

g/l

2.92

300

Respiratory tuberculosis, confirmed and not-confirmed

336

2.05

7.10

1.4

1.5

37.29

31.08

g/l

2.92

300

Chronic diseases of tonsils and adenoids

263

2355

0.71

7.07

1.4

34.19

34.26

g/l

0.03

242

2146

Other symptoms and signs involving the urinary system

540

1.82

7.07

1.7

1.5

30.46

31.85

g/l

0.55

485

Other and unspecified coagulation defects

118

2.83

7.02

1.5

1.4

33.07

32.50

g/l

0.08

103

Methotrexate

100

564

1.78

6.95

1.3

1.4

34.83

32.76

g/l

0.84

507

Other diseases of urinary system

750

3411

1.24

6.90

1.5

1.4

31.54

33.24

g/l

2.83

656

3092

Benign neoplasm: Transverse colon

552

1.80

6.90

1.4

1.5

32.74

32.04

g/l

0.22

499

Other noninfective gastroenteritis and colitis

169

1093

1.55

6.89

1.4

1.5

31.19

32.29

g/l

0.51

147

978

Carcinoma in situ of other and unspecified digestive organs

3.32

6.87

1.4

31.49

27.60

g/l

0.70

Other viral diseases, not elsewhere classified

107

617

1.74

6.82

1.4

1.5

34.21

33.06

g/l

0.41

101

566

Other coagulation defects

222

2.27

6.81

1.5

1.4

31.76

33.08

g/l

0.27

197

Benign neoplasm of major salivary glands

307

2.07

6.80

1.6

1.5

31.30

28.64

g/l

0.80

268

Benign neoplasm: Ascending colon

121

728

1.68

6.73

1.8

1.5

30.21

32.07

g/l

1.06

108

653

Noninfective enteritis and colitis

296

2145

1.38

6.66

1.4

1.5

30.71

33.40

g/l

2.89

265

1924

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

251

1048

1.44

6.64

1.5

31.93

30.90

g/l

0.56

208

932

Use of rivastigmine

970

0.46

6.62

1.4

1.5

28.35

30.16

g/l

0.52

843

Complications of internal orthopaedic prosthetic devices, implants and grafts

187

1250

1.51

6.61

1.4

1.5

31.68

32.20

g/l

0.24

158

1122

Other symptoms and signs involving cognitive functions and awareness

378

2673

1.33

6.60

1.4

1.5

31.64

32.53

g/l

0.67

325

2409

Embolic stroke with flimmer

101

2.93

6.51

1.3

23.99

32.73

g/l

2.79

Other diseases of biliary tract

417

1.89

6.50

1.5

30.16

31.51

g/l

0.39

377

Abnormal weight loss

410

1.90

6.50

1.4

1.5

32.25

31.98

g/l

0.05

368

Gingivitis and periodontal diseases

685

2846

1.25

6.50

1.5

1.4

32.93

33.17

g/l

0.17

611

2555

Injury of intra-abdominal organs

3.69

6.50

1.5

35.59

33.62

g/l

0.27

Alcohol withdrawal state with delirium

320

2.02

6.49

1.4

1.5

32.72

32.44

g/l

0.05

285

Other functional intestinal disorders

333

2354

1.35

6.47

1.5

1.4

31.90

32.93

g/l

0.75

295

2115

Benign neoplasm: Sigmoid colon

159

1033

1.55

6.44

1.6

1.5

34.06

31.68

g/l

1.67

143

927

Benign neoplasm of urinary organs

130

2.65

6.40

1.6

1.5

32.33

27.20

g/l

1.29

115

Carcinoma in situ of skin

449

1.85

6.38

1.4

1.5

31.02

31.19

g/l

0.04

409

Diabetic neuropathy

114

682

1.68

6.37

1.6

1.5

27.37

31.42

g/l

2.29

595

Dental operations

583

2371

1.27

6.34

1.5

1.4

31.15

33.07

g/l

2.86

515

2101

Fitting and adjustment of other devices

270

1809

1.39

6.34

1.4

30.10

32.21

g/l

1.85

248

1611

Pneumonitis due to solids and liquids

472

1.82

6.31

1.5

28.11

30.44

g/l

0.80

417

Personality disorders, excluding more controls

109

648

1.69

6.31

1.5

36.90

35.51

g/l

0.49

102

594

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

474

1.81

6.20

1.3

1.5

30.79

27.78

g/l

1.31

414

Soft tissue disorders

726

3071

1.23

6.20

1.5

1.4

31.46

33.33

g/l

3.33

649

2749

Cystic kidney disease

104

2.83

6.18

1.7

1.4

24.59

32.08

g/l

2.85

Malignant neoplasm of head and neck

446

1.84

6.18

1.4

1.5

32.50

31.85

g/l

0.17

401

Drug-induced osteoporosis with pathological fracture

3.85

6.14

1.3

1.2

25.29

31.18

g/l

0.91

Abnormal findings in nipple discharge synovial fluid wound secretions

4.20

6.12

1.3

1.4

31.73

34.15

g/l

0.32

Other and unspecified nonorganic psychotic disorders

512

1.77

6.12

1.5

34.86

34.74

g/l

0.03

462

Smoking dependency

307

2.01

6.08

1.3

1.5

36.41

33.09

g/l

1.26

275

Actinic keratosis

361

2603

1.32

6.07

1.5

31.23

31.71

g/l

0.31

313

2314

Injuries to the elbow and forearm

426

2984

1.29

6.07

1.4

1.5

31.22

33.51

g/l

3.06

382

2678

Dizziness and giddiness

543

3519

1.26

5.99

1.5

31.98

33.07

g/l

1.20

484

3182

Exposure to other specified factors

442

3238

1.28

5.95

1.5

1.4

33.27

33.47

g/l

0.12

404

2921

Mental and behavioural disorders due to tobacco

310

1.99

5.93

1.3

1.5

36.41

33.22

g/l

1.19

279

Abscess of anal and rectal regions

290

2.02

5.89

1.5

33.40

33.52

g/l

0.02

265

Benign neoplasm: Parotid gland

237

2.13

5.86

1.6

1.5

32.23

29.20

g/l

0.83

208

Adenocarcinoma and ductal carcinoma of pancreas

180

2.32

5.84

1.1

1.4

36.13

30.58

g/l

1.02

161

Diaphragmatic hernia

280

2062

1.36

5.84

1.6

1.5

31.81

32.69

g/l

0.58

250

1840

Benign neoplasm: Rectum

154

1018

1.52

5.82

1.5

31.45

31.96

g/l

0.19

130

918

Other disorders of urethra and urinary system

490

2904

1.27

5.81

1.5

1.4

31.75

32.94

g/l

1.21

427

2633

Right hemicolectomy

313

1.98

5.81

1.3

1.5

28.04

31.49

g/l

1.15

285

Squamous cell neoplasms and carcinomas of the skin

130

829

1.58

5.79

1.4

1.5

28.76

30.77

g/l

1.10

117

735

Noninfectious colitis NAS

544

1.72

5.78

1.3

1.5

30.15

32.42

g/l

0.87

497

Dental caries 3

675

2811

1.23

5.78

1.5

1.4

31.27

32.88

g/l

2.29

592

2524

Skin changes due to chronic exposure to nonionizing radiation

365

2648

1.31

5.75

1.5

31.23

31.66

g/l

0.28

315

2357

Transient ischemic attack

451

2938

1.28

5.75

1.5

29.41

33.00

g/l

7.23

402

2662

Abdominal aortic aneurysm (AAA)

120

747

1.61

5.71

1.5

29.88

31.83

g/l

0.89

108

664

Carbimazole or st.post thyroidectomy, condition for graves disease

116

722

1.61

5.68

1.5

32.06

32.81

g/l

0.26

109

653

377

2739

1.30

5.63

1.5

31.40

31.74

g/l

0.21

325

2445

Sleep apnoea

644

3571

1.23

5.60

1.5

34.15

33.11

g/l

1.26

586

3227

Disorders of skin appendages

257

1878

1.37

5.60

1.5

32.75

33.64

g/l

0.50

233

1705

Abnormalities of gait and mobility

107

658

1.64

5.55

1.4

1.5

32.60

31.56

g/l

0.33

596

Dental pulpitis 2

591

2443

1.24

5.54

1.5

1.4

30.93

32.69

g/l

2.48

523

2182

Other reaction to severe stress, and adjustment disorders

156

1044

1.50

5.53

1.5

1.4

35.23

34.52

g/l

0.27

139

956

291

1927

1.35

5.47

1.4

1.5

29.82

31.53

g/l

1.58

265

1700

Superficial injury of hip and thigh

115

722

1.60

5.46

1.6

1.5

31.88

31.25

g/l

0.24

105

637

Dental caries 1

651

2721

1.23

5.41

1.5

1.4

31.16

32.88

g/l

2.55

569

2440

Benign lipomatous neoplasm of other sites/unspecified

272

2.00

5.41

1.4

1.5

29.98

27.92

g/l

0.50

239

Leisure time condition

119

756

1.58

5.38

1.5

30.24

32.40

g/l

0.98

107

686

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

246

2.05

5.36

1.4

1.5

33.47

27.45

g/l

2.78

219

Umbilical hernia

192

1349

1.43

5.34

1.4

1.5

32.37

33.29

g/l

0.44

167

1220

Cyst of kidney

337

1.89

5.33

1.5

1.4

29.70

32.36

g/l

0.90

303

Benign neoplasm: Rectum, anus and anal canal

171

1177

1.46

5.33

1.5

31.95

31.84

g/l

0.04

146

1056

Postmenopausal atrophic vaginitis

720

0.56

5.32

1.3

1.4

33.26

32.63

g/l

0.17

636

Other skin changes

135

886

1.53

5.31

1.3

1.5

31.00

31.62

g/l

0.24

124

794

Unspecific neurodegenerative disorder

248

2313

0.74

5.28

1.3

1.5

30.29

31.32

g/l

0.71

222

2051

Alcohol abuse, main dg, excluding more controls

574

1.66

5.27

1.3

1.5

33.83

33.89

g/l

0.01

527

Dental caries, including avohilmo

649

2721

1.22

5.26

1.5

1.4

31.12

32.87

g/l

2.62

567

2439

Diseases of spleen

3.20

5.23

1.5

32.29

31.58

g/l

0.08

Retinal vascular disorders

114

724

1.59

5.21

1.5

29.60

31.03

g/l

0.59

100

641

Benign neoplasm: Skin of other and unspecified parts of face

354

1.85

5.18

1.4

1.5

32.42

28.20

g/l

1.86

309

Dermatophytosis

104

647

1.62

5.17

1.4

1.5

31.48

32.70

g/l

0.40

582

Spondylopathies

614

3059

1.22

5.13

1.5

1.4

32.58

33.06

g/l

0.40

558

2741

Myeloproliferative diseases

414

1.78

5.13

1.3

1.5

31.54

32.18

g/l

0.19

374

Injuries to the knee and lower leg

800

3850

1.19

5.09

1.5

1.4

31.85

33.34

g/l

2.61

715

3468

Other diseases of stomach and duodenum

302

1.91

4.99

1.8

1.4

29.42

32.09

g/l

0.74

275

Other and unspecified vascular occlusions

531

1.67

4.96

1.6

1.5

31.04

31.02

g/l

0.00

470

Dental pulpitis 2, only avohilmo

600

2517

1.22

4.93

1.5

1.4

30.96

32.68

g/l

2.41

529

2248

Diseases of the musculoskeletal system and connective tissue

355

1372

1.30

4.92

1.6

1.4

32.72

34.27

g/l

1.41

316

1221

Other disorders of adrenal gland

130

2.41

4.90

1.6

1.4

26.70

32.80

g/l

1.67

115

Epilepsy

220

1603

1.37

4.89

1.4

1.5

32.90

32.56

g/l

0.14

207

1437

Retinal vascular occlusion

111

712

1.57

4.89

1.5

29.97

30.94

g/l

0.36

631

Dental caries 2 and operation codes, only avohilmo

243

2024

0.74

4.85

1.5

34.31

33.07

g/l

0.85

225

1850

Other systemic involvement of connective tissue (FG)

182

1284

1.41

4.80

1.4

31.56

32.74

g/l

0.60

162

1141

Alcohol-induced chronic pancreatitis

285

1.91

4.79

1.6

1.5

34.22

32.71

g/l

0.33

254

Procreative management

128

713

1.52

4.78

1.4

35.43

34.95

g/l

0.15

114

650

Other specified disorders of kidney and ureter

120

2.45

4.74

1.1

1.4

27.87

31.51

g/l

0.64

107

Fracture of skull and facial bones

133

893

1.50

4.73

1.4

1.5

33.62

33.47

g/l

0.05

117

812

Disorders of parathyroid gland

157

1076

1.45

4.72

1.5

30.18

31.94

g/l

0.85

137

951

Other diseases of liver

112

726

1.55

4.70

1.6

1.5

30.30

33.27

g/l

1.42

102

660

Other benign neoplasms of connective and other soft tissue

252

1.96

4.67

1.4

1.5

31.76

29.03

g/l

0.83

221

Hernia of abdominal wall

327

2548

1.29

4.67

1.4

1.5

32.57

32.96

g/l

0.22

295

2284

Schizophrenia or delusion, excluding more controls

157

1084

1.44

4.64

1.4

1.5

34.93

33.89

g/l

0.53

141

985

Fracture of foot, except ankle

129

865

1.50

4.62

1.5

1.4

34.00

33.67

g/l

0.10

113

787

Injury of nerves and spinal cord at thorax level

14.48

4.61

1.7

1.8

32.23

27.68

g/l

—

Adrenocortical insufficiency

110

2.49

4.56

1.7

1.4

25.12

33.38

g/l

2.34

Gastro-oesophageal reflux disease

453

3254

1.24

4.53

1.5

1.4

33.62

33.41

g/l

0.13

410

2949

Dementia in Alzheimer disease

1198

0.63

4.50

1.3

1.5

29.03

30.39

g/l

0.52

1051

Acute upper respiratory infections of multiple and unspecified sites

444

2688

1.24

4.48

1.5

1.4

32.61

33.26

g/l

0.47

406

2401

Fracture of forearm

325

2380

1.28

4.48

1.4

1.5

30.63

33.19

g/l

3.01

288

2138

Focal epilepsy

144

994

1.45

4.47

1.4

1.5

33.99

32.28

g/l

0.90

138

896

Disorders of eyelid, lacrimal system and orbit

593

3874

1.20

4.47

1.4

1.5

31.94

32.98

g/l

1.25

538

3480

Dental caries 3 and operation codes

701

3026

1.19

4.43

1.5

1.4

31.34

33.05

g/l

2.66

621

2713

Dental caries 1 and operation codes

686

2957

1.19

4.40

1.5

1.4

31.20

33.03

g/l

2.92

606

2649

Alzheimer disease, including avohilmo

212

2055

0.74

4.40

1.3

1.5

30.03

30.98

g/l

0.56

188

1820

Disorders of the thyroid gland

657

3610

1.19

4.36

1.6

1.4

32.58

32.85

g/l

0.21

598

3240

Background retinopathy and retinal vascular changes

2.63

4.34

1.2

1.4

31.82

30.03

g/l

0.23

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

12.37

4.34

1.1

1.2

38.47

26.42

g/l

—

Benign neoplasm: Skin of trunk

2.61

4.31

1.8

1.5

32.73

27.21

g/l

1.23

Other systemic involvement of connective tissue

186

1355

1.38

4.28

1.4

1.5

31.36

32.33

g/l

0.47

166

1215

Symptoms and signs involving the skin and subcutaneous tissue

438

3552

1.23

4.27

1.5

32.58

33.04

g/l

0.32

405

3196

Oesophageal obstruction

179

2.10

4.24

1.5

1.4

33.38

31.83

g/l

0.34

162

Other and unspecified effects of external causes

131

898

1.46

4.24

1.5

33.21

33.30

g/l

0.03

118

819

Intestinal adhesions without obstruction

401

1.71

4.23

1.4

1.5

30.21

31.75

g/l

0.48

365

Neurological diseases

578

2417

1.21

4.21

1.5

1.4

32.01

33.77

g/l

2.36

518

2164

Inguinal hernia

463

2550

1.23

4.21

1.5

32.56

33.00

g/l

0.30

419

2277

Sarcoidosis

563

1.59

4.20

1.7

1.5

31.08

33.33

g/l

0.93

507

Benign lipomatous neoplasm

141

983

1.44

4.18

1.4

1.5

33.01

30.13

g/l

1.83

127

867

Other necrotizing vasculopathies

343

1.77

4.18

1.7

1.5

29.12

31.77

g/l

0.93

310

Any prescribed medicine buy

+∞

4.13

1.8

0.0

26.80

—

g/l

—

Infections with a predominantly sexual mode of transmission

108

715

1.51

4.13

1.4

33.20

34.86

g/l

0.70

647

Injuries to unspecified part of trunk, limb or body region

397

1.70

4.10

1.6

1.5

31.98

32.19

g/l

0.05

357

Unknown and unspecified causes of morbidity

272

1.85

4.09

1.5

32.64

32.56

g/l

0.01

252

Dermatitis and eczema

716

4000

1.18

4.09

1.5

1.4

32.78

33.12

g/l

0.27

659

3582

Other spirochaetal diseases

1196

0.62

4.07

1.4

1.5

33.52

33.12

g/l

0.11

1079

Benign neoplasm: Skin of eyelid, including canthus

491

1.62

4.02

1.4

1.5

33.09

28.90

g/l

2.30

424

Alcohol abuse, main dg

617

1.55

4.02

1.3

1.5

33.83

33.73

g/l

0.02

562

Hyperparathyroidism

136

940

1.44

4.00

1.5

30.04

31.96

g/l

0.91

117

828

Familial hypercholesterolemia, with ischemic heart disease

588

1.56

3.97

1.9

1.4

31.46

32.71

g/l

0.44

532

Hydrocele

120

822

1.47

3.96

1.4

1.5

32.57

32.03

g/l

0.17

726

Ulcer of oesophagus

379

1.71

3.96

1.5

1.4

29.03

32.03

g/l

1.08

340

Injuries to the ankle and foot

347

2533

1.25

3.94

1.5

1.4

32.93

33.98

g/l

0.79

309

2309

Barrett oesophagus

212

1.96

3.93

1.4

1.5

29.43

32.79

g/l

0.93

192

Benign neoplasm of other and ill-defined parts of digestive system

129

897

1.45

3.93

1.5

30.95

31.98

g/l

0.39

109

808

Sleep apnoea, including avohilmo

655

3609

1.18

3.92

1.5

1.4

33.93

33.11

g/l

0.90

597

3262

Other diseases of oesophagus

503

1.60

3.91

1.9

1.4

31.55

31.77

g/l

0.05

457

Lyme disease

1182

0.63

3.88

1.4

1.5

33.52

33.14

g/l

0.10

1066

Spondyloarthritis

123

850

1.45

3.86

1.5

32.41

32.54

g/l

0.04

113

760

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

101

663

1.51

3.85

1.5

37.94

33.84

g/l

2.96

603

Nerve, nerve root and plexus disorders

734

3957

1.17

3.84

1.5

1.4

31.96

33.17

g/l

1.63

661

3560

Other and unspecified vasculitis limited to skin

2.46

3.83

1.4

1.5

34.74

30.43

g/l

0.55

Amputation of thigh

173

2.06

3.83

1.6

1.5

24.92

29.39

g/l

0.98

158

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

12.69

3.81

2.5

1.6

37.83

25.20

g/l

—

Specific personality disorders

633

1.52

3.80

1.5

1.4

37.57

34.51

g/l

1.79

576

Other inflammatory liver diseases

229

1.89

3.78

1.8

1.4

30.27

33.24

g/l

0.59

203

Idiopathic pulmonary fibrosis

485

1.60

3.77

1.7

1.5

33.05

30.63

g/l

1.19

433

Coxarthrosis [arthrosis of hip](FG)

436

2596

1.22

3.76

1.5

1.4

31.63

33.08

g/l

1.66

397

2312

Obesity, other/unspecified

163

1191

1.37

3.73

1.7

1.4

34.39

33.71

g/l

0.30

149

1084

Macular pucker

123

859

1.44

3.70

1.4

1.5

30.08

32.22

g/l

1.00

108

767

Primary gonarthrosis, bilateral

275

3038

0.79

3.69

1.5

1.4

33.56

32.44

g/l

0.82

256

2715

Viral and other specified intestinal infections

522

1.56

3.65

1.4

1.5

31.40

33.86

g/l

0.87

475

Other metabolic disorders

396

1.65

3.62

1.5

1.4

32.13

33.81

g/l

0.45

360

Paracetamol of NSAID medication

128

445

1.45

3.62

1.5

1.4

31.25

31.28

g/l

0.01

111

396

Carcinoma in situ of skin of scalp and neck

150

2.11

3.62

1.6

29.41

30.89

g/l

0.27

134

Disorders of continuity of bone

291

1.76

3.61

1.6

1.4

31.92

33.55

g/l

0.35

265

Personality disorders

109

747

1.46

3.60

1.5

1.4

36.90

34.97

g/l

0.77

102

678

Other diseases of anus and rectum

217

1665

1.31

3.58

1.5

1.4

30.56

32.49

g/l

1.39

194

1482

Exclusions for E4_PCOS_BROAD

611

1.51

3.55

1.4

1.5

30.14

33.48

g/l

1.45

556

Melanoma of uvea

3.93

3.54

1.8

1.2

36.84

26.32

g/l

—

Cysts of oral region, not elsewhere classified

165

2.02

3.50

1.3

1.5

31.99

33.84

g/l

0.28

148

Fall on and from stairs and steps

162

1198

1.36

3.48

1.5

32.68

32.43

g/l

0.08

140

1081

Palmar fascial fibromatosis [Dupuytren]

149

1090

1.38

3.45

1.5

32.45

32.19

g/l

0.09

139

968

Sequelae of injuries, of poisoning and of other consequences of external causes

136

979

1.39

3.45

1.5

32.61

33.60

g/l

0.39

124

887

Cholecystectomy

485

3608

1.19

3.44

1.4

1.5

32.33

32.74

g/l

0.27

432

3250

Other disorders of ear

649

3715

1.17

3.43

1.5

31.79

33.08

g/l

1.76

584

3332

Alzheimer disease

187

1851

0.76

3.43

1.4

1.5

29.85

30.70

g/l

0.45

166

1636

Vasculitis limited to skin, not elsewhere classified

107

2.28

3.41

1.4

1.5

34.78

31.69

g/l

0.38

Disorders of sclera, cornea, iris and ciliary body

324

2630

1.23

3.39

1.4

1.5

32.14

33.46

g/l

1.02

290

2372

Injury of unspecified body region

305

1.72

3.37

1.7

1.4

32.47

31.85

g/l

0.14

271

Symptoms and signs involving the nervous and musculoskeletal systems

373

3077

1.21

3.32

1.5

32.45

32.82

g/l

0.22

331

2772

Cholangitis (primary sclerosing, PSC)

277

1.75

3.31

1.4

30.43

31.34

g/l

0.19

250

Visual impairment including blindness (binocular or monocular)

307

1.71

3.31

1.4

29.26

30.66

g/l

0.36

281

Retinal detachments and breaks

269

2147

1.26

3.30

1.4

1.5

33.01

32.76

g/l

0.12

242

1931

Schizophrenia, schizotypal and delusional disorders

159

1183

1.35

3.30

1.4

34.93

33.78

g/l

0.59

143

1069

Hypothyroidism, strict autoimmune

465

2585

1.19

3.26

1.6

1.4

32.70

33.35

g/l

0.49

422

2338

Myocardial infarction, with ST-elevation

166

1248

1.34

3.25

1.6

1.5

28.66

31.58

g/l

2.18

147

1101

196

1429

1.30

3.20

1.4

1.5

29.41

30.89

g/l

0.96

183

1249

Inflammatory diseases of the central nervous system

295

1.71

3.19

1.3

1.4

30.08

31.86

g/l

0.37

263

Focal epilepsy, strict definition

129

936

1.38

3.16

1.4

1.5

33.59

32.08

g/l

0.71

124

844

Drug-induced adrenocortical insufficiency

3.00

3.15

1.6

1.5

22.11

33.02

g/l

1.54

Urticaria and erythema

179

1367

1.31

3.12

1.5

33.91

33.56

g/l

0.13

160

1238

Schizophrenia or delusion

157

1177

1.34

3.12

1.4

34.93

33.79

g/l

0.60

141

1065

Use of other anti-dementia drugs

153

1767

0.75

3.11

1.4

1.5

29.85

30.58

g/l

0.33

132

1560

Use of memantine

153

1767

0.75

3.11

1.4

1.5

29.85

30.58

g/l

0.33

132

1560

Coxarthrosis

406

2298

1.20

3.10

1.5

1.4

31.47

33.21

g/l

2.11

367

2049

Osteoporosis with pathological fracture (FG)

321

1.67

3.09

1.4

25.93

31.26

g/l

1.90

278

Gonarthrosis, primary, with knee surgery

328

3247

0.82

3.05

1.5

32.99

32.40

g/l

0.41

302

2901

Other anxiety disorders

172

1160

1.32

3.05

1.5

1.4

33.65

34.63

g/l

0.43

158

1068

Colectomy operation

129

944

1.37

3.03

1.3

1.5

30.28

31.67

g/l

0.61

117

846

Use of donepezil

105

1411

0.71

3.03

1.3

1.5

30.58

30.28

g/l

0.09

1232

Collagenous colitis

363

1.61

2.98

1.5

33.02

32.51

g/l

0.11

326

Spinal stenosis

421

2781

1.19

2.96

1.5

1.4

31.85

32.70

g/l

0.67

375

2491

Disorders of adult personality and behaviour

110

787

1.40

2.95

1.5

1.4

37.57

35.03

g/l

1.31

103

714

Acute lymphadenitis

148

1.97

2.95

1.3

34.64

32.79

g/l

0.27

128

Other otitis externa (chronic)

228

1.77

2.91

1.5

32.58

32.52

g/l

0.01

205

Conductive and sensorineural hearing loss

596

3578

1.16

2.90

1.5

31.84

32.90

g/l

1.22

541

3205

Traumatic subdural haemorrhage

114

811

1.39

2.89

1.5

30.00

32.16

g/l

1.01

719

Juvenile osteochondrosis

2.60

2.88

1.1

1.4

34.45

32.65

g/l

0.24

Dorsalgia

665

3142

1.15

2.84

1.5

1.4

32.80

33.26

g/l

0.39

600

2820

Combinations of oral blood glucose lowering drugs

207

1635

1.27

2.84

1.5

1.4

31.38

33.16

g/l

1.16

185

1487

Episodal and paroxysmal disorders

740

3331

1.14

2.83

1.5

1.4

32.79

33.19

g/l

0.33

657

2986

Degenerative diseases of the nervous system

217

2049

0.79

2.83

1.4

1.5

30.59

31.00

g/l

0.19

195

1809

Acute suppurative otitis media

523

1.47

2.81

1.4

1.5

35.25

34.64

g/l

0.14

474

Fibroblastic disorders

189

1479

1.28

2.80

1.6

1.4

32.67

32.69

g/l

0.01

176

1319

Myeloproliferative diseases (CML excluded)

378

1.57

2.78

1.2

1.5

30.93

31.98

g/l

0.30

343

Other inflammation of eyelid

555

1.47

2.78

1.4

1.5

30.41

32.32

g/l

0.63

501

Coeliac disease

442

1.52

2.76

1.4

1.5

29.03

33.80

g/l

1.94

403

Delivery, wide proxy

105

775

0.72

2.76

1.4

32.34

32.30

g/l

0.01

701

Alzheimer’s disease, wide definition

145

1590

0.76

2.75

1.4

1.5

30.40

30.58

g/l

0.06

126

1400

Follow-up examination after treatment for conditions other than malignant neoplasms

271

1442

1.23

2.74

1.5

1.4

32.22

33.61

g/l

0.99

243

1299

Myocardial infarction, unclassifiable

225

1610

1.25

2.69

1.4

1.5

26.66

31.32

g/l

5.72

194

1419

Other maternal disorders predominantly related to pregnancy

114

974

0.73

2.68

1.4

35.95

34.98

g/l

0.35

105

904

Carcinoma in situ of skin, other sites/unspecified

2.85

2.67

1.6

1.4

30.47

24.98

g/l

0.96

Acute and transient psychotic disorders

366

1.56

2.66

1.5

37.18

33.76

g/l

1.60

328

CR(E)ST syndrome

2.83

2.66

1.4

1.3

28.76

33.73

g/l

0.51

Malignant melanoma

113

830

1.37

2.65

1.7

1.5

31.56

31.79

g/l

0.07

103

749

Benign neoplasm: Adrenal gland

328

1.60

2.63

1.8

1.5

32.46

32.32

g/l

0.02

297

Presence of other devices

175

1368

1.28

2.63

1.4

1.5

28.91

32.61

g/l

3.65

160

1215

Acute alcohol intoxication, ICD10

116

856

1.36

2.63

1.3

1.5

32.72

33.77

g/l

0.36

105

774

Bacterial, viral and other infectious agents

266

1.66

2.62

1.7

1.4

30.74

33.30

g/l

0.78

236

Lesion of lateral popliteal nerve

199

1.77

2.60

1.8

1.5

33.39

32.38

g/l

0.11

177

Malignant neoplasm of oral cavity

163

1.86

2.59

1.4

31.43

32.91

g/l

0.23

143

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

4.09

2.59

1.3

1.1

33.31

24.07

g/l

—

Degenerative macular diseases

707

1.39

2.57

1.5

29.81

31.25

g/l

0.61

625

Acute sinusitis

252

1921

1.22

2.54

1.5

33.36

33.82

g/l

0.22

228

1739

Gonarthrosis,primary

536

3866

0.87

2.54

1.5

1.4

33.08

32.64

g/l

0.37

502

3457

Behavioural syndromes associated with physiological disturbances and physical factors

134

1016

1.32

2.53

1.4

1.5

33.14

33.54

g/l

0.14

115

930

Dental caries 1, only avohilmo

639

2869

1.14

2.52

1.5

1.4

31.27

32.77

g/l

1.98

561

2562

Oesophagitis

247

1.67

2.50

1.7

1.4

31.47

32.10

g/l

0.11

221

Acute alcohol intoxication

170

1335

1.28

2.49

1.4

1.5

33.38

33.06

g/l

0.12

152

1185

Other diseases of jaws

255

1.66

2.48

1.6

1.5

26.73

33.29

g/l

2.24

233

Other blood glucose lowering drugs, excl. Insulins

127

961

1.33

2.47

1.5

30.30

32.17

g/l

0.96

114

855

Benign neoplasm: Tongue

2.40

2.47

1.4

1.2

30.22

26.42

g/l

0.64

Nontoxic multinodular goitre

124

935

1.33

2.47

1.4

1.5

33.38

32.15

g/l

0.51

115

846

Overexertion and strenuous or repetitive movements

350

1.55

2.45

1.6

1.5

31.00

33.07

g/l

0.57

311

Burns and corrosions

504

1.45

2.45

1.4

1.5

29.60

33.41

g/l

1.50

457

Melanocytic naevi of trunk

439

1.49

2.44

1.5

33.75

32.68

g/l

0.25

395

Alcohol-induced acute pancreatitis

152

1.86

2.44

1.4

1.5

29.72

32.08

g/l

0.38

134

Other nonthrombocytopenic purpura

3.01

2.43

2.0

1.3

28.59

33.96

g/l

—

Other and unspecified glaucoma

359

1.54

2.43

1.5

31.65

30.63

g/l

0.23

330

Dementia

283

2344

0.83

2.42

1.3

1.5

30.10

31.43

g/l

1.08

257

2081

Speech therapy

174

1376

1.27

2.42

1.7

1.4

32.39

32.35

g/l

0.02

157

1233

Varicose veins

448

2922

1.16

2.41

1.5

1.4

32.67

32.86

g/l

0.11

409

2621

Embolic stroke

305

1.59

2.39

1.4

1.5

28.99

30.53

g/l

0.29

280

Migraine

115

1296

0.75

2.38

1.5

1.4

36.11

34.57

g/l

0.76

106

1192

Complications of labour and delivery

151

1082

0.78

2.38

1.4

36.59

34.28

g/l

1.37

144

991

Sensorineural hearing loss

573

3524

1.14

2.38

1.4

1.5

31.83

32.86

g/l

1.13

520

3158

Colorectal cancer

187

1496

1.25

2.38

1.4

1.5

30.64

31.63

g/l

0.49

167

1321

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

3.70

2.37

1.3

1.1

30.02

22.85

g/l

—

Respiratory disorders in diseases classified elsewhere

2.65

2.37

1.7

1.5

42.40

32.10

g/l

1.41

Use of antiglaucoma preparations and miotics

467

1.47

2.37

1.5

1.6

29.10

30.49

g/l

0.33

419

severe traumatic brain injury, does not include concussion

175

1390

1.26

2.36

1.5

29.65

31.56

g/l

1.16

152

1231

Other and unspecified tonsillitis

112

708

1.34

2.36

1.6

1.4

37.66

35.47

g/l

0.99

105

645

Dementia, including avohilmo

305

2500

0.84

2.36

1.3

1.5

30.48

31.46

g/l

0.71

277

2221

Dental caries 2, only avohilmo

254

2419

0.83

2.35

1.5

1.4

34.51

34.19

g/l

0.16

235

2204

Complications of other internal prosthetic devices, implants and grafts

154

1.83

2.35

1.3

1.4

31.61

31.22

g/l

0.05

137

Mental disorders, not otherwise specified

176

1.77

2.33

1.5

35.87

34.47

g/l

0.24

157

Carcinoma in situ of other and unspecified digestive organs

133

1.91

2.33

1.4

31.49

31.32

g/l

0.02

118

Bullous disorders

268

1.62

2.33

1.6

1.4

28.56

31.34

g/l

0.82

242

Superficial injury of ankle and foot

299

1.58

2.32

1.5

33.27

33.44

g/l

0.03

271

Benign neoplasm: Appendix

3.27

2.32

1.2

1.3

34.28

25.47

g/l

—

Benign neoplasm: Rectosigmoid junction

207

1.71

2.31

1.3

1.4

33.57

31.99

g/l

0.23

188

Contact with and exposure to communicable diseases

675

1.37

2.31

1.5

34.08

35.36

g/l

0.43

618

Dental caries 3, only avohilmo

653

2956

1.13

2.31

1.5

1.4

31.52

32.79

g/l

1.57

575

2641

Use of selegiline

261

0.42

2.31

1.5

35.28

31.73

g/l

0.48

233

Nonalcoholic fatty liver disease

284

1.59

2.30

1.7

1.5

30.21

33.40

g/l

0.80

253

Other peripheral vascular diseases

292

1.58

2.30

1.3

1.4

33.36

33.09

g/l

0.04

264

Seronegative rheumatoid arthritis

553

1.42

2.30

1.4

32.98

33.12

g/l

0.04

489

Fracture of neck

293

1.58

2.28

1.6

1.5

33.20

31.55

g/l

0.36

264

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

313

2590

1.19

2.28

1.5

33.73

33.56

g/l

0.09

284

2351

Colitis, primary sclerosing

3.52

2.28

1.4

1.3

33.75

32.32

g/l

—

Alzheimer’s disease (Late onset)

137

1506

0.78

2.27

1.4

1.5

30.04

30.41

g/l

0.14

118

1321

Female genital prolapse

100

778

0.74

2.27

1.3

1.4

32.13

32.67

g/l

0.15

684

Low back pain

457

3059

1.15

2.27

1.4

31.32

33.22

g/l

2.45

411

2743

Benign neoplasm of middle ear and respiratory system

247

1.63

2.24

1.3

1.5

30.67

28.98

g/l

0.32

216

Malignant neoplasm of bone and articular cartilage

3.17

2.24

1.2

1.5

32.94

26.90

g/l

—

Benign neoplasm of other and unspecified intrathoracic organs

3.15

2.24

2.1

1.1

36.48

23.36

g/l

—

Tinnitus

1138

0.73

2.23

1.6

1.4

33.17

33.19

g/l

0.01

1023

Rheumatic valve diseases

128

1.90

2.23

1.5

1.4

27.79

30.22

g/l

0.67

112

Dental operations, only avohilmo

580

2618

1.14

2.22

1.5

31.08

32.83

g/l

2.43

512

2317

Rheumatic fever incl heart disease

172

1.76

2.22

1.5

29.60

30.70

g/l

0.24

155

Disorders of muscles

416

1.47

2.22

1.5

1.4

32.34

33.26

g/l

0.21

381

Disorders of lacrimal system

247

2051

1.21

2.21

1.4

1.5

31.62

32.98

g/l

0.92

231

1845

Anxiety (asthma-related co-morbidities)

241

1569

1.21

2.21

1.4

34.21

34.44

g/l

0.09

220

1442

Arthropathies

568

2544

1.14

2.21

1.6

1.4

31.86

33.70

g/l

2.71

513

2275

Peptic ulcer

2.67

2.20

1.8

1.3

31.70

31.19

g/l

0.04

Soft tissue disorders related to use, overuse and pressure

169

1350

1.26

2.20

1.6

1.4

32.17

33.82

g/l

0.92

154

1216

Monoplegia

2.53

2.20

1.5

1.6

32.94

30.44

g/l

0.24

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

2.53

2.20

1.5

1.4

36.57

29.07

g/l

1.16

Other specified/unspecified hearing loss

409

1.48

2.19

1.3

1.5

34.00

31.54

g/l

0.71

364

Acute epiglottitis

2.65

2.19

2.4

1.5

28.83

33.75

g/l

0.77

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

3.39

2.19

1.4

1.2

31.45

24.18

g/l

—

Benign neoplasm of other and unspecified endocrine glands

560

1.40

2.16

1.6

1.5

33.00

32.55

g/l

0.11

508

Injuries to the shoulder and upper arm

542

4014

1.13

2.15

1.5

1.4

32.48

33.10

g/l

0.58

493

3598

Shoulder lesions

539

2908

1.14

2.14

1.5

1.4

33.15

33.25

g/l

0.06

494

2604

Benign neoplasm: Caecum

570

1.39

2.14

1.6

1.5

29.54

32.29

g/l

1.16

514

Tonsillectomy and adenotomy

120

1084

0.77

2.13

1.4

1.5

35.04

35.55

g/l

0.17

113

985

Triptan medication for migraine, min. 3 purchases

116

1189

0.77

2.11

1.5

1.4

37.00

34.82

g/l

1.37

106

1094

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

2.28

2.08

1.4

1.5

36.20

28.96

g/l

1.40

Burns and corrosions of external body surface, specified by site

373

1.48

2.07

1.3

1.5

27.37

32.91

g/l

2.28

334

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

2.35

2.06

1.1

1.2

36.39

25.76

g/l

1.89

Fracture at wrist and hand level

178

1443

1.24

2.04

1.5

1.4

30.94

33.59

g/l

2.05

164

1302

Malignant neoplasm of tongue

2.13

2.04

1.4

1.5

34.16

31.59

g/l

0.31

Erythema multiforme

2.13

2.03

1.7

1.5

31.29

32.53

g/l

0.14

Benign neoplasm: Stomach

475

1.42

2.02

1.5

29.69

31.74

g/l

0.56

435

Non-selective monoamine reuptake inhibitors

252

2055

1.19

2.00

1.4

1.5

32.80

32.81

g/l

0.01

227

1848

Visual disturbances and blindness

311

2662

1.17

2.00

1.4

1.5

31.44

32.83

g/l

1.20

279

2389

Polyuria

160

1287

1.25

2.00

1.6

1.5

31.60

31.92

g/l

0.12

143

1158

Wet age-related macular degeneration

151

1185

1.26

1.99

1.4

1.5

30.01

30.89

g/l

0.38

131

1035

Other disorders of bone

697

1.34

1.99

1.5

1.4

34.02

33.75

g/l

0.07

639

Heartburn

393

1.46

1.99

1.6

1.4

33.00

31.93

g/l

0.23

358

Other disorders of lacrimal gland

192

1575

1.22

1.99

1.4

1.5

31.45

33.30

g/l

1.23

182

1422

Dental pulpitis 4, only avohilmo

751

3535

1.11

1.99

1.5

1.4

33.59

32.81

g/l

0.89

680

3169

Herpesviral [herpes simplex] infections

435

1.43

1.98

1.7

1.5

32.35

32.80

g/l

0.09

393

Pregnancy, childbirth and the puerperium

103

707

0.76

1.96

1.5

1.4

31.29

31.74

g/l

0.12

629

Injury of muscle and tendon at shoulder and upper arm level

172

2107

0.81

1.96

1.5

33.42

33.23

g/l

0.07

161

1898

Malignant neoplasm of pancreas

362

1.47

1.96

1.2

1.5

35.56

30.91

g/l

1.10

328

Type 1 diabetes, definitions combined

163

1.72

1.96

1.4

1.3

34.41

35.43

g/l

0.14

148

Focal brain injury

305

1.52

1.95

1.3

1.4

29.29

32.26

g/l

0.91

273

Parkinson's disease, strict definition

949

0.72

1.95

1.5

34.79

31.00

g/l

1.83

852

Retinal detachment with retinal break

692

1.34

1.94

1.2

1.5

33.35

32.23

g/l

0.34

621

Hyperkinetic disorders (excl. ADHD)

4.53

1.93

1.4

1.3

44.52

38.80

g/l

—

Parkinson's disease

1016

0.73

1.92

1.5

35.07

30.99

g/l

2.32

903

Type 1 diabetes, strict (exclude DM2)

164

1.71

1.92

1.4

1.3

34.41

35.13

g/l

0.10

150

Hypertrophic disorders of skin

143

1.76

1.89

1.4

27.53

32.44

g/l

1.20

126

Keratitis

193

1594

1.21

1.89

1.4

1.5

31.05

33.02

g/l

1.23

173

1436

Other dorsopathies, not elsewhere classified

663

3144

1.11

1.88

1.5

1.4

32.81

33.25

g/l

0.37

596

2821

Dental caries 1 and operation codes, only avohilmo

118

760

0.78

1.88

1.5

1.4

31.61

32.31

g/l

0.25

106

700

Blood alcohol or alcohol intoxication level

2.32

1.88

1.1

1.4

35.98

33.87

g/l

0.20

Hypothyroidism, other/unspecified

565

3331

1.12

1.87

1.5

1.4

32.48

32.85

g/l

0.28

513

2995

Benign neoplasm of urinary organs

213

1.61

1.86

1.6

1.4

32.33

32.26

g/l

0.01

192

Sequelae of injuries of lower limb

318

1.48

1.83

1.4

1.5

32.08

33.32

g/l

0.22

283

Polymyalgia rheumatica

101

778

1.30

1.83

1.4

1.5

31.19

31.02

g/l

0.05

694

Injury of urinary and pelvic organs

2.14

1.83

1.2

1.5

29.73

31.28

g/l

0.18

Use of galantamine

477

0.62

1.82

1.2

1.5

31.78

29.57

g/l

0.56

427

Superficial injury of abdomen, lower back and pelvis

571

1.35

1.80

1.6

1.5

33.15

32.63

g/l

0.13

518

Toxic liver disease

2.37

1.78

1.5

31.13

33.93

g/l

0.23

Malignant neoplasm of rectum

547

1.36

1.78

1.4

1.5

30.43

31.69

g/l

0.35

486

Unspecified dementia

780

0.72

1.78

1.3

1.5

30.31

29.80

g/l

0.12

676

Colorectal adenocarcinoma

155

1262

1.23

1.78

1.3

1.5

30.79

31.50

g/l

0.29

140

1115

Schizophrenia

556

1.35

1.76

1.3

1.5

36.13

34.23

g/l

0.82

501

Adverse effects, not elsewhere classified

626

1.33

1.75

1.6

1.5

33.42

33.39

g/l

0.01

567

Other and unspecified injuries of abdomen, lower back and pelvis

2.52

1.74

1.9

1.3

27.90

36.41

g/l

—

Benign neoplasm of ovary

618

1.33

1.74

1.3

1.4

32.44

33.11

g/l

0.17

558

Other infective otitis externa

217

1.58

1.73

1.4

32.20

32.11

g/l

0.01

194

Iridocyclitis

130

1041

1.25

1.73

1.4

1.5

33.80

33.08

g/l

0.25

117

939

Sexual dysfunction

2.69

1.73

1.1

1.6

33.66

34.69

g/l

—

Abnormal serum enzyme levels

246

2070

1.18

1.73

1.5

30.41

32.56

g/l

1.79

208

1859

Parkinson's disease, including avohilmo

1063

0.76

1.71

1.5

34.32

31.02

g/l

1.73

944

Inguinal hernia, bilateral

682

1.31

1.70

1.6

1.5

33.87

32.20

g/l

0.62

603

Allergic purpura

1.96

1.70

1.4

1.3

31.52

31.96

g/l

0.04

Other autoimmune haemolytic anaemias

2.22

1.69

1.4

26.13

32.05

g/l

0.65

Psoriasis vulgaris

109

859

1.27

1.67

1.7

1.5

33.47

33.18

g/l

0.08

779

False labour

242

0.60

1.67

1.2

1.4

41.11

36.68

g/l

0.88

225

Special screening examination for neoplasms

236

1.54

1.65

1.4

30.19

32.10

g/l

0.41

213

Vitamin B12 deficiency anaemia

589

1.33

1.65

1.5

29.60

31.22

g/l

0.53

530

Diseases of external ear

200

1684

1.19

1.64

1.5

32.76

32.51

g/l

0.09

177

1506

Inguinal or femoral hernia, bilateral

695

1.30

1.63

1.6

1.5

33.75

32.30

g/l

0.52

613

Otitis externa

115

916

1.26

1.62

1.5

32.99

33.03

g/l

0.01

104

827

Recurring oral aphthae, including avohilmo

539

1.34

1.62

1.4

1.5

31.76

32.05

g/l

0.07

488

Nonorganic sleeping disorders, excluding more controls

565

1.33

1.61

1.6

1.5

32.56

33.35

g/l

0.20

522

Kyphosis

2.35

1.61

1.3

1.5

30.98

30.47

g/l

—

Progressive vascular leukoencephalopathy

206

1.57

1.61

1.3

1.4

27.98

29.89

g/l

0.36

192

Postmenopausal osteoporosis with pathological fracture

254

1.51

1.61

1.3

1.4

26.59

31.35

g/l

1.14

233

Nontoxic goitre/thyroid nodule

171

1423

1.20

1.60

1.4

1.5

33.13

32.34

g/l

0.35

154

1282

Cardiac murmurs and other cardiac sounds

211

1.55

1.60

1.4

1.3

34.33

32.96

g/l

0.24

198

Conjunctivitis (acute, non atopic)

128

1031

1.24

1.59

1.3

1.4

32.78

33.27

g/l

0.17

118

934

Female infertility, associated with anovulation

2.00

1.59

1.1

1.4

36.62

35.07

g/l

0.12

Chronic laryngitis and laryngotracheitis

690

1.29

1.57

1.4

1.5

34.30

32.72

g/l

0.59

622

Appendectomy

318

2686

1.14

1.54

1.5

1.4

34.98

33.78

g/l

0.96

290

2438

Psoriasis

161

1338

1.21

1.54

1.5

33.46

33.05

g/l

0.15

146

1209

Malignant neoplasm of thyroid gland

232

1.52

1.54

1.5

1.4

33.16

32.33

g/l

0.16

206

Schizoaffective disorder

192

1.57

1.54

1.4

1.5

35.91

33.73

g/l

0.48

169

All anxiety disorders

241

1666

1.17

1.53

1.4

34.22

34.30

g/l

0.03

220

1535

Orchitis and epididymitis

510

1.34

1.53

1.6

1.5

32.48

32.00

g/l

0.11

460

Benign neoplasm: Parotid gland

357

1.41

1.52

1.6

1.5

32.23

32.09

g/l

0.03

325

Other strabismus

709

1.28

1.52

1.6

1.5

34.38

33.31

g/l

0.32

644

Urticaria

127

1033

1.23

1.51

1.5

1.4

34.69

33.44

g/l

0.51

113

937

Benign neoplasm: salivary glands, exclude unknown (D119)

400

1.38

1.51

1.7

1.5

30.86

32.16

g/l

0.28

360

Moderate visual impairment, binocular

154

1.64

1.51

1.6

1.4

29.06

29.18

g/l

0.02

141

Adenomyosis (Endometriosis of uterus)

549

0.69

1.49

1.6

1.4

33.02

32.84

g/l

0.03

486

Anterior Iridocyclitis

112

900

1.25

1.49

1.4

1.5

33.59

32.83

g/l

0.25

101

820

Endometriosis

106

790

0.80

1.49

1.5

1.4

34.12

32.82

g/l

0.47

700

Dental pulpitis 1, only avohilmo

742

3552

1.09

1.49

1.5

1.4

33.69

32.77

g/l

1.11

671

3184

Other abnormal immunological findings in serum

2.24

1.47

1.1

1.5

39.48

32.11

g/l

—

Benign neoplasm of major salivary glands

471

1.34

1.46

1.6

1.5

31.30

32.29

g/l

0.23

424

Hypothyreosis and Thyroxine purchase for inclusion criteria

577

3462

1.10

1.45

1.5

1.4

32.53

32.86

g/l

0.24

525

3112

Memory loss

542

1.32

1.44

1.6

31.00

31.25

g/l

0.06

484

Oral lichen ruber planus, including avohilmo

201

0.50

1.43

2.6

1.4

30.57

33.53

g/l

—

179

Dermatitis due to substances taken internally

188

1.55

1.43

1.6

1.4

31.93

32.66

g/l

0.11

166

Benign neoplasm of other and unspecified intrathoracic organs

2.28

1.41

2.1

1.4

36.48

31.42

g/l

—

Malignant neoplasm of colon

112

908

1.24

1.41

1.3

1.5

30.79

30.93

g/l

0.04

103

808

Subjective visual disturbances

130

1071

1.22

1.39

1.4

1.5

33.45

32.79

g/l

0.26

117

965

Symptoms and signs involving speech and voice

195

1667

1.17

1.39

1.6

1.5

33.27

32.59

g/l

0.33

178

1500

Sleep disorders

739

1.26

1.38

1.5

32.24

33.43

g/l

0.39

676

Other diseases of blood and blood-forming organs

280

1.44

1.38

1.3

1.5

28.66

31.78

g/l

0.89

249

Urethral stricture

356

1.38

1.6

1.5

30.53

31.47

g/l

0.18

319

Benign neoplasm: Appendix

2.22

1.38

1.2

1.3

34.28

33.24

g/l

—

Papillary adenocarcinoma of thyroid gland

158

1.59

1.37

1.6

1.4

33.12

32.14

g/l

0.15

139

Disorders of vitreous body and globe

325

2812

1.13

1.37

1.4

1.5

31.09

32.96

g/l

1.84

291

2545

Disorders of oesophagus in diseases classified elsewhere

1.85

1.36

1.6

1.4

27.62

32.30

g/l

0.51

Generalized skin eruption due to drugs and medicaments

135

1.64

1.36

1.7

1.3

32.49

32.44

g/l

0.01

121

Migraine without aura and triptan purchases

248

0.56

1.35

1.4

36.76

35.30

g/l

0.30

226

Acute generalized exanthematous pustulosis

151

1.60

1.35

1.7

1.4

32.35

32.00

g/l

0.04

135

Undefined dementia

788

0.77

1.35

1.3

1.5

30.03

29.47

g/l

0.13

685

Malignant neoplasm of corpus uteri

332

1.39

1.35

1.3

1.4

32.45

31.86

g/l

0.12

302

Mandibular retrognathia AND surgery (BSSRO)

0.00

1.34

0.0

1.4

—

34.54

—

Carcinoma in situ of other and unspecified genital organs

2.15

1.34

2.1

1.2

32.70

32.60

g/l

—

Functional dyspepsia

138

1149

1.20

1.34

1.4

32.82

33.25

g/l

0.14

125

1044

Dental caries 3 and operation codes, only avohilmo

138

835

0.83

1.34

1.5

1.4

31.29

32.42

g/l

0.49

126

769

Open wound of shoulder and upper arm

2.05

1.33

1.3

1.4

33.54

32.63

g/l

0.08

Diseases of inner ear

279

3095

0.88

1.33

1.4

1.5

33.37

32.68

g/l

0.42

252

2779

Spontaneous abortion

105

879

0.81

1.32

1.3

1.4

35.40

33.99

g/l

0.55

815

Adenocarcinoma and papilloma adenocarcinoma of rectum

551

1.29

1.30

1.4

1.5

30.80

31.61

g/l

0.20

491

Other specified/unspecified soft tissue disorders

209

1.49

1.30

1.3

1.4

33.75

31.80

g/l

0.30

192

Single spontaneous delivery

135

864

0.83

1.30

1.5

1.4

32.45

32.55

g/l

0.03

119

788

Vasomotor and allergic rhinitis

110

1321

0.82

1.30

1.5

1.4

33.20

34.39

g/l

0.48

1207

Acute gastritis

343

1.38

1.30

1.8

1.4

30.78

31.92

g/l

0.29

313

Abnormality of red blood cells

2.83

1.29

1.8

1.6

28.46

32.54

g/l

—

Any dementia

270

2159

0.88

1.29

1.3

1.5

29.82

31.27

g/l

1.20

243

1909

Open wound of hip and thigh

1.77

1.29

1.8

1.4

37.94

32.50

g/l

0.94

Viral warts

301

1.40

1.29

1.4

1.5

30.96

32.64

g/l

0.40

269

Bipolar affective disorders

534

1.29

1.28

1.2

1.4

35.92

34.07

g/l

0.70

485

Fenamates

614

0.78

1.28

1.6

1.5

32.95

30.70

g/l

0.75

540

Erosion of teeth, including avohilmo

567

1.28

1.5

33.17

33.66

g/l

0.12

529

Noninflammatory disorders of female genital tract

134

810

0.83

1.27

1.4

35.14

32.86

g/l

1.07

126

716

Malignant melanoma of skin

615

1.27

1.6

1.5

30.81

31.95

g/l

0.40

556

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.30

1.27

1.5

1.1

37.89

26.64

g/l

—

Papulosquamous disorders

223

1945

1.15

1.25

1.5

33.54

33.28

g/l

0.11

199

1762

Superficial injury of lower leg

114

940

1.21

1.24

1.4

30.82

33.14

g/l

1.27

101

852

Benign paroxysmal vertigo

127

1518

0.83

1.24

1.5

33.97

32.35

g/l

0.76

111

1364

Other/unspecified dorsalgia

219

1899

1.15

1.24

1.5

1.4

32.77

33.07

g/l

0.13

193

1703

Endometriosis of rectovaginal septum and vagina

290

0.62

1.23

1.3

1.4

35.94

32.06

g/l

0.57

266

Benign neoplasm: Skin of scalp and neck

1.92

1.23

1.2

1.3

34.46

27.13

g/l

1.11

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

2.06

1.22

1.8

1.3

36.84

24.69

g/l

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

2.18

1.22

1.8

1.2

32.23

26.07

g/l

—

Kela-code for severe mental illness

173

1484

1.17

1.22

1.3

1.5

35.33

33.50

g/l

1.30

157

1348

Unspecified mental disorder

188

1623

1.16

1.21

1.4

1.5

35.45

33.60

g/l

1.41

170

1475

Pain in joint

340

2014

1.12

1.21

1.5

1.4

32.71

33.80

g/l

0.85

300

1822

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

575

1.27

1.21

1.4

1.5

30.54

31.60

g/l

0.28

512

Myalgia

108

889

1.22

1.21

1.5

1.4

34.22

33.99

g/l

0.06

814

Infectious mononucleosis

1.72

1.21

1.3

1.5

37.83

34.18

g/l

0.54

Polycystic ovarian syndrome, broad definition

1.72

1.21

1.1

1.6

37.98

35.54

g/l

0.24

Disorders of ocular muscles, binocular movement, accommodation and refraction

211

1824

1.15

1.20

1.5

33.69

33.55

g/l

0.05

188

1651

Diseases of salivary glands

101

828

1.22

1.18

1.3

1.4

32.59

33.47

g/l

0.28

758

Headache

280

2078

1.13

1.18

1.5

1.4

32.67

34.21

g/l

1.12

256

1876

Impotence

307

1.38

1.18

1.5

1.6

34.46

31.64

g/l

0.70

277

Etanercept

141

1.57

1.17

1.5

1.4

38.75

32.76

g/l

1.36

123

Delivery

138

865

0.84

1.16

1.5

1.4

32.06

32.55

g/l

0.14

122

788

Other diseases of lip and oral mucosa

740

1.23

1.16

1.6

1.4

30.99

33.05

g/l

0.81

675

Disorders of male genital organs in diseases classified elsewhere

2.53

1.15

1.6

1.9

22.98

31.24

g/l

—

Alzheimer disease, excluding more controls

115

920

0.83

1.15

1.3

1.5

29.45

32.19

g/l

1.71

102

822

Other sleep disorders

500

1.28

1.14

1.4

1.5

30.66

33.59

g/l

1.16

456

Benign neoplasm: Skin of trunk

150

1.54

1.14

1.8

1.4

32.73

31.95

g/l

0.11

134

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

199

1860

0.87

1.14

1.4

1.5

33.46

33.41

g/l

0.02

188

1694

Intercostal neuropathy

2.37

1.13

1.1

1.5

30.24

33.53

g/l

—

Iron deficiency

2.34

1.12

1.0

1.3

34.77

34.24

g/l

—

Use of interferon beta-1a

2.34

1.12

1.6

1.4

37.16

34.41

g/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

505

3160

1.09

1.12

1.5

1.4

33.00

32.85

g/l

0.10

457

2836

Allergic rhinitis

814

0.79

1.12

1.4

1.5

34.58

34.57

g/l

0.00

741

Visual disturbances

269

2397

1.12

1.4

1.5

31.86

32.94

g/l

0.74

242

2153

Deep endometriosis

282

0.64

1.11

1.3

1.4

35.94

32.21

g/l

0.54

258

Parkinson's disease, strict definition, excluding more controls

846

0.80

1.09

1.5

34.79

32.45

g/l

0.89

755

Certolizumab pegol

2.39

1.09

1.0

1.4

39.06

31.18

g/l

—

Other joint disorders

519

2540

1.09

1.08

1.5

1.4

32.50

33.69

g/l

1.31

467

2272

Allergic urticaria

235

1.41

1.08

1.4

35.62

33.34

g/l

0.39

211

Other and unspecified disorders of vitreous body

196

2222

0.88

1.08

1.4

1.5

32.79

33.32

g/l

0.24

176

2017

Localized swelling, mass and lump of skin and subcutaneous tissue

178

1548

1.15

1.08

1.4

1.5

31.36

32.80

g/l

0.84

162

1393

Dislocation, sprain and strain of joints and ligaments of knee

215

2263

0.88

1.08

1.4

33.43

34.69

g/l

0.76

200

2068

Other and unspecified urticaria

648

1.24

1.07

1.7

1.5

35.33

32.81

g/l

1.02

591

Carcinoma in situ of skin, other sites/unspecified

1.82

1.06

1.6

1.4

30.48

30.14

g/l

0.04

Other mental disorders due to brain damage and dysfunction and to physical disease

650

1.24

1.05

1.5

32.25

30.63

g/l

0.60

577

Agoraphobia

2.13

1.05

1.6

1.2

46.71

35.20

g/l

—

Lower back pain or/and sciatica

629

4054

1.08

1.05

1.5

32.20

33.19

g/l

1.15

563

3649

Other hearing loss

219

1904

1.13

1.04

1.4

1.5

31.98

31.64

g/l

0.14

191

1671

Otosclerosis

360

0.69

1.04

1.5

31.10

32.31

g/l

0.20

326

Acute and subacute iridocyclitis

101

841

1.20

1.04

1.4

1.5

33.31

32.97

g/l

0.09

766

Other disorders of the musculoskeletal system and connective tissue

678

1.23

1.04

1.3

1.5

31.83

32.41

g/l

0.16

614

Burn and corrosion of wrist and hand

1.67

1.04

1.6

1.4

27.97

33.45

g/l

0.92

Neuromuscular dysfunction of bladder

428

1.29

1.04

1.5

32.70

32.42

g/l

0.06

390

Open wound of thorax

1.97

1.04

1.9

1.4

30.34

32.07

g/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

115

1359

0.84

1.04

1.5

34.29

33.23

g/l

0.42

103

1233

Nonorganic sleeping disorders

606

1.24

1.04

1.6

1.5

32.56

33.54

g/l

0.26

554

Postmenopausal bleeding

115

750

0.84

1.03

1.4

32.97

32.51

g/l

0.15

105

658

Parkinson's disease, excluding more controls

897

0.81

1.02

1.5

35.07

32.61

g/l

1.07

801

Corneal ulcer

735

1.21

1.01

1.4

1.5

30.20

33.45

g/l

1.66

666

Disorders of vitreous body

308

2727

1.11

1.00

1.4

1.5

31.14

33.01

g/l

1.79

276

2468

Post-traumatic stress disorder

107

1.59

0.99

1.7

1.6

33.32

34.41

g/l

0.12

Ventral hernia

147

1271

1.16

0.99

1.5

32.54

32.71

g/l

0.06

139

1128

Contusion of ankle

1.72

0.99

1.7

1.4

33.89

33.36

g/l

0.05

Dental caries 2

284

2474

0.90

0.98

1.5

1.4

34.52

34.25

g/l

0.14

264

2255

Other headache syndromes

155

1781

0.87

0.98

1.4

1.5

33.46

33.74

g/l

0.10

142

1623

Hyperprolactinaemia

1.81

0.98

1.5

36.84

34.53

g/l

0.21

Deficiency of other B group vitamins

1.64

0.97

1.2

1.4

35.17

31.58

g/l

0.67

Glaucoma

412

3321

1.09

0.97

1.4

1.5

30.48

32.44

g/l

2.35

370

2972

Mental retardation, wide definition

1.67

0.97

1.4

40.02

32.62

g/l

1.61

Gastrojejunal ulcer

1.87

0.97

1.5

1.4

31.84

33.80

g/l

—

Any dementia, excluding more controls

254

1964

0.90

0.97

1.4

1.5

29.78

31.36

g/l

1.28

230

1743

Idiopathic thrombocytopenic purpura

116

1.56

0.97

1.3

1.4

29.20

31.50

g/l

0.48

104

Propionic acid derivatives

187

1070

0.88

0.97

1.5

31.72

30.74

g/l

0.53

167

943

Sleep disorders, other/unspecified

1.86

0.96

1.7

1.4

31.65

33.23

g/l

—

Other abnormal products of conception

314

0.74

0.96

1.4

38.17

35.84

g/l

0.63

294

Benign neoplasm: Skin of lower limb, including hip

1.78

0.94

1.9

1.4

30.85

27.32

g/l

0.57

Abnormal findings in secretions and smears from cervix uteri vagina vulva

101

940

0.84

0.94

1.3

1.4

34.14

34.57

g/l

0.12

869

Unspecified lump in breast

498

1.25

0.93

1.4

34.17

32.89

g/l

0.39

454

Malignant neoplasm of other and unspecified parts of biliary tract

1.75

0.93

1.1

1.5

37.17

32.75

g/l

—

Other ill-defined and unspecified causes of mortality

392

1.28

0.92

1.9

1.5

30.88

30.45

g/l

0.10

352

Benign leiomyoma with endometriosis

600

0.78

0.92

1.5

1.4

33.79

32.80

g/l

0.20

549

Other keratitis

384

1.28

0.90

1.4

1.5

32.64

33.32

g/l

0.10

340

ILD medications: nintedanib

2.10

0.90

1.7

1.5

32.63

31.77

g/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

653

0.80

0.89

1.3

1.5

33.80

33.81

g/l

0.00

589

Mental retardation, excluding more controls

1.75

0.89

1.4

1.5

40.75

31.58

g/l

1.77

Circumscribed brain atrophy

104

0.48

0.89

1.0

1.5

25.00

29.40

g/l

—

Benign neoplasm: Vulva

2.08

0.89

1.3

1.1

32.38

23.96

g/l

—

Salpingitis and oophoritis

537

1.23

0.89

1.4

32.65

33.84

g/l

0.31

491

Artificial joint operation, meniscal resection

556

3963

0.93

0.89

1.5

33.28

32.86

g/l

0.35

520

3545

Anxiety disorders, excluding more controls

424

2594

1.08

0.88

1.5

1.4

34.29

33.69

g/l

0.43

382

2345

Atopic dermatitis, strict definition with reimbursement

715

1.19

0.88

1.5

1.4

34.67

34.88

g/l

0.05

648

Hyperplasia of prostate

322

1675

1.10

0.87

1.5

32.23

32.88

g/l

0.42

289

1504

Benign mammary dysplasia

512

1.23

0.87

1.4

34.23

32.23

g/l

0.60

466

Voice disturbances

141

1231

1.15

0.87

1.6

1.5

33.02

32.60

g/l

0.15

130

1110

Dermatitis herpetiformis

1.73

0.86

1.7

1.4

28.17

32.45

g/l

0.60

Speech disturbances, not elsewhere classified

441

1.25

0.86

1.5

33.90

31.19

g/l

0.84

400

Postpartum care and examination

1.47

0.85

1.3

37.39

37.47

g/l

0.01

Leiomyoma of uterus

266

1369

1.11

0.84

1.4

33.70

33.19

g/l

0.24

240

1242

Disorders of vestibular function (Vertigo)

238

2611

0.90

0.83

1.5

34.07

32.60

g/l

1.08

215

2338

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

138

0.58

0.83

1.9

1.4

32.63

34.13

g/l

—

123

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

380

1.26

0.82

1.4

1.5

28.61

31.01

g/l

0.66

347

Benign neoplasm: Skin of other and unspecified parts of face

534

1.22

0.82

1.4

1.5

32.42

31.60

g/l

0.21

488

Benign leiomyoma with endometriosis

372

1.27

0.82

1.5

33.79

29.06

g/l

1.52

319

Other and unspecified mood [affective] disorders

113

1.51

0.82

1.4

38.25

34.17

g/l

0.81

103

Dental caries 2 and operation codes

278

2421

0.91

0.82

1.5

1.4

34.44

34.25

g/l

0.09

259

2207

Superficial injury of forearm

293

1.30

0.81

1.2

1.5

32.68

32.14

g/l

0.09

264

Hereditary ataxia

1.71

0.81

1.3

1.7

30.09

33.06

g/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.71

0.81

1.0

1.2

25.82

25.80

g/l

—

Other specific joint derangements/joint disorders

383

2373

1.08

0.80

1.6

1.4

32.56

33.78

g/l

1.13

344

2128

Benign lipomatous neoplasm of other sites/unspecified

437

1.24

0.79

1.4

1.5

29.98

31.61

g/l

0.38

397

Benign neoplasm: Tongue

1.54

0.78

1.4

30.22

32.10

g/l

0.26

Artrosis, including avohilmo

519

3043

0.94

0.78

1.5

1.4

32.34

32.99

g/l

0.56

471

2732

Crushed, pushed or stepped on by crowd or human stampede

148

1.42

0.77

1.4

34.31

32.90

g/l

0.19

130

Other disorders of eyelid

307

2726

1.09

0.77

1.4

1.5

30.91

32.38

g/l

1.34

274

2439

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

206

0.72

0.77

1.4

37.82

38.01

g/l

0.03

197

Cervicobrachial syndrome

943

0.85

0.76

1.4

32.15

33.69

g/l

0.61

861

Suppurative and unspecified otitis media

122

944

1.15

0.76

1.4

1.5

33.68

33.76

g/l

0.02

111

854

Intentional self-harm by sharp object

1.77

0.76

1.5

1.4

36.85

30.93

g/l

—

Inflammatory bowel disease

150

1331

1.13

0.75

1.4

1.5

30.78

33.38

g/l

1.46

138

1204

Redundant prepuce, phimosis and paraphimosis

114

989

1.15

0.75

1.6

1.5

31.89

33.68

g/l

0.72

100

883

Fissure and fistula of anal and rectal regions

130

1145

1.14

0.74

1.5

1.4

32.07

33.03

g/l

0.39

121

1027

Flat foot [pes planus] (acquired)

368

0.76

0.73

1.3

1.4

28.71

33.33

g/l

0.92

331

Dorsopathies

653

3147

1.06

0.72

1.5

1.4

32.65

33.26

g/l

0.55

585

2824

Benign neoplasm of male genital organs

1.59

0.72

1.2

1.5

25.94

28.35

g/l

0.26

Manic episode

1.62

0.71

1.3

1.4

38.59

35.24

g/l

0.57

Strabismus

117

1024

1.14

0.71

1.5

34.46

32.82

g/l

0.69

106

929

Excessive, frequent and irregular menstruation

128

809

0.88

0.71

1.5

1.4

33.97

32.84

g/l

0.45

120

715

Nasal polyp

1086

0.86

0.71

1.4

1.5

33.24

33.02

g/l

0.06

977

Other specified and unspecified disorders of eye and adnexa

134

1.42

0.71

1.1

1.4

31.15

32.27

g/l

0.12

116

Intracerebral haemorrhage

775

1.16

0.71

1.4

1.5

34.54

31.50

g/l

1.58

693

Thyrotoxicosis with diffuse goitre

462

1.21

0.71

1.3

1.5

30.62

32.81

g/l

0.60

420

Hallux valgus (acquired)

161

1301

0.89

0.70

1.4

32.91

33.38

g/l

0.18

149

1167

Contact with nonpowered hand tool

158

0.63

0.70

1.5

1.6

36.05

32.35

g/l

—

138

Endocrine disorders, other/unspecified

1.56

0.70

1.1

1.4

33.11

33.43

g/l

—

Extrapyramidal and movement disorders

204

2244

0.91

0.70

1.4

1.5

32.77

32.16

g/l

0.29

183

1997

Other benign neoplasms of connective and other soft tissue

400

1.23

0.69

1.4

1.5

31.76

32.17

g/l

0.09

361

Other obstetric conditions, not elsewhere classified

216

0.75

0.68

1.4

36.87

37.99

g/l

0.17

205

Carcinoma in situ of breast, other/unspecified

1.86

0.68

1.0

1.2

30.40

26.62

g/l

—

Mild mental retardation

1.67

0.68

1.1

1.4

42.84

31.06

g/l

—

Impacted maxillary molar

1.67

0.68

1.6

1.1

39.47

33.94

g/l

—

Ulcerative colitis (strict definition, require KELA)

596

0.82

0.68

1.3

1.5

33.47

33.71

g/l

0.04

541

Mental retardation

1.60

0.68

1.4

1.3

40.75

31.74

g/l

1.75

Benign neoplasm of brain and other parts of central nervous system

170

1.36

0.67

1.4

1.5

33.40

28.25

g/l

1.24

150

Fourth [trochlear] nerve palsy

0.55

0.67

1.8

1.4

26.42

32.08

g/l

—

Inflammatory bowel disease, strict (require KELA)

833

0.85

0.67

1.4

1.5

34.15

34.21

g/l

0.01

750

Female infertility, tubal origin

0.55

0.67

1.0

1.4

34.46

34.72

g/l

—

Polycystic ovarian syndrome

1.63

0.66

1.1

1.3

37.37

36.15

g/l

—

Pedal cyclist injured in transport accident

854

0.85

0.66

1.5

34.24

33.33

g/l

0.23

772

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

1.80

0.66

1.0

1.3

39.30

25.94

g/l

—

Cystitis

521

3001

1.06

0.66

1.5

1.4

31.88

33.00

g/l

1.16

466

2726

Alzheimer’s disease, wide definition, excluding more controls

110

850

0.88

0.66

1.4

1.5

30.02

32.03

g/l

1.01

758

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.60

0.65

1.6

1.2

41.44

27.01

g/l

—

Ill-defined and unknown causes of mortality

449

1.21

0.65

1.8

1.5

30.92

30.20

g/l

0.19

405

Family history of certain disabilities and chronic diseases leading to disablement

1.62

0.65

1.3

30.06

33.92

g/l

—

L04AC Interleukin inhibitors

103

1.46

0.65

1.5

1.4

35.99

33.89

g/l

0.27

Pneumoconiosis due to asbestos and other mineral fibres

163

1.36

0.65

1.5

35.44

30.39

g/l

1.35

148

Other bursopathies

652

1.17

0.64

1.5

1.4

29.42

33.23

g/l

1.75

592

Lumbar disc prolapse

331

2824

0.93

0.64

1.5

1.4

33.13

33.25

g/l

0.06

302

2541

Sudden idiopathic hearing loss

505

1.19

0.64

1.5

33.06

32.29

g/l

0.16

454

Colon adenocarcinoma

737

1.16

0.63

1.3

1.5

30.79

30.97

g/l

0.05

659

Follow-up examination after treatment for malignant neoplasms

579

1.18

0.63

1.5

32.47

32.09

g/l

0.10

518

Disorders of breast

179

1505

1.10

0.63

1.3

1.4

35.45

33.29

g/l

1.56

165

1368

Labour and delivery complicated by umbilical cord complications

1.52

0.62

1.3

1.4

34.30

33.89

g/l

0.04

Alzheimer’s disease (Atypical or mixed)

641

0.84

0.62

1.3

1.5

29.17

29.06

g/l

0.02

557

Malignant neoplasm of tonsil

1.60

0.62

1.3

1.5

37.65

30.91

g/l

—

Sicca syndrome [Sjögren]

316

1.24

0.61

1.4

1.5

28.14

32.80

g/l

1.07

286

Persons encountering health services in circumstances related to reproduction

175

1305

0.91

0.61

1.4

35.94

35.35

g/l

0.25

155

1195

Organic, including symptomatic, mental disorders

399

2704

1.07

0.60

1.4

1.5

31.04

31.94

g/l

0.74

364

2415

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

115

1023

1.13

0.60

1.6

1.4

30.69

34.17

g/l

2.27

109

935

Follicular cysts of skin and subcutaneous tissue

816

1.14

0.60

1.4

1.5

32.45

32.91

g/l

0.12

740

Oter anti-inflammatory and antirheumatic agents, non-steroids

202

1024

1.10

0.59

1.5

31.54

30.31

g/l

0.69

182

903

Fall on same level involving ice and snow

306

2853

1.07

0.59

1.5

31.60

33.18

g/l

1.37

277

2574

Melanocytic naevi

133

1194

1.12

0.59

1.5

33.31

32.94

g/l

0.13

117

1078

Neurotic, stress-related and somatoform disorders

425

2844

1.06

0.59

1.5

1.4

34.27

33.72

g/l

0.39

383

2585

Malignant neoplasm of oropharynx

1.54

0.59

1.3

1.5

36.95

31.46

g/l

0.81

IBD patients in KELA-register

822

0.86

0.59

1.4

1.5

34.15

34.27

g/l

0.03

741

Disorders of refraction and accommodation

842

1.14

0.59

1.5

1.4

33.06

33.95

g/l

0.32

764

Acute upper respiratory infections

651

3885

1.05

0.58

1.5

1.4

32.92

32.97

g/l

0.03

597

3482

Lichen ruber planus, wide definition including periferal and oral lichen planus

949

0.87

0.58

1.6

1.5

34.27

32.81

g/l

0.46

856

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.52

0.58

1.5

37.89

33.93

g/l

—

Erectile dysfunction

585

1.17

0.58

1.5

1.6

31.34

31.82

g/l

0.11

521

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

1.73

0.58

1.8

1.4

36.27

26.20

g/l

—

Polycystic ovarian syndrome, consortium definition

263

1470

1.08

0.57

1.5

1.4

33.78

33.36

g/l

0.20

248

1321

Meniscus derangement

319

2334

0.93

0.57

1.5

1.4

33.68

33.40

g/l

0.15

298

2086

Other meningitis

1.67

0.57

1.5

32.55

31.39

g/l

—

Inflammation of lacrimal passages (chronic)

1.52

0.56

1.7

1.4

33.28

32.93

g/l

0.03

Other disorders of choroid

1.46

0.56

1.3

1.5

31.04

31.00

g/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

502

0.84

0.55

1.3

1.5

29.81

31.14

g/l

0.36

448

Presbycusis

113

1007

1.12

0.54

1.4

1.5

30.78

30.62

g/l

0.04

876

Mouth breathing

185

2011

0.92

0.54

1.4

1.5

35.65

33.79

g/l

1.31

166

1816

Guillain-Barre syndrome

1.51

0.54

1.2

1.5

22.99

33.77

g/l

—

Insomnia

505

1.17

0.54

1.4

1.5

32.28

33.85

g/l

0.43

459

Rotator cuff syndrome

399

2796

1.06

0.54

1.5

1.4

33.25

33.17

g/l

0.04

363

2502

Nontraumatic intracranial haemmorrhage

142

1288

1.10

0.54

1.6

1.5

32.79

31.60

g/l

0.55

125

1148

Ulcerative colitis

115

1032

1.12

0.54

1.4

1.5

30.97

33.28

g/l

0.97

104

931

Disorders of optic nerve, not elsewhere classified

1.44

0.53

1.4

1.5

24.05

31.54

g/l

—

Other hammer toe(s) (acquired)

911

0.88

0.52

1.5

1.4

34.65

32.72

g/l

0.84

814

Benign neoplasm of other and unspecified female genital organs

133

0.67

0.52

1.2

1.3

34.69

32.93

g/l

—

118

Malignant neoplasm of stomach

296

1.22

0.51

1.4

1.5

32.65

30.72

g/l

0.42

267

Benign neoplasm: Cranial nerves

1.47

0.51

1.5

1.3

31.75

28.22

g/l

0.56

Cluster headache, strict

1.47

0.50

1.8

1.4

37.83

33.97

g/l

0.36

Nonsuppurative otitis media

552

1.14

0.50

1.3

1.5

34.68

33.45

g/l

0.32

503

Persistent mood disorders

800

1.13

0.50

1.6

1.5

33.00

32.63

g/l

0.10

727

Lesion of plantar nerve

247

0.77

0.50

1.5

1.4

35.76

33.12

g/l

0.50

224

Chondropathies

556

1.15

0.50

1.6

1.5

34.13

33.16

g/l

0.26

511

Benign neoplasm of thyroid gland

1.50

0.49

1.6

1.3

35.52

26.01

g/l

—

Acute appendicitis, with complications

108

972

1.11

0.49

1.7

1.5

32.79

32.94

g/l

0.04

100

881

Other degenerative diseases of the nervous system

185

1294

1.08

0.49

1.3

1.5

31.39

33.08

g/l

1.10

168

1159

Injury of nerves and spinal cord at neck level

1.44

0.49

1.5

1.4

24.38

31.34

g/l

0.94

Chronic sinusitis

216

2007

1.08

0.49

1.7

1.4

33.70

33.74

g/l

0.01

196

1824

Malignant neoplasm of testis

1.56

0.49

1.9

1.7

31.09

32.98

g/l

—

Other benign neoplasms of skin

223

2079

1.07

0.48

1.4

1.5

32.22

32.41

g/l

0.08

204

1850

Unspecified visual impairment (binocular)

1.50

0.47

1.4

26.69

32.64

g/l

—

Special screening examination for infectious and parasitic diseases

466

1.14

0.47

1.3

1.4

37.80

36.74

g/l

0.31

425

Pulmonary eosinophilia, not elsewhere classified

1.47

0.47

1.3

1.5

28.93

33.34

g/l

—

Other diseases of hard tissues of teeth

333

2345

1.06

0.46

1.5

1.4

31.96

33.67

g/l

1.66

308

2127

Vestibular neuronitis

397

0.83

0.46

1.4

1.5

35.82

32.55

g/l

0.86

360

Blepharochalasis

178

1648

1.08

0.46

1.4

1.5

31.27

32.70

g/l

0.88

161

1473

Premature rupture of membranes

204

0.79

0.46

1.2

1.4

37.86

36.45

g/l

0.20

189

Anxiety disorders

431

2907

1.05

0.45

1.5

1.4

34.29

33.62

g/l

0.52

388

2644

Monoamine oxidase A inhibitors

533

1.15

0.45

1.3

1.5

35.98

33.06

g/l

1.07

482

Hypermobility syndrome

0.61

0.45

1.4

1.5

38.38

35.80

g/l

—

Coxarthrosis, primary

430

3555

1.05

0.45

1.5

31.51

32.51

g/l

0.97

395

3177

Diplopia

609

1.13

0.45

1.4

1.5

31.30

32.35

g/l

0.29

553

Obstructive hydrocephalus

1.38

0.44

1.7

1.5

41.51

33.53

g/l

—

Chronic Coagulation defects

1.38

0.44

1.6

1.5

26.09

32.16

g/l

—

Menorrhagia

132

798

0.91

0.44

1.6

1.4

33.28

32.69

g/l

0.19

121

704

Ovarian cyst

126

798

0.91

0.44

1.5

1.4

33.42

32.74

g/l

0.21

117

707

Atypical facial pain

163

0.73

0.43

1.4

1.3

29.01

32.26

g/l

0.55

144

Other and unspecified visual disturbances

386

1.17

0.43

1.3

1.6

32.67

33.05

g/l

0.07

353

Other symptoms and signs involving the nervous and musculoskeletal systems

211

1974

1.07

0.42

1.5

33.26

33.17

g/l

0.03

192

1781

Other disorders of optic [2nd] nerve and visual pathways

221

1.22

0.42

1.4

1.5

27.66

32.36

g/l

1.41

198

Alzheimer’s disease (Late onset), excluding more controls

110

805

0.91

0.42

1.4

1.5

30.06

31.79

g/l

0.85

717

Injury of eye and orbit

510

0.86

0.42

1.5

1.4

32.76

33.73

g/l

0.16

464

Excessive attrition of teeth

166

834

1.08

0.41

1.4

1.5

32.26

33.19

g/l

0.41

155

767

Other juvenile arthritis

1.38

0.41

1.8

1.1

27.79

35.10

g/l

—

Dyshidrosis [pompholyx]

1.52

0.41

2.4

1.5

27.40

30.80

g/l

—

Effects of foreign body entering through natural orifice

1088

0.91

0.40

1.4

1.5

33.54

33.59

g/l

0.01

988

303

0.82

0.40

1.8

1.4

29.99

29.60

g/l

0.05

266

Visual field defects

408

1.15

0.40

1.4

1.5

30.95

31.99

g/l

0.20

367

Injuries to the neck

863

1.10

0.39

1.6

1.5

32.62

33.17

g/l

0.14

782

Car occupant injured in noncollision transport accident

1.34

0.39

1.5

1.4

31.51

32.97

g/l

0.18

Factitial dermatitis

0.00

0.39

0.0

1.4

—

29.92

—

Reactive arthropathies

381

1.16

0.39

1.4

35.13

33.50

g/l

0.44

350

Calcific tendinitis of shoulder

215

0.79

0.39

1.3

1.5

31.93

34.12

g/l

0.34

197

Diseases of male genital organs

379

1827

1.05

0.39

1.5

32.26

33.49

g/l

1.15

336

1640

Recurrent or chronic depression

135

1055

0.92

0.38

1.5

1.4

35.17

34.75

g/l

0.14

124

965

Mood disorders, excluding more controls

533

3118

1.04

0.38

1.5

34.62

33.22

g/l

1.70

481

2808

Ovarian dysfunction

1.38

0.38

1.4

38.19

34.30

g/l

0.34

Transport accidents

212

1768

1.06

0.38

1.6

1.4

32.33

34.20

g/l

1.22

192

1592

Polyp of the female genital tract

124

783

0.92

0.37

1.6

1.4

34.43

32.71

g/l

0.75

114

691

Benign lipomatous neoplasm

141

1518

0.93

0.37

1.4

1.5

33.01

32.72

g/l

0.10

127

1369

Guttate psoriasis

1.35

0.37

1.6

1.5

35.28

32.20

g/l

—

Benign neoplasm: Short bones of upper limb

1.35

0.37

1.2

1.3

35.80

32.56

g/l

—

Other disorders of conjunctiva

744

1.10

0.36

1.5

29.13

31.93

g/l

1.20

672

Disorders of synovium and tendon

250

2375

0.95

0.36

1.6

1.4

33.46

33.47

g/l

0.00

228

2130

Mixed and other personality disorders

171

1.23

0.35

1.2

1.5

37.42

34.87

g/l

0.33

151

LSIL lesion of the cervix uteri

168

0.77

0.35

1.3

1.4

39.11

35.06

g/l

0.53

157

Acute nasopharyngitis (common cold)

336

1.15

0.35

1.6

1.4

33.66

35.05

g/l

0.26

298

Otitis media, unspecified

225

0.82

0.35

1.4

33.99

33.88

g/l

0.01

201

Striking against or struck by other objects

138

1284

1.07

0.35

1.4

1.5

34.36

33.62

g/l

0.28

125

1168

Pedal cyclist injured in noncollision transport accidents

384

0.86

0.35

1.4

1.5

37.62

32.80

g/l

1.26

341

Dermatographic urticaria

167

0.78

0.34

1.4

32.10

33.29

g/l

0.13

150

Status post-ami

497

0.89

0.34

1.4

1.5

29.85

32.26

g/l

0.82

446

Glaucoma-related operations

302

1.16

0.34

1.3

1.5

28.83

30.87

g/l

0.43

274

Other nutritional anaemias

1.34

0.34

1.3

1.5

35.92

31.77

g/l

—

Hyperkinetic disorders

1.34

0.34

1.3

1.4

43.42

37.61

g/l

1.14

Cluster headache, wide

1.32

0.33

1.8

1.5

39.45

33.38

g/l

0.67

Crowding of teeth, including avohilmo

0.69

0.33

1.2

1.4

37.03

35.54

g/l

—

Crossbite

0.69

0.33

1.0

1.4

36.30

35.07

g/l

—

Ganglion

792

0.91

0.33

1.6

1.4

33.59

34.51

g/l

0.23

721

Primary coxarthrosis, bilateral

180

1908

0.94

0.32

1.5

31.26

31.96

g/l

0.34

168

1690

Subarachnoid haemorrhage

540

1.11

0.32

1.7

1.5

31.30

32.44

g/l

0.28

485

Cervical disc disorders

195

2061

0.95

0.32

1.5

1.4

31.99

33.25

g/l

0.66

181

1852

Other abnormal uterine and vaginal bleeding

111

733

1.08

0.32

1.4

31.01

32.62

g/l

0.61

103

645

Oral leukoplakia and related diseases, including avohilmo

379

1.14

0.32

1.4

1.5

32.28

32.55

g/l

0.05

338

L02BB Anti-androgens

716

0.91

0.31

1.5

29.36

31.02

g/l

0.58

631

Abnormal involuntary movements

589

1.10

0.31

1.4

1.5

30.94

32.40

g/l

0.46

536

Other noninflammatory disorders of uterus, except cervix

731

0.92

0.31

1.4

32.06

32.49

g/l

0.14

641

Other/unspecified enthesopathies of lower limb, excluding foot

221

1.18

0.30

1.9

1.5

28.54

32.13

g/l

0.82

204

Golimumab

1.30

0.30

2.4

1.4

36.86

34.96

g/l

—

Glucosamine medication

326

2709

0.96

0.30

1.5

32.41

32.09

g/l

0.18

289

2425

Benign neoplasm: Skin of scalp and neck

1.29

0.30

1.2

1.5

34.46

31.59

g/l

0.33

Lesion of sciatic nerve

271

0.85

0.29

1.4

1.5

34.94

30.62

g/l

0.76

246

Seborrhoeic keratosis

132

1239

1.07

0.29

1.4

1.5

30.00

32.46

g/l

1.34

119

1112

Twin gestation

106

0.75

0.29

1.6

1.4

38.76

36.24

g/l

—

Anankastic personality disorder

1.23

0.29

1.9

1.4

42.70

33.79

g/l

—

Myopia

288

1.15

0.29

1.4

1.5

35.60

33.60

g/l

0.43

260

Multiple gestation

111

0.72

0.28

1.6

1.4

38.76

36.84

g/l

—

102

Conductive hearing loss, unspecified

334

0.87

0.28

1.6

1.5

33.57

32.43

g/l

0.22

302

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

232

1.17

0.28

1.5

1.4

31.86

34.52

g/l

0.39

208

Peritonsillar abscess

732

0.91

0.28

1.5

1.4

32.90

34.54

g/l

0.49

659

Pure hyperglyceridaemia

1.30

0.28

1.7

1.4

31.16

32.80

g/l

0.11

Postprocedural disorders of nervous system

140

1.22

0.27

1.4

38.89

35.01

g/l

0.68

125

Bicipital tendinitis

172

0.81

0.27

1.2

1.5

30.78

33.55

g/l

0.29

158

Benign neoplasm: Skin of upper limb, including shoulder

1.23

0.27

1.0

1.4

25.82

31.84

g/l

—

Short Achilles tendon (acquired)

1.23

0.27

2.1

1.3

29.25

33.37

g/l

—

Pregnancy with abortive outcome

234

1281

0.95

0.27

1.5

1.4

35.48

32.89

g/l

2.21

213

1164

Deforming dorsopathies

122

1297

0.94

0.26

1.5

1.4

34.09

33.26

g/l

0.31

113

1184

Other disorders of cornea

395

1.12

0.26

1.5

29.68

32.40

g/l

0.68

357

Pedestrian injured in collision with car, pick-up truck or van

0.70

0.26

1.4

34.92

32.23

g/l

—

Viral meningitis

0.67

0.26

1.4

36.44

34.60

g/l

—

Type 1 diabetes, wide definition, subgroup 2

1.25

0.25

1.6

1.4

29.49

28.92

g/l

—

Laparoscopic left hemicolectomy

1.24

0.25

1.4

1.6

32.76

30.64

g/l

—

Scoliosis

256

0.86

0.25

1.4

34.41

32.22

g/l

0.34

234

Myasthenia gravis

1.22

0.25

1.6

1.4

32.42

32.67

g/l

—

Other and unspecified hydrocephalus

1.22

0.25

1.6

1.5

33.29

31.06

g/l

—

Benign neoplasm of other and unspecified female genital organs

1.22

0.25

1.2

1.4

34.69

28.23

g/l

—

Mood [affective] disorders

533

3603

0.97

0.25

1.5

1.4

34.67

33.08

g/l

2.13

481

3235

Oxicams

174

1040

0.95

0.25

1.4

1.5

33.47

30.43

g/l

2.49

158

915

Postpartum haemorrhage due to retained placenta

137

0.80

0.24

1.3

1.5

41.12

36.80

g/l

0.73

128

Open wound of wrist and hand

191

1978

0.96

0.24

1.5

34.74

33.74

g/l

0.50

182

1774

Benign neoplasm of brain and other parts of central nervous system

265

0.87

0.24

1.4

1.5

33.40

32.11

g/l

0.21

235

Aneurysms, operations, SAH

832

1.07

0.23

1.6

1.5

31.71

32.79

g/l

0.33

749

Temporal arteritis

190

1.16

0.23

1.5

27.97

31.02

g/l

0.60

172

Excessive vomiting in pregnancy

136

0.81

0.23

1.3

1.4

33.23

34.32

g/l

0.11

127

Retinal breaks without detachment

757

1.07

0.22

1.5

36.43

32.95

g/l

2.08

685

Other disorders of bladder

728

1.07

0.22

1.7

1.5

31.94

32.03

g/l

0.02

652

Struck by thrown, projected or falling objec

146

0.82

0.22

1.8

1.5

34.98

31.63

g/l

0.58

128

Inflammatory disorders of breast

116

1.21

0.22

1.4

29.26

33.10

g/l

0.60

106

Lichen planus, including avohilmo

824

0.93

0.22

1.5

34.06

32.63

g/l

0.41

745

Other sudden death, cause unknown

0.00

0.21

0.0

1.7

—

28.19

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.8

—

33.11

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

1.19

0.21

2.0

1.5

42.76

30.89

g/l

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.5

—

28.18

—

Other and unspecified trigeminal disorders

1.19

0.21

1.6

1.3

35.62

30.96

g/l

—

Fatigue fracture of vertebra

0.00

0.21

0.0

1.5

—

28.02

—

Lateral epicondylitis

492

0.91

0.21

1.9

1.4

35.84

35.38

g/l

0.08

448

Subacute thyroiditis

103

0.78

0.21

1.6

1.4

36.81

33.88

g/l

—

6-mercaptopurine

1.16

0.21

1.4

1.6

28.22

34.49

g/l

—

Giant cell arteritis with polymyalgia rheumatica

192

1.15

0.20

1.5

27.97

30.71

g/l

0.52

174

Coxibs

208

1064

1.04

0.20

1.5

31.69

30.70

g/l

0.52

182

938

Other cestode infections

0.00

0.20

0.0

1.1

—

31.91

—

Injuries to the wrist and hand

519

3849

0.98

0.20

1.5

1.4

32.89

33.33

g/l

0.34

484

3459

Carpal tunnel syndrome

329

2884

1.03

0.20

1.5

1.4

32.20

33.39

g/l

0.93

294

2604

malignant neoplasm of male genital organs

363

2241

1.03

0.20

1.5

31.20

32.35

g/l

0.96

309

2024

Mood disorders

538

3613

0.98

0.19

1.5

1.4

34.67

33.07

g/l

2.17

486

3244

Corneal degeneration

1.18

0.19

1.2

1.5

28.63

33.01

g/l

—

Malignant neoplasm of bladder

510

1.08

0.19

1.5

30.87

30.50

g/l

0.08

443

Acetic acid derivatives and related substances

212

1064

1.04

0.19

1.5

31.36

30.69

g/l

0.33

185

938

Other and/or unspecified nontoxic goitre

337

1.10

0.19

1.6

1.5

35.27

32.21

g/l

0.85

305

Helminthiases

1.13

0.18

1.0

1.4

27.42

33.11

g/l

—

Other and unspecified injuries of thorax

1.13

0.18

1.2

1.4

34.07

31.17

g/l

—

Other/unspecified disorders of vestibular function

164

0.85

0.18

1.6

1.5

27.84

31.04

g/l

0.52

145

Trochanteric bursitis

580

0.93

0.18

1.4

32.29

33.61

g/l

0.29

528

Colonic or urogenital fistula

139

1332

1.04

0.18

1.5

31.73

32.85

g/l

0.50

129

1197

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.19

0.18

1.6

1.4

41.44

32.43

g/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.19

0.18

1.9

1.6

34.93

30.94

g/l

—

Spermatocele

507

0.93

0.17

1.3

1.5

32.42

31.97

g/l

0.07

459

Other specified/unspecified inflammatory spondylopathies

110

1.18

0.17

1.2

1.5

26.60

31.99

g/l

0.69

Hypopituitarism

205

1.12

0.17

1.3

1.6

32.68

34.12

g/l

0.18

182

Mixed conductive and sensorineural hearing loss

660

1.06

0.16

1.3

1.5

30.62

31.88

g/l

0.37

591

Inflammatory diseases of prostate (prostatitis)

836

1.05

0.16

1.7

1.5

31.38

32.70

g/l

0.49

750

Somatoform disorder

563

1.07

0.16

1.4

1.5

33.01

33.09

g/l

0.02

515

Entropion and trichiasis of eyelid

534

1.07

0.16

1.2

1.5

28.10

31.10

g/l

1.22

483

Lichen planus

577

0.94

0.16

1.4

1.5

34.88

32.09

g/l

0.78

522

Certain zoonotic bacterial diseases

1.11

0.16

1.3

1.4

32.33

32.78

g/l

—

Disturbance of activity and attention

1.11

0.16

1.3

41.04

37.49

g/l

—

Spondylolisthesis/Spondylolysis

863

0.95

0.16

1.4

34.11

33.55

g/l

0.16

789

Benign neoplasm of middle ear and respiratory system

370

1.08

0.15

1.3

1.5

30.67

32.18

g/l

0.29

335

Malignant neoplasm of rectosigmoid junction

0.77

0.15

1.5

30.13

31.41

g/l

—

Diseases of middle ear and mastoid

238

1894

1.03

0.15

1.4

1.5

33.22

33.52

g/l

0.13

213

1704

Gonarthrosis

411

2408

0.98

0.15

1.5

1.4

33.13

33.34

g/l

0.12

382

2150

Metatarsalgia

361

1.08

0.15

1.6

1.4

34.31

33.79

g/l

0.10

325

Pregnancy hypertension

859

0.95

0.15

1.6

1.4

34.88

35.15

g/l

0.07

797

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.10

0.15

2.3

1.4

38.14

36.17

g/l

—

Embedded and impacted teeth

340

1.08

0.15

1.3

1.5

37.79

35.20

g/l

0.58

306

Testicular hypofunction

1.08

0.14

1.6

31.19

33.25

g/l

—

Foreign body or object entering through skin

202

0.89

0.14

1.2

1.5

35.38

33.41

g/l

0.34

177

Chronic rhinitis, nasopharyngitis and pharyngitis

139

1342

1.04

0.14

1.7

1.5

35.45

33.86

g/l

0.94

127

1221

Benign neoplasm: Lip

1.19

0.14

1.0

1.4

33.25

32.10

g/l

—

Ankylosing spondylitis, strict definition

0.83

0.13

1.1

1.4

35.83

33.20

g/l

—

Other enthesopathy of foot (+metatarsalgia)

373

1.07

0.13

1.6

1.4

34.30

33.79

g/l

0.10

336

Benign neoplasm: Skin of eyelid, including canthus

755

1.05

0.13

1.4

1.5

33.09

31.92

g/l

0.39

679

Oral leukoplakia, including avohilmo

107

0.84

0.13

1.8

1.4

32.90

31.98

g/l

—

Inflammatory diseases of female pelvic organs

202

1482

1.03

0.12

1.4

33.59

33.64

g/l

0.02

187

1351

Glaucoma, exfoliation

687

1.05

0.12

1.4

1.5

29.66

30.35

g/l

0.17

606

Other arthrosis

311

2271

0.98

0.12

1.5

1.4

32.95

33.39

g/l

0.26

279

2025

Cluster headache, strict, including avohilmo

104

1.15

0.12

1.8

1.4

38.09

33.72

g/l

0.47

Hypertrophy of breast in women and men

590

1.05

0.12

1.4

1.5

34.64

33.79

g/l

0.22

539

Disorders of optic nerve and visual pathways

317

1.07

0.12

1.4

1.5

29.23

32.47

g/l

0.88

285

Other enthesopathies

137

1329

1.03

0.11

1.7

1.4

34.48

34.45

g/l

0.01

122

1215

5-aminosalicylic acid

739

1.04

0.11

1.4

33.37

34.07

g/l

0.17

666

Injury of nerves at wrist and hand level

105

1.14

0.11

1.3

1.4

33.19

33.10

g/l

0.01

Diseases of appendix

367

3399

0.98

0.11

1.6

1.4

33.71

33.41

g/l

0.18

333

3066

Chorioretinal inflammation

1.16

0.11

1.1

1.4

39.30

31.65

g/l

—

Other extrapyramidal and movement disorders in other diseases

113

1166

0.97

0.10

1.4

1.5

32.35

32.18

g/l

0.05

102

1046

Traumatic amputation of wrist and hand

202

1.09

0.10

1.5

1.6

30.40

31.95

g/l

0.22

180

Maternal care for known or suspected malpresentation of fetus

140

0.90

0.10

1.1

1.4

35.03

37.52

g/l

0.40

131

Other and unspecified corneal deformities and disorders

1.15

0.10

1.5

1.4

25.28

34.65

g/l

1.84

Antepartum haemorrhage, not elsewhere classified

1.15

0.10

1.5

1.4

40.58

35.12

g/l

0.54

Other and unspecified paralytic syndromes

1.14

0.10

1.6

1.4

32.24

33.37

g/l

—

Radiculopathy

951

0.97

0.10

1.4

34.70

32.27

g/l

1.14

850

Synovial cyst of popliteal space [Baker]

349

1.06

0.10

1.5

28.85

32.61

g/l

1.02

320

Carcinoma in situ of breast, other/unspecified

1.09

0.09

1.0

1.2

30.40

32.10

g/l

—

Deviated nasal septum

182

1859

0.98

0.09

1.5

32.97

33.37

g/l

0.17

163

1677

Occlusion and stenosis of arteries, not leading to stroke

1.15

0.09

1.7

1.5

25.90

29.29

g/l

—

Atopic dermatitis

179

1561

0.98

0.09

1.6

1.5

33.92

34.53

g/l

0.26

168

1416

conjunctival degenerations and deposits

1.15

0.09

1.2

1.5

31.04

32.69

g/l

—

Foreign body in ear

1.06

0.09

1.2

1.4

32.64

32.16

g/l

—

Other disorders of binocular movement

1.04

0.09

1.4

28.64

33.27

g/l

—

Conjunctivitis

321

2754

1.02

0.09

1.4

34.09

33.60

g/l

0.30

289

2491

Gastrointestinal stromal tumor and sarcoma

1.11

0.09

1.8

1.5

36.27

29.98

g/l

—

Exfoliative dermatitis

1.11

0.09

1.5

1.4

31.28

31.53

g/l

—

Enteropathic arthropathies

1.11

0.09

1.3

1.2

34.25

34.80

g/l

—

Major anomalies of jaw size

1.11

0.09

1.2

1.4

33.57

33.84

g/l

—

Effects of other external causes

1.09

0.09

1.5

1.4

28.58

33.44

g/l

—

Other disorders of amniotic fluid and membranes

143

0.90

0.08

1.2

1.4

39.89

36.20

g/l

0.52

131

Acute appendicitis, no complications

233

2364

0.98

0.08

1.5

34.24

34.02

g/l

0.10

209

2149

Selective serotonin reuptake inhibitors

634

3303

1.01

0.08

1.4

1.5

33.73

32.95

g/l

0.78

569

2980

Benign neoplasm of thyroid gland

113

0.88

0.08

1.6

1.4

35.52

32.53

g/l

—

100

Arthrosis

453

2460

1.01

0.08

1.5

1.4

31.95

33.42

g/l

1.62

410

2197

Hyperhidrosis

1.09

0.08

1.1

1.5

37.49

33.84

g/l

—

Disturbances of skin sensation

102

993

1.03

0.08

1.6

1.5

35.61

33.83

g/l

0.61

900

Appendicitis, broad definition

364

3370

0.99

0.08

1.6

1.4

33.79

33.46

g/l

0.20

330

3039

Complications predominantly related to the puerperium

529

1.04

0.08

1.4

36.75

35.39

g/l

0.35

490

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.05

0.08

1.9

1.4

40.51

34.66

g/l

—

Depression or dysthymia

431

2383

1.01

0.08

1.6

1.5

34.12

33.19

g/l

0.78

398

2145

Pre-eclampsia or poor fetal growth

580

0.96

0.08

1.8

1.4

32.77

35.51

g/l

0.73

537

Mumps

1.03

0.08

1.6

1.5

36.37

32.23

g/l

—

Other abnormal findings in urine

0.83

0.07

2.0

1.5

18.67

29.90

g/l

—

Lupus erythematosus

0.83

0.07

1.5

1.3

30.90

32.69

g/l

—

Other disorders of the genitourinary system

571

0.96

0.07

1.6

1.5

32.94

31.97

g/l

0.23

515

Oral leukoplakia

0.80

0.07

2.0

1.4

32.02

30.91

g/l

—

Suppurative otitis media, unspecified

1.08

0.07

1.5

34.04

31.16

g/l

—

Urolithiasis

203

2064

0.98

0.07

1.6

1.5

31.83

32.40

g/l

0.25

179

1855

Oligomenorrhoea

1.04

0.07

1.3

1.4

32.57

32.78

g/l

—

Foreign body entering into or through eye or natural orifice

294

1.05

0.07

1.7

1.5

32.41

32.46

g/l

0.01

261

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

153

0.91

0.07

2.2

1.4

37.14

35.39

g/l

0.22

140

Intrahepatic Cholestasis of Pregnancy (ICP)

1.03

0.07

2.3

1.4

38.14

35.19

g/l

—

Medical abortion

234

1253

1.01

0.06

1.5

1.4

34.73

32.94

g/l

1.19

216

1141

Testicular dysfunction

1.11

0.06

1.5

1.6

31.01

33.31

g/l

0.40

Use of pramipexole

119

1166

1.02

0.06

1.4

1.5

30.94

31.99

g/l

0.40

110

1043

Internal derangement of knee

198

1946

1.01

0.06

1.5

1.4

32.90

33.67

g/l

0.42

171

1745

Lichen sclerosus et atrophicus

355

1.04

0.06

1.5

1.4

31.64

32.47

g/l

0.16

319

Acute appendicitis

341

3184

1.01

0.05

1.5

1.4

33.77

33.52

g/l

0.14

309

2877

Vascular dementia (undefined)

281

0.95

0.05

1.4

1.5

27.53

27.66

g/l

0.02

248

Anti-inflammatory and antirheumatic products, non-steroids

210

1070

0.99

0.05

1.5

31.73

30.74

g/l

0.56

185

943

Disorders of conjunctiva

387

3211

1.01

0.05

1.4

33.24

33.44

g/l

0.12

350

2893

Cerebral aneurysm, nonruptured

356

1.04

0.05

1.2

1.5

33.81

33.04

g/l

0.13

322

Other fall from one level to another

970

1.02

0.05

1.7

1.5

31.62

33.26

g/l

0.63

883

Fall on and from ladder

384

0.96

0.05

1.4

1.5

33.45

31.95

g/l

0.36

347

Car occupant injured in other and unspecified transport accidents

656

0.98

0.05

1.7

1.5

28.48

33.58

g/l

2.22

596

Vascular dementia

624

0.97

0.05

1.3

1.5

28.31

29.51

g/l

0.37

538

Cluster headache, wide,, including avohilmo

120

1.08

0.05

1.7

1.4

39.57

34.16

g/l

0.64

105

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

198

1923

1.01

0.04

1.4

34.52

33.79

g/l

0.39

175

1754

Other intervertebral disc disorders

502

3093

0.99

0.04

1.5

1.4

33.06

33.15

g/l

0.05

454

2774

Benign neoplasm: Skin of lower limb, including hip

101

1.09

0.04

1.9

1.4

30.85

32.26

g/l

0.19

Other diseases of upper respiratory tract

716

3752

0.99

0.04

1.5

1.4

32.26

32.97

g/l

0.78

650

3369

Ocular pain

220

0.95

0.03

1.5

34.71

32.85

g/l

0.19

196

Cervicalgia

102

1005

1.02

0.03

1.4

1.5

31.71

32.92

g/l

0.48

909

Haemorrhoids and perianal venous thrombosis

177

1751

1.01

0.03

1.5

1.4

32.30

32.52

g/l

0.08

162

1565

Polyarthrosis

111

1050

1.01

0.03

1.5

1.4

33.25

32.88

g/l

0.10

101

933

Trigger finger

602

0.98

0.03

1.8

1.4

33.01

33.95

g/l

0.22

547

Primary open-angle glaucoma

219

2151

0.99

0.03

1.4

1.5

30.73

31.70

g/l

0.51

196

1900

Malignant neoplasm of prostate

355

2228

1.01

0.03

1.5

31.18

32.32

g/l

0.96

302

2012

Depression

476

3292

1.00

0.03

1.5

1.4

34.96

33.37

g/l

1.93

432

2962

Diseases of the ear and mastoid process

690

3504

1.00

0.02

1.5

32.92

33.30

g/l

0.31

618

3144

Stenosis and insufficiency of lacrimal passages

420

1.02

0.02

1.5

30.81

32.12

g/l

0.27

385

Endometriosis diagnosis and infertility diagnosis occurring together

172

1.05

0.02

1.2

1.4

39.83

35.43

g/l

0.69

157

Calculus of kidney and ureter

187

1858

1.01

0.02

1.6

1.5

31.99

32.56

g/l

0.23

164

1667

Gonarthrosis [arthrosis of knee](FG)

473

2793

1.00

0.02

1.5

1.4

32.97

33.30

g/l

0.23

442

2493

Perineal laceration during delivery

140

0.95

0.01

1.2

1.4

36.75

35.50

g/l

0.18

131

Nonspecific lymphadenitis

153

1.05

0.01

1.9

1.5

30.46

34.42

g/l

0.40

133

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

107

1059

1.01

0.01

1.6

1.4

34.85

34.64

g/l

0.06

100

968

Sciatica+with lumbago

261

2471

1.00

0.00

1.5

1.4

33.99

33.41

g/l

0.33

232

2225

Injury of muscle and tendon at lower leg level

706

0.99

0.00

1.5

31.01

34.07

g/l

1.21

647

Glaucoma suspect

210

2106

1.00

0.00

1.4

1.5

29.82

32.38

g/l

2.02

191

1883

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

114

992

1.01

0.00

1.6

1.4

34.57

34.92

g/l

0.09

103

921

Amenorrhoea

105

1.05

0.00

1.3

1.4

36.95

32.83

g/l

0.65

Primary open-angle glaucoma, strict

174

1740

1.00

0.00

1.4

1.5

30.78

31.57

g/l

0.34

158

1541

Impingement syndrome of shoulder

126

1255

1.00

0.00

1.4

31.89

34.48

g/l

1.43

113

1141

Allergic conjunctivitis

205

2018

1.00

0.00

1.4

34.67

33.80

g/l

0.50

182

1845

Amblyopia ex anopsia

102

0.98

0.00

1.2

1.4

27.28

32.84

g/l

—

Ulcerative ileocolitis

112

0.98

0.00

1.2

1.4

36.11

32.45

g/l

0.64

Benign neoplasm of male genital organs

121

0.99

0.00

1.2

1.5

25.94

31.10

g/l

0.68

107

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

351

1.00

0.00

1.5

1.4

30.28

34.07

g/l

1.11

320

Coxarthrosis, primary, with hip surgery

325

3085

1.00

0.00

1.5

32.01

32.24

g/l

0.13

300

2749

Benign neoplasm: Cranial nerves

113

0.97

0.00

1.5

31.75

32.76

g/l

0.13

104

Spondylosis

331

2835

1.00

0.00

1.5

1.4

33.45

33.00

g/l

0.26

304

2534

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

143

0.98

0.00

2.2

1.4

37.14

34.76

g/l

0.32

131

Other disorders of eye and adnexa

495

1.01

0.00

1.4

1.5

31.26

32.33

g/l

0.19

451

Flexion deformity

0.00

0.0

1.2

—

24.13

—

Drug-induced aplastic anaemia

0.00

0.0

1.2

—

28.02

—

Disorders of puberty, other/unspecified

0.00

0.0

1.4

—

24.28

—

Maxillary prognathism

0.00

0.0

1.4

—

34.10

—

Degenerative and vascular disorders of ear

0.00

0.0

1.4

—

30.00

—

Actinic reticuloid

0.00

0.0

1.5

—

26.83

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

2.0

—

34.29

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

1.7

—

36.47

—

Congenital syphilis

0.00

0.0

1.2

—

27.66

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.1

—

30.31

—

Use of bromocriptine

0.00

0.0

1.4

—

35.33

—

Discharge from other and unspecified firearms

0.00

0.0

1.4

—

35.12

—

Relapsing fevers

0.00

0.0

1.4

—

32.76

—

Gender identity disorders

0.00

0.0

1.4

—

36.95

—

Toxic effect of contact with venomous animals

110

1.00

0.00

1.3

1.4

37.13

31.33

g/l

0.74

Diseases of thymus

0.00

0.0

1.4

—

26.62

—

Lichen planopilaris

0.00

0.0

1.5

—

32.08

—

Other sexually transmitted chlamydial diseases

0.93

0.00

1.6

1.5

35.16

38.06

g/l

—

Sunburn

0.00

0.0

1.2

—

20.72

—

Precocious central puberty

0.00

0.0

1.4

—

27.96

—

Pelvic region

0.00

0.0

1.2

—

33.02

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.0

1.4

—

34.82

—

Postpartum haemorrhage due to anatomy

0.93

0.00

1.6

1.5

32.27

37.13

g/l

—

Traumatic subcutaneous emphysema

0.00

0.0

1.7

—

25.53

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.0

1.1

—

31.89

—

Lipodystrophy, not elsewhere classified

0.00

0.0

1.8

—

34.34

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.0

1.2

—

35.90

—

Enterobiasis

0.00

0.0

1.5

—

35.83

—

Benign neoplasm: Vulva

1.02

0.00

1.3

1.2

32.38

33.53

g/l

—

Congenital hydrocephalus

0.00

0.0

1.8

—

29.94

—

Fractures involving multiple body regions

0.00

0.0

1.6

—

32.16

—

Vascular dementia (mixed)

0.99

0.00

1.2

1.5

27.03

28.76

g/l

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.00

0.0

1.3

—

28.38

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

2.0

—

34.38

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.4

—

32.20

—

Other hypertrichosis

0.00

0.0

1.2

—

29.00

—

Polyp of middle ear

0.00

0.0

1.2

—

37.44

—

Toxic encephalopathy

0.00

0.0

1.2

—

28.24

—

Pediculosis and phthiriasis

0.00

0.0

1.3

—

30.17

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.5

—

26.98

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.0

1.6

—

34.44

—

Pedal cyclist injured in collision with motor vehicle

0.91

0.00

1.3

1.4

37.16

33.59

g/l

—

Other and unspecified disorders of refraction

0.00

0.0

1.7

—

34.45

—

Calcium deposit in bursa

0.00

0.0

1.3

—

33.44

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

33.25

—

Nonadministration of surgical and medical care

0.00

0.0

1.8

—

30.04

—

Defect, injury or illness of face

0.00

0.0

1.6

—

34.92

—

Dysplastic lesion of the vagina of unknown severity

0.00

0.0

1.2

—

24.86

—

Urethritis and urethral syndrome

0.97

0.00

1.6

1.3

37.81

32.91

g/l

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.6

—

37.74

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS